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SCIENTIFIC OPINION 
Scientific Opinion on the scrapie situation in the EU after 10 years of 
monitoring and control in sheep and goats
1
 
EFSA Panel on Biological Hazards (BIOHAZ)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
To assess the effectiveness of the strategies implemented in the European Union (EU) to control Classical 
scrapie (CS), epidemiological data have been compared in the context of the efforts in terms of control measures 
applied over time. Official EU surveillance data and results from questionnaire surveys of EU Member States 
(MSs) have been used along with case studies. A spatio-temporal description of the occurrence of small 
ruminants TSEs in MSs in the period 2002-2012 is provided, with a particular focus on CS in sheep. Based on 
information collected from MSs, the potential effectiveness of breeding programmes for resistance to CS (BP-
CS) in the dissemination of resistance into the general sheep population has been assessed for those countries for 
which the CS trend analysis has been performed. CS in sheep was reported in 17 MSs (average prevalence: 
8.7 cases/10 000 tests), with heterogeneous trends and geographical distribution: among the 13 countries 
reporting a consistent number of cases, the trend analysis shows a statistically significant decreasing trend only 
for six of them. Variations in the implementation of genetic and non-genetic measures for the control of CS may 
explain the failure to improve the disease situation in the remaining seven MSs. At a national level, a reduction 
in CS seems to be linked to better-achieving BP-CSs. Control options applied to CS in sheep and goats indicate 
that a CS eradication policy that relies solely on the detection of infected flocks by post-mortem testing and 
subsequent depopulation would be unlikely to succeed. A minimum frequency of the ARR allele in a sheep 
population above which CS may be expected to fade-out could be estimated for each specific national sheep 
population. Recommendations for additional/alternative measures to control CS in sheep and goats are 
formulated. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following a request from the European Commission (EC), the EFSA Panel on Biological Hazards 
(BIOHAZ) was asked to deliver a scientific opinion on the scrapie situation in the European Union 
(EU) after 10 years of monitoring and control in sheep and goats. In particular, in order to evaluate the 
measures in place and assess the progress accomplished, the EC consulted EFSA to gain a better 
understanding of the dynamics of the epidemiological situation of Classical scrapie (CS) and Atypical 
scrapie (AS), and a retrospective analysis of the effectiveness of the control tools encompassed by EU 
legislation. 
The opinion provides background information in relation to CS and AS in sheep and goats, including 
information on the nature of the agents, genetic susceptibility of the hosts, transmission pathways and 
epidemiology of the diseases. 
Based on information from the EU TSE surveillance database, CS and AS in sheep and goats in the 
period 2002-2012 have been analysed to provide a spatio-temporal description of the occurrence of the 
diseases, after appropriate statistical adjustment accounting for the main known confounding factors. 
Due to the heterogeneity of the distribution of CS within the different EU Member States (MSs), and, 
to some extent, of the monitoring and control measures implemented, it was not considered 
meaningful to present an overall EU trend of the disease. Therefore, the temporal trends have been 
considered country-by-country. 
CS in sheep was reported in 17 MSs, with an overall average prevalence of 8.7 cases per 10 000 rapid 
tests performed. Both the temporal trend and geographical distribution of CS showed great 
heterogeneity across the MSs. Among countries reporting a sufficient number of cases of CS in sheep 
over the years, six MSs showed a statistically significant decreasing trend, and seven showed a trend 
not statistically different from a flat one. 
CS in goats was reported in eight MSs, with an overall prevalence of 9.8 cases per 10 000 rapid tests 
performed. This is mostly explained by the unique epidemic in one MS, while the overall prevalence 
in the remaining seven MSs was 2.2 cases per 10 000 rapid tests. A statistically decreasing trend was 
detected in one MS for the period 2002-2012, and in two more MSs for the period 2007-2012. 
Although it was not possible to identify causes that can explain objectively the failure to improve the 
situation of CS in some MSs, the assessment of country-specific data, obtained through ad hoc surveys 
to MSs, and related to the implementation of surveillance and of genetic and non-genetic control 
measures, allowed the formulation of some hypotheses. In the case of sheep, these included ineffective 
implementation of genetic and non-genetic measures for the control of the disease, whereas in goats 
these included the absence of genetic measures and the variability of the non-genetic measures 
applied. 
AS in sheep was reported in 21 MSs, with an overall prevalence of 5.8 cases per 10 000 rapid tests 
performed. A similar prevalence over time and space was observed, with no large epidemics, and only 
sporadic detection in five MSs. Only two MSs show a statistically significant trend, decreasing in one 
case and increasing in the other case. 
AS in goats was reported by five countries, at a very low prevalence and with no statistically 
significant trend in any of them. 
The different control options available for CS in sheep and goats are discussed. Firstly, non-genetic 
control measures are described, with the support of data from two case-studies in non-EU countries 
applying exclusively non-genetic measures for a period of time. Detection and eradication measures in 
affected flocks were effective in reducing the observed prevalence of CS in a population with a high 
prevalence of disease. However, it is concluded that, due to the pathogenesis and the epidemiological 
characteristics of CS, and to the high persistence of the CS agent in the environment, a CS eradication 
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policy that relies solely on detection of infected flocks by post-mortem testing and subsequent 
depopulation would be unlikely to succeed. 
Secondly, the use of genetic measures, i.e. breeding programmes for resistance to CS (BP-CS), is 
discussed. During the last ten years, BP-SC have been implemented by 17 MSs as a strategy to control 
the disease. Based on information collected from MSs, the potential effectiveness of these BP-CS in 
the dissemination of resistance into the general sheep population was assessed for those countries for 
which the CS trend analysis was performed. There was a clear heterogeneity in the characteristics of 
the BP-CSs implemented by the different MSs. There was also heterogeneity within MSs according to 
different geographical areas, ARR allele frequency in the general population prior to BP-CS 
implementation, breeds and production types. Given the characteristics of each national BP-SC, a 
deterministic model was used to estimate the ARR/ARR frequency in the general sheep population 
over time. Subsequently, the outputs of the model were compared with the national CS situations. The 
results obtained suggest that, at national level, a favourable reduction in CS seems to be linked to 
better-achieving BP-CSs. 
Given the very strong resistance to CS of sheep of the homozygote ARR genotype, one may expect 
that a minimum frequency of the ARR allele in a sheep population exists, above which CS may be 
expected to fade-out. Some case-studies are presented, showing that this hypothetical minimum 
frequency is not universal and that it is affected by parameters such as disease prevalence and the 
national characteristics of the sheep industry. In those cases studied, the required minimum frequency 
ranged between 53 % and close to 100 %, in a context where no additional control or eradication 
measures were applied. 
Additional/alternative measures to control CS in sheep and goats are recommended. These focus on: i) 
the improvement of surveillance and control measures and their adaptation to the individual MSs, ii) 
the reinforcement and improvement of the policy of breeding for resistance in sheep, iii) the 
introduction of breeding policies in goats, and iv) knowledge transfer on scrapie. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The situation of scrapie has been actively surveyed in the Member States since the implementation of 
a compulsory programme for the monitoring of TSEs in sheep and goats in 2002, on the basis of a 
random sampling of healthy slaughtered animals on one hand and fallen stock on the other. Targeted 
population and sample sizes have evolved over time. 
Mandatory eradication measures have simultaneously been enforced by Regulation (EC) No 
999/20014, hereafter designated as the TSE Regulation, in holdings where TSE cases were confirmed, 
combining culling, movement restrictions and reinforced surveillance measures. 
Recognising that some polymorphisms of the PRNP gene are associated with differences in the 
phenotypic expression of prion diseases in sheep (incubation period, physiopathology and clinical 
signs), several Member States have been implementing since the 1990s breeding programmes aimed at 
increasing the level of alleles associated with resistance (ARR) and decreasing the frequency of alleles 
associated with susceptibility (VRQ) in their sheep population. As of 2004, the EU made compulsory 
the introduction by the Member States of a breeding programme to be applied to the flocks of high 
genetic merit, until it became facultative again in 2007. 
This global strategy for monitoring and controlling TSEs in sheep and goats has now been in place for 
approximately 10 years. Among other goals, one of its underlying objectives is the eradication of 
Classical scrapie in EU population of sheep and goats. Today, the situation of Classical scrapie 
appears to be heterogeneous among the Member States, with no clear trend perceived by the 
Commission with regards to the evolution of its prevalence rate at the scale of the European Union. In 
order to assess the progress accomplished and evaluate the measures in place, the Commission needs a 
better understanding of the dynamics of the epidemiologic situation of Classical scrapie, and a 
retrospective analysis of the efficiency of the control tools foreseen by the TSE Regulation. There is a 
similar need for a better understanding of the dynamics of the Atypical scrapie situation in the EU. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
EFSA is requested to provide a scientific opinion on the following questions: 
1. On the basis of the results of the TSE monitoring programme laid down in the TSE Regulation, 
what is the trend since 2002 of the situation of Classical scrapie and Atypical scrapie in sheep and 
in goats respectively, in the EU as a whole and in the 27 Member States individually? Where no 
favourable trend can be observed, what are the identifiable causes for failure to improve the 
situation of Classical scrapie? 
2. Has the evolution of the Classical scrapie situation been statistically different in the MS which 
have implemented a breeding programme from 2004 to 2011 compared to the MS without a 
breeding programme in the same period? 
3. On the basis of the above analysis, can a minimum level of frequency of the ARR allele in the 
sheep population in a MS be defined or estimated above which Classical scrapie can be expected 
to fade-out, in a context where no control and eradication measure is being applied? 
4. In a context where no breeding programme is implemented, are the present mandatory measures in 
terms of active monitoring, eradication and control of Classical scrapie effective to achieve a 
decline of this disease and its eradication on the long term? 
5. What additional measures can EFSA recommend in view of achieving the eradication of Classical 
scrapie in the MS? 
                                                     
4  Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for 
prevention, control and eradication of certain transmissible spongiform encephalopathies. 
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ASSESSMENT 
1. Introduction 
1.1. Approach to answer to the terms of reference 
The different Terms of Reference (ToRs) of the mandate for the present Scientific Opinion are tightly 
linked, and the answers to the single ToRs often need consideration of aspects dealt with when 
replying to the others. For example, as explained later in detail, the observed epidemiological trends of 
the disease depend on a series of factors, obviously including the control measures implemented at 
international, national, and local level. Consideration to the latter thus needs to be given in order to 
discuss the observed trends and the potential reasons for the positive or not positive evolution of 
scrapie (ToR 1). On the other side, there is a need to first analyse the evolution of Classical scrapie 
(CS) to allow the comparison of the trend of the disease in countries implementing or not certain 
control measures (ToR 2). 
This first chapter of the Opinion aims at providing some background information in relation to CS and 
Atypical scrapie (AS) in sheep and goats, including information on the nature of the agents, genetic 
susceptibility of the hosts, transmission pathways and epidemiology of the diseases. 
The second chapter presents the legal background for the monitoring and surveillance of 
Transmissible Spongiform Encephalopathies (TSEs) in small ruminants in the European Union (EU), 
and the data gathered by Member States (MSs) and the European Commission. It discusses in detail 
the sensitivity of the EU monitoring system, and the factors that affect surveillance. This is expected to 
provide useful background to inform the assessment of the scrapie trends in the EU. 
The analysis of the trends of both CS and AS in sheep and goats is presented in the third chapter of the 
Opinion. A spatio-temporal description of the occurrence of the diseases is provided, after appropriate 
statistical adjustment accounting for the main known confounding factors. Due to the heterogeneity of 
the distribution of CS within the different EU MSs, and, to some extent, of the characteristics of the 
monitoring and control measures implemented, it would not be meaningful to present an overall EU 
trend of the diseases, and therefore the trends are to be analysed and discussed country-by-country, 
assessing, when data allow, the evolution of the disease over the years. This chapter provides useful 
information to answer the first part of ToR 1. Potential reasons for the absence of a decreasing trend, 
which answers the second part of ToR 1, are discussed later in the opinion (i.e. in Chapter 4), since 
there is a need to first consider in detail the measures implemented to control the disease. 
Chapter 4 focuses on the control options available for CS in sheep and goats, differentiating and 
discussing genetic and non-genetic measures. Firstly, non-genetic control measures are described, with 
the support of data from two case-studies in non-EU countries applying exclusively non-genetic 
measures for a period of time. Conclusions from these case-studies are used to provide an answer to 
ToR 4 of the mandate. 
Secondly, the use of genetic breeding programmes for resistance to CS (BP-CS), as a strategy to 
control the disease implemented in many EU MSs in the last ten years, is discussed. ToR 2 asks for a 
comparison of the evolution of the CS situation between MS having or not having implemented a BP-
CS. However, since there were no MSs without a BP-CS with sufficient cases of CS in order to 
estimate a trend, such comparison was not possible. Therefore, based on information collected from 
MSs, the potential effectiveness of BP-CS in the dissemination of resistance into the general sheep 
population was assessed for those countries for which the CS trend analysis was performed. 
Subsequently, the evolution of the CS situation between MSs, depending on the potential effectiveness 
of their BP-CS, was compared. 
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The answer to ToR 3 of the mandate is also provided in Chapter 4, making use of case-studies 
(countries or regions) to discuss the possibility to define a minimum frequency of the ARR allele in a 
sheep population above which fade-out of CS is expected. 
Finally, as requested in ToR 5, the last part of Chapter 4 includes a series of recommendations for 
additional/alternative measures to control CS in sheep and goats, based on the current state of 
knowledge. All information and conclusions discussed in earlier parts of the document are used to 
substantiate the recommendations formulated. 
1.2. Classical scrapie 
1.2.1. Background 
Scrapie in small ruminants is the archetype of the TSEs, or prion diseases, and has been recognised as 
a disease in sheep and goats for almost 300 years although many aspects of the disease are still poorly 
understood. It was reported for the first time in sheep in the United Kingdom in 1732 and a few years 
later, in 1759, in Germany. Since then, scrapie has become endemic in the national flocks of several 
countries (Detwiler, 1992). CS has also been reported as a naturally-occurring disease in goats since it 
was first described in France in the 1940s (Chelle, 1942).  
TSEs in small ruminants are characterized by long asymptomatic incubation periods that usually range 
between two and seven years, during which time infected animals are a potential source of 
contamination (vanKeulen et al., 1996; Andreoletti et al., 2002a; Baylis et al., 2004). The disease is 
thought to have spread across the world through the export of asymptomatic infected animals (for 
review see Detwiler and Baylis (2003)). 
1.2.2. Genetic susceptibility 
CS is an infectious disease of small ruminants for which the susceptibility is strongly influenced by 
different polymorphisms of the PRNP gene that encodes for prion protein (PrP). In sheep the 
polymorphism at codons 136 (A or V), 154 (R or H) and 171 (R, Q or H) have been demonstrated to 
be of major importance (Clouscard et al., 1995; Hunter et al., 1996). Under natural exposure 
conditions VRQ/VRQ, ARQ/VRQ and ARQ/ARQ genotype animals are considered to be the most 
susceptible to CS, whereas homozygous or heterozygous AHQ and heterozygous ARR animals only 
show a marginal susceptibility. ARR/ARR sheep are considered to be strongly (but not absolutely) 
resistant to CS (Elsen et al., 1999; Groschup et al., 2007). Beside these three major polymorphisms 
other polymorphisms like the K176 or the T137 have more recently been recognized to be associated 
with resistance to CS infection (Vaccari et al., 2009b), and experimental studies have identified a 
resistance to Bovine Spongiform Encephalopathy (BSE) in sheep with the T112  polymorphism 
(Saunders et al., 2009), although the significance of this substitution for CS susceptibility has not been 
established.   
In goats, the information related to PrP polymorphisms associated with susceptibility to CS is more 
limited than for sheep, and the data available for naturally-infected goats have mainly resulted from 
field studies (Gonzalez et al., 2009; EFSA, 2012; Corbiere et al., 2013a; Ortiz-Pelaez et al., 2014b) 
that yielded small numbers of positive animals. The goat PRNP gene is highly polymorphic, but many 
of the polymorphisms have been observed only in one or two countries. However, eight out of the 29 
reported amino acid changes seem to have worldwide distribution (by haplotype ranking, from most 
common: P240, R143, S127, H154, K222, Q211, M142, S146) and at least five of these have been 
suggested to be associated with TSE susceptibility (Vaccari et al., 2009a). Case/control studies carried 
out in Italy and France have demonstrated a potentially highly protective effect of the K222 allele 
(Acutis et al., 2006; Vaccari et al., 2006; Barillet et al., 2009; Corbiere et al., 2013a) against CS. This 
view was recently reinforced by the apparent resistance of animals with the K222 allele to infection 
following experimental challenge with a CS isolate (Acutis et al., 2012). Similarly, the Q211 allele has 
been associated with an increase in resistance to CS in infected French herds (Barillet et al., 2009; 
Corbiere et al., 2013a). The H154 allele has also been associated with some level of resistance to CS 
Scrapie situation in the EU
 
EFSA Journal 2014;12(7):3781 9
in studies carried out in Greece, France, Italy and Cyprus (Billinis et al., 2002; Vaccari et al., 2006; 
Barillet et al., 2009; Corbiere et al., 2013a). Studies conducted in Cyprus support the view that S146 
and D146 polymorphisms of the PRNP gene are likely to be associated with substantial resistance to 
CS in goats naturally exposed to disease (EFSA, 2012; Ortiz-Pelaez et al., 2014b). This contention 
was further supported by the results of an experimental challenge of S146 allele carriers goats 
conducted in the United States of America (USA) (White et al., 2012). 
Until  relatively recently scrapie was thought to be a ’slow virus’ disease, which was passed through 
familial lines, and disease control within a flock centred on the culling of maternal lines. Given what is 
now known on genetic susceptibility, it is not surprising that this method was successful in limiting the 
disease within a flock.   
In addition to the importance of individual genetic susceptibility, it has been suggested that the risk of 
CS occurrence may also be associated to the flock-level PrP genotype profile (Baylis et al., 2000; 
McIntyre et al., 2008b; Tongue et al., 2009; Ortiz-Pelaez and Bianchini, 2011). 
1.2.3. Agent diversity 
Despite the relative uniformity of the clinical signs in the natural host, CS can be caused by TSE 
‘strains’ with different biological features. Historically, the appreciation of the potential diversity of 
the scrapie agent has relied on the serial passaging of natural isolates to a panel of inbred mouse lines. 
The strains that preferentially replicated in the mice were isolated and their biological phenotypes 
compared. However, the considerable strain variations initially described in these experimental 
situations (up to 20 strains (Dickinson, 1976)) might finally be considered to be representative of the 
three main distinct strains which can be recognised in a single wild-type mouse line (Bruce et al., 
2002). The relationship between these mouse-adapted TSE agents and those initially present in the 
TSE field isolates is a matter of debate. The propagation of natural TSE isolates into inbred wild-type 
mouse lines requires passage through a species/transmission barrier that can result in differing 
outcomes depending on the donor/recipient combinations, including changes in the biological 
properties of the agent. Moreover, wild-type mice have been described to be refractory to some TSE 
isolates, such as CH1641 (Foster and Dickinson, 1988) and ‘Suffolk’ scrapie (Thackray et al., 2012), 
and to AS (see below) (Le Dur et al., 2005; Bruce et al., 2007). In that context it is clear that the 
conventional wild-type mouse models do not provide a comprehensive and reliable picture of the 
diversity of the TSE agents in small ruminants, although transgenic mice are proving to be susceptible 
to a wider range of TSEs, enabling more comprehensive characterisation of strains (Thackray et al., 
2012). 
There are many similarities between CS in sheep and goats with regard to clinical signs, pathogenesis 
and pathology, but less is known about the biological diversity of the TSE agents causing disease in 
goats. It has been established experimentally that goat CS isolates can affect sheep (Konold et al., 
2013a) but there has been no systematic assesssment of how much, if any, cross-species transmission 
may occur in a mixed population. 
1.2.4. Disease pathogenesis 
According to studies on the pathogenesis of CS in naturally infected sheep, which focus 
predominantly on VRQ/VRQ sheep born and raised in two individual flocks (one in the Netherlands 
and one in France), infection apparently occurs via the Gut Associated Lymphoid Tissues (GALT) 
before a rapid spread of the agent to draining mesenteric lymph nodes and later to all lymph nodes, 
including those that remain on prepared carcasses (Andreoletti et al., 2000; van Keulen et al., 2000; 
van Keulen et al., 2008). The amount of PrPSc in lymphoid formations increases with age before 
reaching a plateau level. The TSE agent spreads to the central nervous system (CNS) (brain and spinal 
cord) where PrPSc can be shown to accumulate from around half way through the incubation period. 
This neuroinvasion apparently occurs via the enteric nervous system and its nerve fibres (Andreoletti 
et al., 2000; van Keulen et al., 2000), although haematogenous spread has also been proposed as a 
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contributory/alternative route (Siso et al., 2009). From there the agent redistributes (centrifugally) to 
the peripheral nervous system and skeletal muscle (Andreoletti et al., 2004). In blood, infectivity and 
PrPSc can be detected as early as at three months of age, and persist throughout the incubation period 
(Lacroux et al., 2012). This pattern of dissemination is consistent with most of the data reported with 
regard to natural CS cases. However VRQ/VRQ is considered to be the most susceptible/permissive 
sheep PrP genotype for the majority of CS strains (Baylis et al., 2004; Hagenaars et al., 2010). In 
sheep bearing other PrP genotypes the kinetics of agent distribution  in affected animals can vary 
substantially. For example, in heterozygote ARR sheep and under natural exposure conditions, the 
PrPSc distribution seems to be mostly confined to the CNS (vanKeulen et al., 1996; Andreoletti et al., 
2002b). Additionally, in several CS cases in ARQ/VRQ and ARQ/ARQ sheep (Jeffrey et al., 2002; 
Ligios et al., 2006) PrPSc accumulation in the CNS has been reported in the absence of detectable PrPSc 
in the lymphoid tissues. Experimental studies confirm the observations from natural disease that 
amplification and accumulation of PrPSc occurs in LRS tissues, and is host genotype dependent 
(Gonzalez et al., 2014a), but does not necessarily have a marked effect on the outcome of the infection 
(Gonzalez et al., 2014b). Meta-analysis of data from ARR/ARR sheep confirms that these animals are 
extremely resistant to challenge with CS (Jeffrey et al., 2014). 
In goat the kinetics of agent distribution in the organs of affected animals can vary substantially 
depending on PRNP genotype, including cases in which PrPSc accumulation in the central nervous 
system was reported in the absence of detectable PrPSc in the lymphoid tissues (Gonzalez et al., 2009).   
1.2.5. Exposure and transmission 
It is still unclear precisely which sources of infectivity and routes of transmission are possible, and 
which have the greatest effect on the spread and maintenance of infection in a population.  
It is uncertain if true vertical transmission can occur. Although there are no data providing direct 
demonstration of germ cell involvement, data recently reviewed in the context of the EFSA Opinion 
on the risk of transmission of CS via in vivo derived embryo transfer in sheep (EFSA BIOHAZ Panel, 
2013) reinforce the view that CS could be vertically transmitted. Recent improvements in PrP 
detection methods have led to the demonstration of disease-associated PrP in foetuses from CS-
infected ewes, indicating the potential for in utero infection (Carmen Garza et al., 2011). Infectivity 
has also been detected by bioassay in the mesenteric lymph node of a foetus from a CS-affected ewe 
(Spiropoulos et al., 2014). 
It is commonly hypothesised that under conditions of natural exposure, infection with CS mainly 
occurs around birth (maternal transmission) and that placenta, which can accumulate large amounts of 
prions in incubating animals, plays a major role in this process (Race et al., 1998; Tuo et al., 2002; 
Lacroux et al., 2007; O'Rourke et al., 2011). For specific flock-level outbreaks this hypothesis has 
been supported by epidemiological evidence for exposure and/or susceptibility declining with age 
(Matthews et al., 2001; Nodelijk et al., 2011) and for increased transmission during lambing (Touzeau 
et al., 2006). It has been shown that disposing of the placenta in the compost and spreading sheep 
compost on the land were associated with increased probability of scrapie in a sheep flock (Healy et 
al., 2004). Moreover a seasonality in the occurrence of the disease has also been associated with 
lambing time (McIntyre et al., 2008b). The genotype of the foetus is pivotal in determining the extent 
to which PrP can accumulate in the placenta so a breeding for resistance programme can lead to a 
distinct improvement on this aspect of disease control very quickly, by reducing the potential amount 
of infectivity produced by this route by infected animals (Andreoletti et al., 2002a).  
Milk has also been demonstrated to be a route of transmission from dam to lamb. Both colostrum and 
milk were shown to contain infectivity and their capacity to transmit disease to suckling lambs was 
demonstrated (Konold et al., 2008; Lacroux et al., 2008; Konold et al., 2013b). The results obtained in 
these studies clearly demonstrated that even a limited amount of colostrum/milk from CS infected 
ewes is able to transmit CS to genetically susceptible lambs. Lympho-proliferative mastitis seems to 
enhance the efficacy of the transmission; nevertheless colostrum/milk collected from ewes displaying 
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an apparently healthy mammary gland was also efficient in transmitting the disease. The presence of 
infectivity in goat milk has also been recently confirmed (Konold et al., 2013b). 
It has been shown in scrapie and other TSEs (i.e. Chronic Wasting Disease) (Gough and Maddison, 
2010) that faeces, urine and saliva can all carry infectivity, but the extent to which these contribute to 
the spread of scrapie in commercial situations is not clear. It is thought that faecal shedding is likely to 
be linked to the accumulation of PrPSc in the GALT of susceptible animals, which then acts as a source 
of infectivity which could be shed in the faeces. It is well-established that peripheral accumulation of 
PrPSc is very strongly associated with genotype, with widespread dissemination of PrPSc in the most 
susceptible genotypes. The presence of a resistant allele in a heterozygous animal, while not effective 
at preventing disease, will greatly reduce the peripheral accumulation of PrP and, by 
assumption/extrapolation the extent to which that animal represents a source of infection for its flock 
mates. 
CS infectivity is very robust, and cannot readily be inactivated by standard microbiological 
disinfection procedures. Once shed into the environment TSE agents have been shown to resist to 
degradation over long periods in soil (Genovesi et al., 2007; Wiggins, 2009; Smith et al., 2011). There 
is also evidence of environmental persistence on farm equipment such as pens and troughs, in addition 
to pasture (Maddison et al., 2010). 
1.2.6. Epidemiology 
Disease can be introduced into populations by the movement of animals (Palsson, 1979; Healy et al., 
2004; McIntyre et al., 2008b) and it has also been established that healthy adult animals introduced 
into a flock and/or a contaminated environment can develop disease, without exposure to lambing 
environments or close familial contact (Detwiler and Baylis, 2003; Ryder et al., 2004; Dexter et al., 
2009). It has also been demonstrated under controlled conditions that close contact between infected 
and naive animals (even at an early preclinical stage) results in effective transmission between animals 
of susceptible genotype (Konold et al., 2008; Ryder et al., 2009). The efficacy of such lateral 
transmission appeared to be lower in older animals than in younger animals. The mechanism 
underlying such transmission remains unclear and both inter-individual horizontal transmission and/or 
environmental sources could be at their origin. However in general the occurrence of the disease has 
been associated with large flock size, which may increase the probability of interindividual contacts 
(Healy et al., 2004; McIntyre et al., 2008b; Stevens et al., 2009).  
A key management strategy for individual on-farm disease reduction has been to maximise lambing 
hygiene, and reduce as much as possible the contact between animals and placental debris post-partum 
(Dexter et al., 2009).  
Iatrogenic TSE transmissions in sheep have also been reported on several occasions. In the UK, brain, 
spinal cord and spleen tissues from young sheep were used to produce an inactivated vaccine against 
ovine encephalomyelitis or ‘louping-ill’ (Flavivirus). The administration of this vaccine was identified 
as the cause of scrapie outbreaks in a number of flocks (Gordon, 1946). More recently, in Italy, several 
hundred CS cases were observed in sheep and goats that had been vaccinated against Mycoplasma 
agalactiae with a vaccine produced using homogenised, filtered ovine brains, mammary glands and 
lymph nodes (Capucchio et al., 1998): recently a cohort study confirmed the impact of this iatrogenic 
transmission on the spread of CS in Italy (Bertolini et al., 2012).  
The within-flock prevalence of CS is affected by all of the parameters discussed above. Very high 
prevalence can be obtained in experimental flocks where a high proportion of susceptible genotypes 
are actively maintained, and husbandry practices favour the spread of infection (Elsen et al., 1999; 
Dexter et al., 2009). The estimation of individual within-flock prevalence depends on the selected 
flocks and the follow-up period during which positive cases were confirmed. In some cases it is not a 
real prevalence of infection (proportion of positive animals at one point on time). The results obtained 
by monitoring infected flocks may be different from the estimates derived from surveillance data.  In 
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one longitudinal  study of 15 individual commercial infected sheep flocks, the flock-level prevalence 
estimates varied from 0 to 15·4 per cent when culled animals were screened by immunohistochemistry 
(IHC) for evidence of infection (Tongue et al., 2005). McIntyre et al. (2008b) identified 415 cases of 
CS in 30 infected  flocks, with numbers of cases per flock varying from 1 to 131, with seven flocks 
having only a single case of CS. Using the snapshot of 213 infected flocks at the time of cull and 
testing, as part of compulsory eradication measures, an average of 0.65 %  of tested sheep presented 
detectable infection by the available approved diagnostic methods at the time of testing; 68.5 % of the 
flocks did not have any other case (prevalence 0 %) and 22 % of the flocks had a within-flock 
prevalence higher than 1 % (maximum of 8.5 %) (Ortiz-Pelaez and Del Rio Vilas, 2009). In all cases 
the variability of within-flock prevalence was very high. A similar wide range of within-herd 
prevalence has also been reported in goats in several countries (Gonzalez et al., 2009; Corbiere et al., 
2013a; Ortiz-Pelaez et al., 2014b), as discussed in more detail in Section 2.4.5. 
Reducing  the spread of CS based on primary prevention would require the elimination of the main 
risk factors. Unfortunately it is very difficult to reduce or eliminate the exchange of animals between 
farms, to decrease the size of flocks or even act on the age distribution of the animals. Moreover 
within flocks effective disease control is very complex, and needs to take into account the sources of 
contamination, effectiveness of cleaning/decontamination procedures, and the restriction of exposure 
of susceptible animals to such sources. The most powerful tools presently available for disease control 
in any flock which is not disease-free and closed are the effective identification and removal of 
infected animals, and, in the case of sheep, the control of the genetic composition of the flock, i.e. the 
methods covered by the current regulations. For a field study showing the success of selective 
breeding to control CS at the flock level see Nodelijk et al. (2011). Mathematical modelling studies 
have been applied to data of within-flock outbreaks and of data at national-flock level, yielding a 
range of epidemiological insights (for a review see Gubbins et al. (2010)). Concerning within-flock 
outbreaks, some of the insights might be outbreak specific. More generic insights include the 
following: 
- The duration of within-flock CS outbreaks is of the order of 5 years or longer.  
- Most cases arise through horizontal transmission (as opposed to vertical transmission). 
- The hypothesis of increased transmission during lambing has been supported by an analysis of 
CS incidence in French study flock. 
Concerning the national-flock level, modelling has been used to estimate infection levels from 
detected case prevalence, and to assess the efficacy of control strategies including the impact of 
selective breeding.  General insights include: 
- Trading restrictions have a limited impact on controlling CS transmission risks as compared to 
selective breeding and culling. 
Many infected sheep do not survive to show clinical signs, and a large proportion of cases remains 
undetected/unreported to passive surveillance. 
1.3. Atypical scrapie 
1.3.1. Background 
In 1998, the definition of ovine TSEs was extended by the discovery, in Norway, of an experimentally 
transmissible, PrP-related, neurological disease of sheep that was clearly distinguishable from the CS 
cases that had been reported so far. It was therefore considered to be an ‘atypical’ form of scrapie, also 
named ‘Nor98’ scrapie (Benestad et al., 2008). Following its recognition in sheep, AS was also 
detected in goats in France (Le Dur et al., 2005; Arsac et al., 2007), Spain (Vaccari et al., 2009a), 
Switzerland (Seuberlich et al., 2007)  and Italy (Colussi et al., 2008).  
Scrapie situation in the EU
 
EFSA Journal 2014;12(7):3781 13
1.3.2. Genetic susceptibility 
Importantly, the susceptible genotype range is also different from CS, with the genotypes most 
resistant to CS occuring frequently in the atypical population and vice versa. While a clearly increased 
risk for developing AS is associated with AF141RQ and AHQ alleles, the VRQ allele seems to be at 
lower risk. Strikingly ARR allele carriers (both homozygous and heterozygous) can develop the 
disease (Moum et al., 2005; Arsac et al., 2007; Moreno et al., 2007). The differences in observed 
susceptibility of  small ruminants to classical and AS illustrate that successful infection with TSE is 
strongly influenced by the nature of the agent involved, and the genetics of the host. The relative 
effectiveness of CS control measures means that AS is now more common in some populations than 
CS.  
Affected goats from France and Switzerland carried the H154 mutation, and an Italian case control 
study demonstrated that the H154Q222S240 allele is a risk factor for AS (Colussi et al., 2008). This allele 
is homologous to the ovine AHQ allele, which is associated with high susceptibility to AS in sheep, 
suggesting that the agent–host interaction is similar in the two species. Mutation L141F, associated with 
very high risk of AS in sheep, or any other mutation at codon 141, has not been reported in the caprine 
PRNP gene. 
1.3.3. Agent diversity 
In AS cases the abnormal PrPSc that accumulates in the brain of positive animals is only partially 
proteinase K (PK) resistant (Buschmann et al., 2004) and displays a multi-band pattern as shown by 
Western blot (WB) that contrasts with those normally observed in small ruminant TSE cases 
(Benestad et al., 2003). The pathology of AS is also unique (Moore et al., 2008). However, unlike CS, 
the biological properties of these atypical TSE isolates (regardless of host genotype) are very 
consistent, even in experimental rodent assays (Le Dur et al., 2005; Griffiths et al., 2013).  
1.3.4. Disease pathogenesis 
The pathogenesis of AS remains poorly documented. Abnormal PrP has never been demonstrated in 
peripheral tissues collected from field cases or experimental cases (Andreoletti et al, 2011; Benestad et 
al, 2008; Simmons et al., 2011). However, recent information obtained in both natural and 
experimental atypical cases demonstrated that low levels of infectivity can be present in skeletal 
muscle, peripheral nerves and lymphoid tissues of affected animals in the absence of detectable PrPSc 
(Andreoletti et al., 2011; Simmons et al., 2011).  
1.3.5. Exposure and transmission  
The apparent restriction of the infectious agent to the CNS has been widely interpreted to be 
supportive of the hypothesis that AS could be a spontaneous disorder of PrP folding and metabolism, 
occurring in aged animals without external cause (Benestad et al., 2008). In addition, no statistical 
difference in the detectable AS prevalence was observed between the general population and the 
flocks where a positive case had been identified (Fediaevsky et al., 2010), indicating that it does not 
present, epidemiologically, like an infectious disease. This has been interpreted as evidence that AS 
may not be contagious at all. 
While the contagiousness of AS under natural conditions is still debated, the transmissibility of the AS 
agent by the intracerebral route is clearly established in both rodent models (transgenic animals over-
expressing the ovine PrP gene (Le Dur et al., 2005)) and in sheep (Simmons et al., 2007; Simmons et 
al., 2010). Data from an oral challenge study in sheep also indicate that very early  exposure (within 
24 hours of birth) can lead to transmission of the disease, resulting in clinically affected animals  
displaying a similar clinic-pathological pattern to those observed in natural cases (Simmons et al., 
2010). It is probably too early, therefore, to conclude if this is a spontaneous, non-contagious disorder 
or if it can behave like other TSE agents circulating in small ruminants. 
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1.3.6. Epidemiology 
The clinical features observed in AS differ significantly from those observed in CS affected sheep 
(Konold et al., 2007) which may account for the low suspect referral rate, as might the average age at 
onset, with atypical cases usually presenting at a substantially older age (more than 6 years old) than 
CS cases (Benestad et al., 2008).  
Following the introduction of active surveillance of fallen stock and healthy slaughter populations, AS 
has been identified as occurring at a low but very consistent prevalence in small ruminant populations 
in which there has been screening. It has been found in populations in which CS has not been reported, 
such as the USA and Canada (Benestad et al., 2008), and more recently also in Australia and New 
Zealand (Kittelberger et al., 2010), two countries that had so far been considered by the OIE as TSE 
free. A retrospective study carried out in tissues banks allowed the identification of atypical cases in 
sheep samples collected in UK as far back as 1987 (Webb et al., 2009).  The analysis of data collected 
through the epidemio-surveillance system in the UK between 2002 and 2006 suggests that AS 
prevalence in this population could have remained stable over this period (McIntyre et al., 2008a; 
Ortiz-Pelaez and Arnold, 2013). Together these elements suggest that this form of disease might have 
been present but undetected in the small ruminant population at least for several decades. 
AS now represents a substantial proportion of the TSE cases identified in the EU small ruminant 
population. Several studies described the apparent prevalence of AS in sheep slaughtered for human 
consumption (healthy slaughtered animals) or collected as fallen stock. In a study between 2002 and 
2007 that included 11 European countries, the mean prevalence of this disease was estimated to reach 
5.5 cases per ten thousand in abattoir surveillance, and 8.1 cases per ten thousand in fallen stock 
(Fediaevsky et al., 2010). The apparent prevalence of AS in sheep did not present with any important 
variations between countries (Fediaevsky et al., 2008) or over time (Fediaevsky et al., 2008; McIntyre 
et al., 2008a). However, these values are likely to be underestimates of the real situation. Indeed a 
recent study provided evidence that samples from the central nervous system containing high 
infectious titre (as assessed by bioassay) could remain negative in the tests currently used in active 
surveillance programs for the detection of PrPSc in field cases (Andreoletti et al., 2011). This suggests 
that a significant number of animals which may be incubating AS would remain undetected even when 
tested. 
1.4. Concluding remarks 
• TSEs in small ruminants have a long asymptomatic phase, during which animals can circulate in 
the population. 
• With regards to CS: 
- Susceptibility is strongly influenced by different polymorphisms of the PRNP gene. In sheep, 
the A136R154R171 allele provides substantial resistance to the infection in both heterozygote and 
homozygote animals. In goats, the K222, the S146 and the D146 alleles also provide substantial 
resistance to infection. 
- CS can be caused by TSE ‘strains’ with different biological features. There are many 
similarities in the clinical signs, pathogenesis and pathology of CS in sheep and goats, but less 
is known about the biological diversity of the TSE agents causing disease in goats.  
- Detection of infected animals and the resultant sensitivity of active surveillance are dependent 
on the PrPSc distribution within each animal: 
 In the most susceptible genotypes, initial infection occurs via the gut-associated 
lymphoid tissues, then other lymph nodes. The agent spreads to the brain and 
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spinal cord approximately half way through the incubation period, and from there 
redistributes centrifugally to the peripheral nervous system and skeletal muscle.  
 In other PRNP genotypes the kinetics of agent distribution  in affected animals 
can vary substantially. PrPSc accumulation in the nervous system has been 
reported in the absence of detectable PrPSc in the lymphoid tissues. 
- Horizontal transmission is considered to be the main route of transmission, through exposure 
to oral infection (e.g. mainly via placentae or milk from infected animals) or to contaminated 
environments. It is still unclear precisely which sources of infectivity and routes of 
transmission are possible, and which have the greatest effect on the spread and maintenance of 
infection in a population. 
- The genotype of the foetus is pivotal in determining the extent to which PrP can accumulate in 
the placenta so a breeding for resistance programme can lead to a distinct improvement on this 
aspect of disease control very quickly. 
- Infected asymptomatic individuals can also disseminate the infectious agents to susceptible 
offspring and other in-contact animals, and the environment, where the agent can persist for 
long periods. 
- Animal movements, flock size and age are important risk factors, but are difficult to address 
by preventive measures. 
- Disease prevalence in affected flocks is extremely variable. 
- The most powerful tools presently available for disease control in any flock which is not 
closed, and disease-free, are the effective identification and removal of infected animals and 
the control of the genetic composition of the flock, i.e. the methods covered (for sheep) by the 
current EU legislation. 
• With regard to AS: 
- The genotypes most resistant to CS occur frequently in the AS-infected population. The H154 
mutation is considered to be a risk factor for AS in goats. The H154Q222S240 allele is 
homologous to the ovine AHQ allele, which is associated with high susceptibility to AS in 
sheep, suggesting that the agent-host interaction is similar in the two species. 
- The biological properties of atypical TSE isolates (regardless of host genotype) are very 
consistent. 
- The late age at onset and the relative protease sensitivity of the atypical PrP limits the 
sensitivity of AS case detection through current surveillance programmes. 
- AS pathogenesis is poorly documented. PrPSc has never been demonstrated in peripheral 
tissues but low levels of infectivity can still be present in skeletal muscle, peripheral nerves 
and lymphoid tissues of affected animals. 
- AS does not present, epidemiologically, like an infectious disease. This has been interpreted as 
evidence that it may be a spontaneous disease of older animals, and not contagious. However, 
disease can be transmitted experimentally by the oral route.  
- AS has been identified as occurring at a low but very consistent prevalence in every small 
ruminant population in which there has been screening. Retrospective surveys suggest that this 
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form of disease might have been present but undetected in the small ruminant population for 
several decades at least. 
- AS has been found in populations in which CS has not been reported. 
2. Monitoring of TSEs in small ruminants 
2.1. EU legal background 
Legislation related to TSEs in the EU was enforced as a consequence of the emergence of BSE in 
cattle in the UK in the late 80s. The first legislative act linked to TSE dates back to 1989 and 
established trade restrictions of certain live cattle from the UK to the other MSs5. Other measures were 
progressively implemented in the EU, especially linked to cattle BSE, in order to prevent and limit the 
spread of the disease to ruminants (e.g. feedban, measures applied to suspect and confirmed TSE 
cases, trade restrictions) and to humans (e.g. removal of specified risk material (SRM) from animals 
slaughtered for human consumption). 
Whereas BSE was included in the  the Community list of animal diseases subject to notification as 
early as 1990, scrapie became a compulsorily notifiable disease in all MSs in 1993 (Council Directive 
91/68/EEC). Requirements for the detection of both BSE in cattle and scrapie in ovine and caprine 
animals were first established in 1998 (Decision 98/272/EC), focusing on animals showing clinical 
signs compatible with TSE and on certain categories of high risk animals (i.e. animals originating 
from countries with indigenous TSE, animals consuming potentially contaminated feedstuffs, and 
animals with TSE-infected parents). This Decision also introduced into the EU legislation the 
obligation to notify to the competent authorities, the suspected presence of any TSE in any animal 
species. 
The key piece of legislation integrating all measures for the prevention, control and eradication of TSE 
Regulation (EC) No 999/2001 (‘TSE Regulation’), dates back to 2001, which, after many subsequent 
amendments, is still in force today. The TSE Regulation sets out the framework for all the measures 
related to the prevention and control of scrapie in the EU, including notification and monitoring of 
animal TSE, the feed ban, SRM removal, movement restrictions and other measures for suspect and 
confirmed cases, and the placing on the market of animal products. 
The monitoring systems for scrapie in sheep and goats have evolved over the years. Initially the only 
testing was of animals showing scrapie-like symptoms, but from 2002 sample-based surveys (active 
surveillance) were implemented in two (Regulation (EC) No 1248/2001) additional categories of small 
ruminants: healthy animals slaughtered for human consumption (SHC) and animals not slaughtered for 
human consumption (fallen dead on farm) (NSHC) over 18 months of age, to be tested using  a rapid 
screening test and a confirmatory test.  
The introduction into the legislation of the use of discriminatory tests to differentiate BSE from 
scrapie in positive TSE cases in small ruminants dates back to 2005 (Regulation (EC) No 36/2005). 
During the same year a goat was confirmed positive for BSE in France (Eloit et al., 2005). As a result, 
TSE testing requirements for goats were increased in the EU. A similar increase in TSE tests to be 
carried out in sheep was implemented in 2006, due to the identification of two possible BSE-like cases 
in sheep in France and one in Cyprus, which were subsequently confirmed to be scrapie rather than 
BSE6 . In the absence of further BSE positive findings in sheep or goats, the target for TSE testing was 
decreased again in both species in 2007. In the same year, the requirement to differentiate between CS 
and AS cases was introduced into the EU legislation. Currently, the number of tests to be carried out in 
both sheep and goats over 18 months of age is dependent on the adult population size, with a 
requirement to test up to 10 000 representative samples for each species and risk category in MSs with 
                                                     
5  Commission Decision 89/469/EEC of 28 July 1989 concerning certain protection measures relating to bovine spongiform 
encephalopathy in the United Kingdom, OJ L 225, 3.8.1989, p.51. 
6  See: http://europa.eu/rapid/press-release_IP-06-288_en.htm 
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populations larger than 750 000. Additional samples are required from animals belonging to infected 
flocks culled following compulsory eradication  measures, and, voluntarily, in other categories of 
animals. 
2.2. Information to be reported in the EU TSE Database 
The TSE Regulation requires all  EU MSs to submit a yearly report to the Commission including  the 
results of the monitoring of TSE in ruminants. The Commission produces an annual report 
summarising the information provided by all MSs7. In relation to small ruminants, MSs report to the 
Commission information on the general results of the monitoring programme carried out, on TSE 
suspected cases and TSE positive cases, which are gathered into the EU TSE Database. 
In particular, MSs report the number of ovine and caprine animals tested within each subpopulation in 
the framework of the monitoring programme, together with the method for sample selection and the 
results of the rapid and confirmatory tests. In relation to suspected TSE cases, MSs report the number 
of suspected cases placed under official movement restrictions, the ones subjected to laboratory 
examination per animal species, including the results of the rapid and confirmatory tests, and the 
number of flocks where suspected cases in ovine and caprine animals have been reported and 
investigated. Finally, with respect to positive cases of CS, AS and BSE, MSs report the geographical 
distribution, including the country of origin, the year and, if possible, the month of birth of the animal, 
the results of the primary molecular testing for discriminating scrapie and BSE cases and, for sheep, 
the genotype and, if possible, the breed. 
Throughout the years this information was collected by the European Commission from MSs in 
different ways, until a harmonised database and submission system were implemented in 2006, which 
also enabled the collection of additional information. MSs directly provide national data to the EU 
TSE database by means of two different types of report: ‘monthly reports’ and ‘case reports’, for both 
sheep and goats. 
‘Monthly reports’ are submitted monthly by MSs and include aggregated information in relation to all 
TSE tests performed in sheep and goats and include data on the animals tested (i.e. age, target group), 
on the flock (i.e. whether the flock is under official control following to TSE cases or not, and 
geographical location), the first test (i.e. which rapid test was used as the initial screening test) and the 
total number of animals tested, including positive, negative and inconclusive results. 
‘Case reports’ are submitted yearly by MSs and include detailed individual information related to 
positive TSE cases diagnosed in sheep and goats. Data should be submitted on the positive animal (i.e. 
scrapie type, unique national case number, month and year of birth, country of origin, breed and 
genotype), on the flock of origin of the animal (national flock identification number, geographical 
location), and on the tests performed (i.e. type and result of rapid test(s) and confirmation method(s) 
used to identify the case, discriminatory method(s) used to differentiate CS from BSE). 
2.3. A questionnaire survey on the monitoring sampling strategy in EU Member States 
As further discussed below, the design and practical implementation of surveillance activities, and the 
control and eradication measures in place, can substantially influence the collected data and their 
interpretation. In order to collect information on the sampling strategy and control measures 
implemented in EU MSs, a questionnaire was developed and circulated to all MSs. The questionnaire 
included, for both active surveillance target groups (i.e. healthy slaughtered animals (abattoir survey) 
and animals not slaughtered for human consumption (fallen stock)), a set of questions on the sampling 
design, representativeness of the sheep and goats tested, potential bias, evolution of the strategy and 
screening testing protocol over the years, specific monitoring measures implemented in the country, 
etc. In addition, it included questions on the measures implemented for the control and eradication of 
classical and AS in sheep and goats, any derogations implemented, the epidemiological investigations 
                                                     
7  See: http://ec.europa.eu/food/food/biosafety/tse_bse/monitoring_en.htm 
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carried out in outbreaks, etc. A copy of the questionnaire circulated to MSs and an overview of the 
replies collected is included in Appendix A.1. 
The information gathered from MSs was taken into consideration when interpreting the results of the 
analysis of the trends of classical and AS in the EU MSs, also in association with the potential impact 
of the control measures implemented, in order to inform the response to Term of Reference 1 of the 
mandate for this Opinion (see Sections 3.2 and 4.5.5). 
2.4. Sensitivity of the current EU monitoring system 
2.4.1. Passive surveillance 
Initially, identification of CS relied on clinical suspicion of disease, and voluntary reporting of this 
suspicion by the farmer to the relevant veterinary authorities (passive surveillance). Such disease 
monitoring relies on farmer knowledge and motivation, and is easily affected by the presence of 
specific economic incentives of disincentives for disease detection. For example, compensation for 
affected animals will be likely to increase reporting, whereas commercial penalties such as animal 
movement restrictions or compulsory culling may be a disincentive to reporting suspicion in a 
previously unaffected flock. Passive surveillance is more likely to record cases from flocks with a 
previous history/knowledge of scrapie, rather than identifying new affected flocks and in general is not 
able to provide additional and complementary information in comparison with the active system 
(Bertolini et al., 2011). An anonymous postal survey of farmers in the UK at the height of TSE 
awareness suggested that only 13 % of farmers who thought they might have had scrapie had actually 
reported this (Hoinville et al., 2000). In the USA, it has been reported that over 80 % of the variability 
in the incidence of scrapie was the result of reporting (Kuchler and Hamm, 2000). Farmers may seek 
to benefit from the favourable regulatory context and compensation schemes linked to statutory 
control and eradications measures (Ortiz-Pelaez and Del Rio Vilas, 2009). This might increase 
farmers' efforts to report disease. Overall, therefore, passive surveillance has a very variable 
efficiency. Given the extremely limited information regarding the clinical presentation of AS, and the 
fact that it is so dissimilar from CS, passive surveillance is particularly poor at detecting this form of 
disease. 
2.4.2. Active surveillance  
In the EU, the active surveillance for TSE in small ruminants, as currently understood, has been 
implemented since 2002. It relies on the testing of a sample of the apparently healthy animals 
slaughtered for human consumption (abattoir survey) and found-dead animals (fallen stock). The data 
collected through surveillance have clearly demonstrated that earlier evaluations of the prevalence of 
TSE in small ruminants and their geographical distribution (on the basis of passive surveillance) were 
largely underestimated, and the within-flock prevalence was on average 20 times higher than the 
apparent prevalence in the general population identified by active surveillance (Fediaevsky et al., 
2008). 
2.4.3. Factors affecting active surveillance – test sensitivity 
Various PrP detection methods are applied in the context of statutory surveillance (ELISA, WB, IHC) 
but all of these are immunodetection methods. None of the antibodies currently used in these tests can 
distinguish between the normal host cellular PrP and the disease related abnormal isoform PrPSc. 
However, the majority of tests exploit the relative protease resistance of PrPSc by introducing a 
preparatory step of PK digestion in the sample preparation, which leaves only the disease-related 
protein for detection. This system has proved robust for BSE and CS, but the discovery of AS, which 
is more PK sensitive (Groschup et al., 2007) has led to concerns about test sensitivity for this form of 
disease.  
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The methods currently approved for use within the EU for statutory screening purposes must meet 
certain minimum standards relative to each other, but, historically, some of the tests used for scrapie 
surveillance have had very poor sensitivity for AS.  
The European Commission (EC) originally commissioned an evaluation exercise of rapid post-mortem 
TSE tests in 1999 (Decision 2000/374/EC). Several tests were assessed using brain tissue from clinical 
cases of BSE in cattle. Three tests were approved under the TSE Regulation. A subsequent laboratory 
evaluation commissioned by the EC examined the performance of further proposed post-mortem rapid 
tests using brain tissue from clinical cases of BSE in cattle which resulted in two further tests being 
approved for use (Regulation (EC) No 1053/2003). In 2003, an EFSA Working Group on TSE testing 
designed a refined laboratory evaluation of selected rapid post-mortem BSE tests leading to seven new 
tests recommended for approval by the European Commission in the framework of the TSE 
Regulation.  
No evaluation of rapid TSE tests on material from small ruminants by the European Commission was 
possible before February 2004. In the absence of such data, tests performing satisfactorily on bovine 
tissues were provisionally approved for small ruminants and used for surveillance of TSE in sheep and 
goats during 2002-2004. In 2005 an EU evaluation exercise of rapid post-mortem TSE tests intended 
for small ruminants was undertaken. This involved an evaluation of diagnostic and analytical 
sensitivity, and diagnostic specificity and repeatability of six rapid post-mortem tests on samples from 
natural scrapie cases. Additionally the capability of these tests and their diagnostic sensitivity for the 
detection of the newly identified ‘atypical’ scrapie strain (Nor98) in sheep tissue were evaluated. 
Based on these data, tests were specifically approved by the EC for the post-mortem testing of 
slaughtered small ruminants in accordance with the TSE Regulation (as amended by Regulation (EC) 
No 253/2006). 
Further modifications were made to Annex X of the TSE Regulation in April 2008 (Regulation (EC) 
No 315/2008), defining twelve approved tests for use in the rapid testing of BSE in cattle and nine 
tests for use in the rapid testing of TSE in sheep and goats. At this point, some tests were not able to 
meet all the requirements for AS and therefore were not recommended for use for TSE monitoring in 
small ruminants, and were subsequently delisted from Annex X of the TSE Regulation. This test 
approval list has remained stable since 2008, although market forces have resulted in the loss of some 
tests from use.  
It should be noted that all of these evaluations were based on sheep samples, and approval 
extrapolated to use in ‘small ruminants’. At no point positive goat samples have been included in any 
manufacturer test development or independent evaluation sample panel.  
All the currently approved tests are required to fall within an analytical sensitivity of a maximal 2log10 
inferiority of the most sensitive test. Despite the potential for apparent differences in analytical 
sensitivity it was concluded by EFSA (EFSA BIOHAZ Panel, 2009) that “no potential differences in 
field detection performance can be inferred on the sole basis of the difference in analytical sensitivity 
reported in this study”. 
While testing laboratories are kept ‘under control’ by the regulatory requirement to apply tests within 
recognised quality systems (ISO 17025 or equivalent (Regulation (EC) No 882/2004)), the initial 
selection of animals and sampling of material falls largely outside this procedural control. 
2.4.4. Factors affecting active surveillance – individual animal sampling 
The basis for the current active surveillance screening activities across the EU is the detection of PrPSc 
accumulation in the brainstem. Regardless of the analytical sensitivity of the test used, sample location 
is key to good diagnostic sensitivity. PrPSc is detectable in the brainstem in pre-clinical disease (see 
Section 1.2.4) and this is the reason why at an individual animal level, the testing of clinically suspect 
animals for confirmation of disease (i.e. passive surveillance) is very effective. The accumulation of 
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PrPSc within the lymphoreticular system (LRS) can also be used to detect preclinical infection, if 
necessary in vivo for high value animals, but successful detection is only possible for disease in 
animals with genotypes that predispose to peripheral PrP accumulation (see Section 1.2.4), so a 
negative result has to be carefully qualified by context. The combination of tissue choice, age at 
testing and the accuracy of sampling will all have an effect on the overall diagnostic sensitivity of 
screening. In brainstem, the anatomical distribution of PrPSc is very localised to the dorsal nucleus of 
the vagus nerve (DNV) in early CS, and the nucleus of the trigeminal tract in AS (even at clinical 
endpoint). Robust and accurate sampling of these target areas is essential to give confidence in a 
negative biochemical result. IHC has the advantage in this regard because anatomical context is 
retained, but this is not practical as a rapid screening test for large populations. 
2.4.5. Factors affecting active surveillance – population sampling and surveillance strategies 
As previously described, EU TSE active surveillance requires MSs to carry out a targeted sample-
based monitoring on adult small ruminants.  
In general, the purposes of surveillance may be different: substantiating freedom from disease, 
monitoring the epidemiological evolution of disease in time and space, or detecting cases of disease to 
facilitate its control (Hoinville et al., 2013). 
2.4.5.1. Surveillance to monitor the epidemiological evolution in time and space. 
In the context of this Opinion, the results of the EU sample-based surveillance strategy are used to 
monitor the evolution of the occurrence of scrapie and to assess the effectiveness of the control 
measures implemented by MSs. However, a sample-based active surveillance programme may enable 
the monitoring of the general evolution of the scrapie epidemic in a country without being able to 
detect a significant proportion of the incident outbreaks. 
The representativeness and comparativeness of the sampling strategy and data collected (e.g. from one 
year to another) are essential to avoid biases in the estimation of the prevalence. When interpreting the 
prevalence estimates obtained, factors that have an impact on the probability of an animal to be 
positive also have to be taken into account. 
A number of factors potentially affect the validity of the prevalence estimates obtained:  
• The surveillance streams targeted by the surveillance (SHC vs. NSHC) and their relative 
proportion may bias the overall estimates, since the NSHC population is more likely to contain 
positive animals (Hopp et al., 2003; Del Rio Vilas et al., 2007). Indeed, clinical suspects that are 
not detected by passive surveillance (e.g. the farmer is not willing to report) may be included in 
the NSHC stream. However, exceptions are possible for various reasons: 
- some animals die in remote areas and the carcass are never collected and tested, or are in a 
condition not suitable for testing and are disposed of on farm; 
- some animals not falling within the scope of the fallen stock group might none-the-less be 
reported as fallen stock, leading to a reduction of the higher risk nature of the NSHC stream 
(Del Rio Vilas et al., 2007); 
- the same incentives/disincentives as described for passive surveillance may also affect the 
submission of carcasses from farms with no history of disease. 
In this case the confounding effect due to the stream can be handled, if data are available, by 
conventional statistical techniques of confounding adjustment, allowing the estimation of 
statistically-unbiased prevalence. 
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• The age of the population selected for testing, which is generally variable over time and space 
(e.g. years and countries), may be too low to ensure the detection of pre-clinical cases. In France, 
the performance of active PrPSc detection in goats was assessed in eight scrapie infected goat herds 
(Corbiere et al., 2013b). The sensitivity of detection using posterior brainstem appeared to be 
strongly dependent on the age of tested individuals, which is consistent with the known 
pathogenesis of TSE. Similar data were obtained from studies of a large UK goat herd (Gonzalez 
et al., 2009) and four scrapie affected goat herds in Cyprus (Ortiz-Pelaez et al., 2014b). These data 
confirm that the age of the tested individuals (incubation stage) strongly influences the probability 
of being detected by surveillance. Even in this case a confounding adjustment would be effective 
but the availability of accurate age data of tested animals is generally more problematic. 
• EU TSE surveillance may not take into sufficient account the heterogeneity of the sheep 
population and of the scrapie distribution within each MS. Within the EU legislation it is stated 
that sampling shall be representative of each region and season and avoid the over-representation 
of any group (e.g. by origin, age, breed, production type); however, no detailed instruction is 
explicitly provided. 
• In a flock or herd with low disease prevalence, the sample size may not be large enough to detect 
the disease. 
In EU surveillance the sampling size only partially takes into account the size of the national sheep 
population. However, this factor only influences the precision of the prevalence estimate and not its 
validity.  
How large the discrepancy is between the observed prevalence from surveillance and the true 
prevalence of scrapie infection in the population is not an easy question to answer. To do so, Gubbins 
and McIntyre (2009) used a back-calculation model, integrating data from multiple surveillance 
streams . The analysis carried out suggests that, in the period (1993-2007) and country (Great Britain) 
studied, the true prevalence was about three to about six times higher than the case prevalence 
detected in healthy slaughter, depending on a scenario parameter for the proportion of the incubation 
period that need to be elapsed for detecting CS preclinically by the rapid test. In other situations the 
discrepancy may be less, for example if the age range of animals in the healthy slaughter stream is 
coinciding better with age range in which the majority of detectable preclinically infected animals are 
expected to be. 
2.4.5.2. Surveillance to detect cases of disease and facilitate its control 
As mentioned above, surveillance may also aim at maximizing the detection of cases of disease to 
facilitate its control. For instance, the National Scrapie Eradication Program (NSEP) in the USA aims, 
through the post-mortem testing of small ruminants, at eradicating CS from the national small 
ruminant population by 2020 (USDA, 2010).  
If the aim is detection for disease control, the relative size of the sample tested compared to the size of 
the sheep population becomes a very important parameter. The strategy should be to target high risk 
subpopulations and perform as many tests as possible in order to detect outbreaks. In such a situation, 
bias is no longer a major concern because the goal is not to obtain a prevalence estimate. Overall, 
when having the same sample size, the testing programme would be much more effective in 
controlling scrapie in a country with small sheep population compared to a country with a larger sheep 
population, because the percentage of animals tested will be much higher.  
However studies based on current active surveillance programmes in goats demonstrated that whatever 
the number of screening tests performed, post-mortem surveillance has limited success in identifying 
infected animals (Gonzalez et al., 2009; Corbiere et al., 2013b; Ortiz-Pelaez et al., 2014b). Similar 
findings were reported by Hopp et al. (2003) when assessing the performance of TSE active 
surveillance in the Norwegian sheep population. 
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In particular Corbiere et al. (2013b) provided quantitative parameters to estimate the performance of 
scrapie active surveillance at population level, through simulation studies of the capacity of TSE 
surveillance programs to detect CS infected herds under different testing scenarios. In a first scenario, 
it was hypothesized that every goat aged over two years that was slaughtered for human consumption 
or eliminated at a rendering plant would be tested (178 000 animals in total). In this scenario, the 
estimated proportion of infected herds that would be identified after one year of surveillance using 
post-mortem PrPSc detection tests on posterior brainstem would be 51.0 % (95 % CI: 49.7-52.4). In a 
second scenario, it was considered that 20 000 tests would be randomly performed each year, 50 % in 
fallen stock and 50 % in healthy slaughtered animals. In that scenario, after one testing year, only 11.8 
% (95 % CI: 10.7 - 12.7) of the CS infected herds would be identified. The comparison between the 
scenarios shows the relevant impact of sample size on the capacity of outbreak detection. 
Moreover in both scenarios the capacity of the surveillance programme to detect infected herds was 
found to be strongly influenced by the herd size; the smaller the herd, the lower the detection 
probability. For instance, while scenario 1 was estimated to detect around 75 % of infected herds that 
contained more than 200 adult goats, only approximately 30 % of the infected herds containing less 
than 50 adult goats could be detected. 
2.5. Concluding remarks 
• Passive surveillance is very ineffective at identifying new affected flocks or herds, especially if the 
prevalence is low and if suspicion reporting may lead to socio-economical consequences such as 
animal movement restrictions or compulsory culling. 
• Active surveillance, enforced since 2002 as a targeted sample-based monitoring of adult small 
ruminants, represents a major improvement of TSE surveillance in the EU. 
• The EU TSE surveillance in small ruminants allows the monitoring of the evolution of the disease 
and the assessment of the effectiveness of control measures implemented by the MSs. It may not 
take into due account the heterogeneity of the sheep population and scrapie distribution in each 
MS: deviation from the representativeness of the sampled population may result in reduced 
validity of the prevalence estimate. 
• The observed prevalence obtained through the EU TSE surveillance programme in small 
ruminants is affected by two main factors: i) the sensitivity of the detection method given the age 
of the tested animal, the stage of the incubation period and the sampling/testing procedures, and ii) 
the distribution of testing by surveillance stream. The availability of the relevant data allows the 
statistical control of their confounding effects. 
• Surveillance programmes could be designed to ensure detection of as many scrapie cases and 
outbreaks as possible as a tool to facilitate the control or the eradication of the disease in a 
country. 
3. Trends of Classical and Atypical scrapie in the EU (2002-2012) 
3.1. Objectives, data and analytical methods 
The objective of this analysis was to provide a spatio-temporal description of scrapie occurrence by 
species, stream, scrapie type and MS, comparing the occurrence between years within MSs. 
Two main sources of information were available: the EU TSE database, which collects standardised 
surveillance data on all testing activities in all MS, and a questionnaire designed specifically to capture 
additional data specific to aid the interpretation of the data (see Section 2.3). Due to the biased and 
variable nature of passive surveillance, data from clinical cases were excluded from the analysis, and 
only the more unbiased active surveillance data, namely the animals slaughtered for human 
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consumption (SHC) and the animals not slaughtered for human consumption (NSHC) were used for 
describing national trends in scrapie prevalence. Additionally, flock/herd identifiers made it possible 
to further filter the data to avoid the inclusion of multiple cases from single premises. Standardised 
data were only available for individual MSs from the point at which they joined the EU. 
A number of limitations/drawbacks were identified in the EU TSE database, such as duplication of 
records (as a consequence of multiple testing), data being unavailable for statistical analysis at flock 
level, poor and incomplete data with regards to breed, age or geographical origin of tested animals. 
The precision and validity of the crude prevalence rates obtained through the analysis of active 
surveillance data may have been affected by the targeted and sample-based design of both the SHC 
and NSHC surveys. Country-specific temporal trends are in general heterogeneous, precluding any 
meaningful interpretation of the overall temporal trend at the EU27-level. Therefore the analysis and 
interpretation of the temporal trends has been conducted only at MS level. 
Data analysis was conducted separately by species (sheep vs. goats) and disease (CS vs. AS). In each 
individual subset, descriptive frequency tables were produced showing the breakdown of animals 
tested, and cases by country, year, surveillance stream (SHC and NSHC) and rapid test. The potential 
for a confounding effect of stream in the case of CS in both sheep and goats became evident after 
comparing the stream-specific prevalence and the different distribution of the number of tests carried 
out in each stream by country or by year. Non-significant differences in the prevalence of AS  by 
stream were observed. 
A spatial description of the presence of the diseases (scrapie types) in the two populations of small 
ruminants was carried out by producing two sets of maps: 
- the occurrence of CS and AS for the period 2002-2012 by species and MS; 
- surveillance stream-adjusted (for CS) and crude (for AS) prevalence rates for the period 2002-
2012 by species and MS, produced through proportional symbol mapping. The point markers 
were drawn using absolute minimum and maximum reference values: that allowed each map 
to be compared with the other maps (e.g. the prevalence of CS in sheep with that in goats). 
The adjustment on surveillance stream was carried out by means of a direct standardization 
using the proportion of tests carried out in the MSs in the NSHC vs. SHC in sheep and goats 
respectively. 
Negative binomial models were used to fit ‘count of cases detected’ and ‘year’ to estimate the country-
specific and stream-adjusted annual prevalence ratios (PRs). Significance levels of the slope of the 
linear function for individual MS and years were used to determine statistically significant temporal 
trends. In a preliminary analysis, the type of rapid test, if changed over the period, was included as a 
covariate in country-level models. However, since no confounding effect was evident, the type of 
rapid test was not included as a covariate in the final analyses. For more details see Appendix B. 
3.2. Results and considerations 
3.2.1. Classical scrapie in sheep 
Based on EU-wide surveillance data,  CS in sheep was detected in 17 out of 27 MSs between 2002 and 
2012 (Figure 1). During the period covered by the present Opinion, the following countries did not 
report cases of CS: Austria, Denmark, Estonia, Finland, Latvia, Lithuania, Luxemburg, Malta, Poland 
and Sweden. 
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Figure 1:  Geographical distribution of ovine CS and AS within EU27. Countries in green reported 
both CS and AS; countries in blue reported only CS; countries in yellow reported only AS; white is 
used for countries where scrapie has been never reported 
 
In these 17 countries some 4.7 million sheep were tested leading to the detection of 4 132 CS cases, 
equal to an overall prevalence of 8.7 cases per 10 000 rapid tests. About one third of the cases (1 464) 
were detected in the SHC stream  whereas the remaining cases (2 668) were detected in the NSHC 
stream. Considering the same group of countries,the stream-specific prevalence was 5.5 and 12.8 cases 
per 10 000 rapid tests in the SHC and the NSHC, respectively.  
The stream-adjusted prevalence of CS in sheep by country is shown in Figure 2 (in the case of 
Belgium only the prevalence within NSHC was considered: the standardisation by stream was not 
carried out because there was only one case detected within the SHC stream out of a small number of 
animals tested). 
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Figure 2:  Prevalence of CS in sheep within EU27. Number of cases/10 000 rapid tests standardized 
by stream, i.e. SHC vs. NSHC over the period 2002-2012. The proportion of tests carried out in all the 
27 MSs in the NSHC vs. SHC in sheep has been used to define the baseline population for the direct 
standardisation. The blue markers are proportional to the prevalence and comparable with those 
presented in the other maps of scrapie prevalence. 
At the EU27 level  over the period 2002-2012, CS in sheep showed annual stream-adjusted prevalence 
rates ranging between 5 and 20 cases per 10 000 rapid tests. The overall temporal pattern is not 
consistent with any statistically significant trend (PR 0.98, 95 % CI: 0.94-1.03) (Figure 3).  
 
Figure 3:  Temporal trend of CS in sheep at the EU27 level. Crosses (+) indicate the annual stream-
adjusted prevalence (cases per 10 000 rapid tests) whereas the lines show respectively the linear trend 
(black line) with its 95 % confidence limits (grey lines). The adjustment on stream was obtained by 
fitting a negative binomial model (internal reference). 
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However, the interpretation of the overall trend at the EU-level is not meaningful: rather than 
indicating a general stable situation in the EU, it is  the result of the aggregated heterogeneous 
epidemiological situation at country level, with large differences in the temporal trend between 
countries. 
The within country differences in the prevalence over the years help us to understand better the 
evolution of CS during the period covered by this Opinion. Bulgaria, Germany, Hungary and Portugal 
reported CS only sporadically, preventing any analysis of the temporal trend, with few cases detected 
every year and a very low prevalence of disease. In these four countries the annual prevalence rates 
were never higher than 10 cases per 10 000 rapid tests. Given the limitations of the data for these 
countries, it was decided to restrict any further investigation to the remaining 13 countries. 
As mentioned above, the analytical strategy focussed on country-level trends. Negative binomial 
models were applied to fit ‘count of cases detected’ to estimate the country-specific and stream-
adjusted annual prevalence ratios (PRs) by year. A PR larger than one indicates an increasing trend 
whereas a PR less than one is associated with a decreasing trend; the PR is statistically significant 
when its 95 % confidence interval does not include one (that would indicate a flat trend). After 
excluding Bulgaria, Germany, Hungary and Portugal from any further temporal analysis, based on 
modelling  outputs, the countries were divided in two main categories as follows: 
• Countries with an observed statistically significantly decreasing trend over the period 2002-
2012: Cyprus, France, Ireland, the Netherlands, Slovenia and the UK. Table 1 reports the 
annual PRs by country obtained in this group of countries, with France showing the most 
substantial decrease. 
• Countries with an observed trend not statistically different from a flat one over the period 
2002-2012: Belgium, Czech Republic, Greece, Italy, Romania, Slovakia and Spain. All the 
countries showed the absence of any statistically significant trend. However, in Belgium and 
Czech Republic scrapie cases have no longer been detected since respectively 2008 and 2009: 
in both the countries, since 2008 the national active surveillance programmes have been 
restricted to the NSHC only. 
Table 1:  The six EU countries showing a statistically significant decreasing trend over the period 
2002-2012. Countries are ranked on the basis of the prevalence ratios (PR) 
Country Prevalence ratios (PR) 95 % CI 
France 0.61 0.56 - 0.67 
Slovenia 0.68 0.54 - 0.85 
Cyprus 0.73 0.61 - 0.87 
United Kingdom 0.74 0.68 - 0.82 
The Netherlands 0.75 0.69 - 0.81 
Ireland 0.84 0.78 - 0.90 
 
The country-specific trends over the period 2002-2012 are shown in Figures 4 and 5. 
Within the six countries with a statistically significant decreasing trend, there are two subgroups 
clearly identified. This is supported by the information gathered from MSs through a survey on the 
monitoring sampling strategy in EU MSs (see Section 2.3), to which the paragraphs below refer. 
Cyprus, Ireland, The Netherlands and Slovenia are small countries with a small ovine population with 
homogeneous characteristics in terms of number of breeds, husbandry and management. Ireland is an 
upper bound of this group with a considerable number of breeds (54) and a sheep population of 
approximately 3.5 million. In general these four countries present a robust implementation of their 
surveillance systems in terms of representativeness and coverage. In some instances they exceed the 
statutory requirements. For example, Ireland has in place a standard operating procedure (SOP) for the 
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SHC to ensure that the correct ratio of eligible animals are selected randomly, and identified, with a 
record generated of all flocks sampled on a particular day that can be used to demonstrate that a 
random sample is achieved. Equally the NSHC monitoring system requires quarterly analysis of the 
scrapie monitoring database to ascertain how representative of season and region the sampling is. In 
the case of Cyprus, collection and sampling of found dead sheep are conducted by a private contractor 
continuously monitored by the Veterinary Services by pre-printing each driver’s report and issuing 
instructions as to whether samples should or should not be collected from a specific farm. The 
Veterinary Services issue lists of non-infected flocks/herds, from which drivers should collect at least 
one sample if possible. The driver's report also includes the total number of samples collected per farm 
in the year to date, to indicate to the driver whether a sample should be collected. The Netherlands 
systematically test 10 % of all sheep over 18 months slaughtered for human consumption, with a 
minimum of 1 per slaughterhouse. In Slovenia, between 2003 and 2010, all fallen stock over 18 
months were tested. Since 2011, and despite logistical and resource constraints, a small sample is 
selected randomly as per an annual plan: every first dead animal from a flock of more than 100 sheep 
or more than 50 goats is selected for testing, ensuring sampling is evenly distributed through regions, 
breeds, production categories, age groups, and avoiding multiple samples from the same flocks. 
In the case of France and the United Kingdom, with the third and largest sheep populations 
respectively in the EU, they are at the other extreme of the spectrum with multiple breeds, varied 
husbandry systems and geographical dispersion. However, these two countries have in place robust 
surveillance systems with strong veterinary governance and a long history of monitoring and 
controlling TSEs, as in the case of the United Kingdom and the BSE epidemic. Both countries have 
systems in place to ensure the representativeness of the surveys. For instance, in NSHC, the “number 
of animals to be tested are annually defined by sampling center and month. Instructions are given to 
choose randomly eligible animals in order to reach this number” (France), “approved Category 1 
incineration, rendering and intermediate plants with a throughput of at least 1,000 adult sheep and 
goat carcases may apply to become sampling sites for the TSE Fallen Sheep and Goat surveys” 
(United Kingdom). To ensure that sampling covers all parts of the country and that samples are taken 
at all times throughout the year, the delivery agency “allocates each participating plant monthly 
quotas of the number of samples to be taken” (United Kingdom). 
All these aspects would have allowed this group of countries to obtain a valid prevalence estimation. 
With regards to follow up of the outbreaks detected through  sampling, four countries declared that all 
rapid test positive (rapid test) cases were traced back, which resulted in the confirmation of inflected 
flocks and the implementation of control measures (Cyprus, Ireland, France and Slovenia); 90 % 
(United Kingdom) and 29 % (The Netherlands). 
Unlike the other countries, France systematically exceeded the required annual sample size. In the 
period 2006-2007, a major monitoring effort is evident (about 488 and 339 thousand sheep tested 
respectively); since then the sample size in the NSHC has exceeded the EU requirements by four to 
seven times. In this case the application of the statistical control for stream confounding was 
particularly helpful in preserving the possibility of sensible comparisons between the prevalence 
estimates. However, an additional consequence of this massive targeted testing may have been a 
dramatic increase in the capacity of outbreak detection and therefore of effective application of control 
measures. 
The potential reasons for the trend not being statistically different from a flat one for the other seven 
countries are discussed later in the Opinion (see Section 4.5.5), since detailed consideration needs to 
be given to the combined impact of the various control measures implemented in those countries (dealt 
with in Chapter 4). 
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Figure 4:  Temporal trend of CS in sheep in countries where a statistically significant decreasing trend was confirmed. Crosses (+) indicate the annual 
stream-adjusted prevalence (cases per 10 000 rapid tests) whereas the lines show respectively the linear trend (black line) with its 95 % confidence limits (grey 
lines). The adjustment on stream was obtained by fitting a negative binomial model (internal reference). 
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Figure 5:  Temporal trend of CS in sheep in countries where the trend was not statistically different from a flat one. Crosses (+) indicate the annual stream-
adjusted prevalence (cases per 10 000 rapid tests) whereas the lines show respectively the linear trend (black line) with its 95 % confidence limits (grey lines). 
The adjustment on stream was obtained by fitting a negative binomial model (internal reference). 
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3.2.2. Atypical scrapie in sheep 
Over the period 2002-2012, AS was reported in 21 countries (see Figure 1) and it was the only ovine 
TSE detected in six of them (Austria, Denmark, Estonia, Finland, Poland and Sweden). Within the 
EU27, the disease has never been reported in Cyprus, Latvia, Lithuania, Luxembourg, Malta or 
Romania. In some countries cases were identified sporadically, as in Austria (2011 and 2012), 
Bulgaria (2008 and 2012), Czech Republic (2007), Estonia (2010 and 2011, when a case was detected 
out of only 10 SHC sheep tested) and Slovenia (2010 and 2011).  
As a consequence of  the limited ability, in the past, of some rapid tests to detect cases of AS, the 
analysis was restricted to few commercial rapid tests, used mainly from 2006 onwards (see Appendix 
B). Thus all the calculations were restricted to 2.51 million (known) tests and the mapping and trend 
analysis were restricted to the period 2006-2012. Prior to 2006, the data from the EU TSE database 
does not include data on the rapid test used, and therefore animals tested with rapid tests unable to 
detect the disease during those years could not be excluded from the denominators. Conversely, some 
of the cases detected since 2006 were excluded from any statistical analysis since data on the rapid test 
used were not available (9 cases) or related to a rapid test with limited ability to detect cases of AS (14 
cases). Moreover, Germany was excluded from the analysis, since data regarding the type of rapid test 
used over time is not available even after 2006.  
The active surveillance carried out since 2006 led to the detection of 1 466 cases equal to an overall 
prevalence of 5.8 cases per 10 000 rapid tests. The stream-specific prevalence rates are very similar 
(5.6 and 6.1 per 10 000 rapid tests in SHC and NSHC, respectively) confirming the absence of a 
confounding effect from the surveillance stream for AS. 
The crude prevalence between 2006 and 2012 (Figure 6) was similar throughout the EU27 without the 
heterogeneity evident for CS. 
 
Figure 6:  Crude prevalence of AS in sheep within EU27 (Estonia prevalence data refer only to the 
NSHC stream and Germany is not shown). Cases/10 000 rapid tests are calculated over the 2006-2012 
period. The blue markers are proportional to the observed crude prevalence and comparable with those 
presented in the other maps of scrapie prevalence. 
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Figure 7 shows crude annual prevalence rates (cases per 10 000 rapid tests) by country restricted to 
animals tested with rapid tests able to detect AS, excluding countries where AS cases were not 
reported in at least three different years (e.g. Belgium). The Netherlands was also excluded as only 
cases detected over the last two-year period, 2011-2012, met the test type requirement. A statistical 
assessment of the slope of the individual regression models havs been carried out (fitting country-
specific Poisson Regression models). France and the United Kingdom (Figure 8) showed a statistically 
significant trend: in the case of France the trend was decreasing (annual PR=0.92, 95 % CI: 0.88-0.97) 
whereas in the UK a statistically increasing trend has been detected (annual PR=1.10, 95 % CI: 1.04-
1.17): in all the remaining countries the PRs were not statistically significant. The decline observed in 
France was less than the one observed for CS in the same country. 
Overall it is not possible to draw any conclusions from these findings, since there has not been any 
apparent difference in the implementation of control measures during this time window. 
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Figure 7:  Temporal trend of AS in sheep in countries where the trend was not statistically different from a flat one. Crosses (+) indicate the annual 
prevalence (cases per 10 000 rapid tests) whereas the lines show respectively the linear trend (black line) with its 95 % confidence limits (grey lines). 
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Figure 8:  Temporal trend of AS in sheep in France and the UK. In the case of France the trend was 
significantly decreasing (annual PR=0.92, 95 % CI: 0.88-0.97), whereas in the UK a statistically 
increasing trend was detected (annual PR=1.10, 95 % CI: 1.04-1.17). Crosses (+) indicate the annual 
prevalence (cases per 10 000 rapid tests) whereas the lines show respectively the linear trend (black 
line) with its 95 % confidence limits (grey lines).  
3.2.3. Classical scrapie in goats.  
Based on  EU-wide active surveillance data, CS in goats was detected in 8 out of 27 MSs between 
2002 and 2012 (Figure 9). Bulgaria, Cyprus, Greece and the UK reported only cases of CS whereas 
both CS and AS were detected in Spain, Italy, Finland and France. 
 
Figure 9:  Geographical distribution of caprine CS and AS within EU27. Countries in green reported 
both CS and AS; countries in blue reported only CS; countries in yellow reported only AS; white was 
used for countries where caprine scrapie was not reported. 
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In the eight countries where cases of scrapie have been confirmed in goats, about 1.4 million goats 
were tested and 1 405 cases of CS were detected, equal to an overall prevalence of 9.8 cases per 
10 000 rapid tests. The annual crude prevalence in Cyprus was between 10 and 864 times higher than 
those observed in the remaining countries where the disease was reported. If the calculation of the 
prevalence is carried out after the exclusion of Cyprus, the overall prevalence in the remaining seven 
countries is 2.2 cases per 10 000 rapid tests.  
About 47 % of the total cases (659) were from the SHC, whereas the remaining cases (746) were 
detected in the NSHC. The overall stream-specific prevalence in the eight countries was 8.3 and 11.6 
cases per 10 000 rapid tests in SHC and NSHC, respectively. The exclusion of Cyprus from the 
calculation of the stream-specific prevalence led to the following figures: 1.0 and 3.7 cases per 10 000 
rapid tests in SHC and NSHC, respectively.   
The heterogeneous prevalence of CS in goats by country over the period 2002-2012 is shown in Figure 
10 through the stream-adjusted prevalence by country. 
 
Figure 10:  Prevalence of CS in goats within EU27. Number of cases/10 000 rapid tests standardized 
by stream, i.e. SHC vs. NSHC over the 2002-2012 period. The proportion of tests carried out in all the 
27 MSs in the NSHC vs. SHC in goats has been used to define the baseline population for the direct 
standardisation. The blue markers are proportional to the prevalence and comparable with those 
presented in the other maps of scrapie prevalence. 
The assessment of the statistical significance of the national trends  related to the period 2002-2012 
has been carried out by fitting negative binomial models (Figure 11). Two countries were excluded 
from the analyses as they reported the disease only in two different years (i.e. Bulgaria in 2009 and 
2010 and Finland in 2002 and 2005). Based on the models, France showed a statistically decreasing 
trend with  an average reduction of nearly 40 % year by year (PR 0.66, 95 % CI: 0.57-0.77) whereas 
Cyprus showed a statistically increasing trend (PR 1.10, 95 % CI: 1.07-1.13). The French case may 
reflect in part also the impact of a strong surveillance pressure able to detect and manage a large 
proportion of outbreaks. As observed for sheep, the surveillance effort applied on the French goat 
 
 
 
 
 
 
BULGARIA
 
 
 
CYPRUS
 
 
 
SPAIN
 
FINLAND
FRANCE
UNITED KINGD
 
GREECE
 
 
 
 
ITALY  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
undetected
detected
Scrapie situation in the EU
 
EFSA Journal 2014;12(7):3781 35
population largely exceeded the EU requirements: between 2005 and 2007 about 495 000 goats were 
submitted for rapid testing and since then the goats tested in the NSHC stream annually has been about 
54 000 compared with the expected 10 000 rapid tests. 
In the case of Cyprus and the UK, if the analyses were restricted to the period 2007-2012, both 
countries would show a statistically decreasing trend (PR 0.91  95 % CI: 0.88-0.95 and PR 0.79, 95 % 
CI: 0.69-0.91 respectively). The particular management and husbandry practices of goat herds in 
Cyprus can explain the increase in prevalence in the early years, which only benefitted from the 
reduction of scrapie in sheep from 2007 onwards. In the case of UK, with very few mixed holdings, 
this effect is more unlikely. 
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Figure 11:  Temporal trend of CS in goats in EU countries where the disease was reported over at least three years. Crosses (+) indicate the annual stream-
adjusted prevalence (cases per 10 000 rapid tests) whereas the lines show respectively the linear trend (black line) with its 95 % confidence limits (grey lines). 
The adjustment on stream was obtained by fitting a negative binomial model (internal reference). France shows a statistically significant decreasing trend. 
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3.2.4. Atypical scrapie in goats 
Over the period 2002-2012, AS in goats has been reported in five countries (Figure 9), i.e. Finland 
(just one case in 2009), France, Italy, Portugal (where it was the only caprine TSE detected) and 
Spain. 
As for sheep, data analysis was restricted to the period 2006-2012. Based on the application of rapid 
tests able to detect AS, about 764 000 animals were tested in the five countries where AS was initially 
reported. The total number of cases detected was 84, equal to an overall prevalence of 1.1 cases per 
10 000 rapid tests. As in sheep, the stream-specific prevalence rates in goats are very similar (0.9 and 
1.2 per 10 000 rapid tests in the SHC and NSHC, respectively). Finland was excluded from the 
analysis, since it reported only one case of AS in one year. 
Figure 12 shows temporal trends of AS in goats in the four countries for which the analysis was 
carried out. None of those countries showed any statistically significant trend. 
 
 
Figure 12:  Temporal trends of AS in goats. No country shows a trend statistically different from a 
flat one. Crosses (+) indicate the annual prevalence (cases per 10 000 rapid tests) whereas the lines 
show respectively the linear trend (black line) with its 95 % confidence limits (grey lines). 
3.3. Concluding remarks in relation to Term of Reference 1 
• The overall EU27 surveillance effort between 2002 and 2012 led to the testing of five million 
sheep and 1.7 million goats. The idiosyncrasies of the EU database, the quality and completeness 
of the data and the heterogeneous implementation of surveillance at country level have determined 
the analytical options to measure the temporal variation of scrapie occurrence over the reporting 
period. 
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• The precision and validity of the crude prevalence rates obtained through active surveillance may 
have been affected by the targeted and sample-based design of both the SHC and NSHC surveys. 
The crude prevalence rates should not be compared between countries. 
• In order to analyse prevalence trends: 
- The statistical analysis was restricted to the MSs reporting scrapie cases in the framework of 
EU active surveillance. 
- Cases identified through passive surveillance, or as a result of culling animals from known 
infected flocks, were removed from the data sets prior to analysis.  
- In the case of CS, and in order to prevent the validity of the estimates of the prevalence rates 
being compromised by the confounding effect of surveillance stream, stream-adjusted 
estimates were systematically obtained through the application of ad hoc statistical techniques. 
• Over the period 2002-2012, the overall average prevalence of CS in the sheep population was 8.7 
cases per 10 000 rapid tests (considering the 4.7 million sheep tested in the 17 MSs where CS has 
been reported). The geographical distribution of CS cases in sheep shows great heterogeneity in 
the level of occurrence in MSs: in some cases only a few, or no, cases were detected, whereas 
Cyprus experienced a large epidemic. 
• Country-specific temporal trends of CS in sheep are heterogeneous, preventing any meaningful 
interpretation of the overall temporal trend at the EU27-level. Therefore the analysis and 
interpretation of the temporal trends must be conducted at MS level. With regard to CS in sheep, 
the results of the analysis allow the classification of the EU27 MSs into four groups: 
- countries where CS has been detected, with a statistically significant decreasing trend (Cyprus, 
France, Ireland, The Netherlands, Slovenia and the United Kingdom): all countries showed 
effective surveillance programmes, in particular France, where the surveillance pressure was 
stronger than in any other country and was likely to facilitate the detection and management of 
a large proportion of outbreaks; 
- countries where CS has been detected with an observed trend not statistically different from a 
flat one (Belgium, Czech Republic, Greece, Italy, Romania, Slovakia and Spain): however, 
Belgium and the Czech Republic have not  reported scrapie cases since 2008 and 2009 
respectively; 
- countries where CS has been reported only sporadically (Bulgaria, Germany, Hungary and 
Portugal); 
- countries with no cases of CS during the period 2002-2012 (Austria, Denmark, Estonia, 
Finland, Latvia, Lithuania, Luxemburg, Malta, Poland and Sweden).  
• Over the period 2002-2012, active surveillance enabled the detection of AS in sheep in 21 MSs. 
Since the ability to detect cases of AS is essentially restricted to few rapid tests, all the 
calculations were done with the 2.5 million (known) tests carried out with these rapid tests in the 
21 MSs. This restricted the temporal analysis to the period 2006-2012. The overall prevalence of 
AS for this period was 5.8 cases per 10 000 rapid tests. 
• Where detected, AS in sheep showed a similar prevalence over time and space: no large epidemics 
were reported and five countries detected AS in sheep only sporadically. Only two countries 
showed a statistically significant trend, with a reduction in the annual prevalence rates in France 
and an increase in the United Kingdom.  
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• CS in goats has been detected in eight MSs, where 1.4 million goats have been tested. The overall 
prevalence of CS in goats (9.8 cases per 10 000 rapid tests) is mostly explained by the unique 
epidemic in Cyprus which paralleled the epidemic in sheep. The prevalence in the remaining 
seven countries where CS in goats was detected was 2.2 cases per 10 000 rapid tests. Statistically 
decreasing trends were evident respectively for France over the entire period (2002-2012) and for 
Cyprus and the United Kingdom after 2007. The favourable French trend may reflect in part the 
impact of a strong surveillance pressure able to detect and manage a large proportion of outbreaks 
in small ruminants. 
• AS in goats was reported by five countries, at a very low prevalence and with no statistically 
significant trend in any of them. 
4. Measures for the control and eradication of Classical scrapie 
4.1. Factors interacting in the control of Classical scrapie 
The epidemiological trend of CS in a given country, estimated through the trend of the prevalence rate 
of CS over the years, is the direct result of the balance between the number of new cases that result 
from the spreading of the disease in the country, the removal of CS-infected animals and the 
prevention of new infections, i.e. the result of the ability of the surveillance system to detect cases and 
of the implementation of control measures. 
The spreading of CS, i.e. the occurrence of newly infected animals within farms, depends on the  
percentage of susceptible animals (that diminishes strongly when the dissemination of the ARR allele 
is high) and the farming activities that can favour disease transmission within farms (mainly lambing 
practices that may increase the risk of infection of newborn lambs, and other sheep, by infected ewes 
at lambing). Between farms, the risk of spread is affected by the trade level of live (infected) animals  
and the physical contacts or sharing of pastures/holdings with sheep from other flocks. 
The removal of infected animals or the prevention of new cases of infection are the direct 
consequences of the combination of the ability of the surveillance system to detect infected animals 
(the surveillance pressure and effectiveness) and the control strategy implemented in infected farms. 
The latter itself is made of two complementary components: culling strategy in detected infected farms 
in order to remove animals of susceptible genotypes (selective culling), and breeding for resistance in 
these infected farms so that only animals carrying the ARR allele are maintained or introduced into the 
farm, which reduces the infection pressure and the capacity of the disease to spread. 
The effectiveness of a given control strategy can therefore differ between countries if the farming 
practices (allowing spreading) and the prevalence of the ARR allele are different. For example, the 
observed effectiveness of the control programme will be higher in countries with low spreading rate of 
the disease (for example when there is a high percentage of closed farms). 
Surveillance pressure is another strong driver of the effectiveness of any control strategy, although this 
is not its principal purpose. Initially surveillance systems aim mainly at providing data to monitor the 
epidemiological situation and trend of CS in a country. However, each detection of a case also allows 
the implementation of appropriate within-flock control measures, which have an impact on the 
situation of CS in the case flock, and other flocks, for a long period. For example, if control measures 
following case detection imply that only genetically resistant animals can remain in the flock, this 
flock would not be a source of CS or a cause of further disease dissemination. 
4.2. Questionnaire surveys on the control measures implemented in EU Member States 
As already described, a number of measures may be implemented with the aim of controlling and 
eradicating CS. These can be roughly classified into two main types of measures: 
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i. non-genetic sanitary policies,  aimed at detecting infected animals, depopulating, cleaning and 
disinfecting infected flocks, and limiting animal movements to contain the spread of the 
disease to other animals/flocks; 
ii. genetic breeding for resistance, aimed at decreasing the susceptibility to CS in the sheep 
population by increasing the frequency of resistant alleles at specific codons of the PRNP 
gene. 
As mentioned in Section 2.3, a first questionnaire was circulated to EU MS to collect information on 
the control and eradication measures implemented in the different coutries over the years. A copy of 
the questionnaire circulated to MSs and an overview of the replies collected are included in Appendix 
A.1. 
Other requests for information were sent to MSs in order to obtain detailed information in relation to 
the implementation of BP-CS in sheep. A questionnaire had already been circulated by the European 
Commission to all MSs in 2010, and the replies collected were considered by EFSA in the framework 
of the mandate for this Opinion (see Appendix A.2). With the aim of gathering more detailed 
information, in 2013 the European Commission requested all MSs having a BP-CS in place to provide 
details on the requirements of BP-CSs and annual reports, in accordance with the TSE Regulation, and 
this information was also considered by EFSA (see Appendix A.2). Finally, an additional 
questionnaire was developed and circulated by EFSA to MSs in 2013, which allowed the collection of 
additional data on the sheep population structure, on the genotyping activities carried out, on the rules 
for the selection of rams in high genetic merit flocks (HGMF) and on their dissemination to 
commercial flocks (CF). A copy of this questionnaire is included in Appendix A.3, with an overall 
summary of the replies gathered. The information collected from MSs was used to assess the type of 
BP-CSs implemented and allow its comparison with the trends of CS (see Chapter 3), in order to 
inform the response to ToR 2 of the mandate for this Opinion. 
4.3. EU legal background 
The control of CS in small ruminants is complex, mainly due to the difficulties of breaking the 
transmission cycle, the inability to identify infected animals before the onset of disease and the 
difficulty in decontaminating an infected environment, which increases the risk of indirect 
transmission (Windl and Dawson, 2012). In addition, movement of animals between flocks/herds is 
also likely to be an important factor in facilitating spread. The knowledge acquired on the genetic 
susceptibility of sheep to CS has offered new possibilities to control this disease in sheep by means of 
genetic selection based on certain polymorphisms of the prion protein gene. 
Regulation (EC) No 270/2002 introduced the requirement that the prion protein genotype of a random 
subsample of the ovine animals tested from the population slaughtered for human consumption (or 
live). This subsample had to represent at least one per cent of the total sample for each MS, and should 
not be less than 100 animals.  
At EU level a first survey of the prion protein genotype in sheep breeds in all MSs was launched in 
2003. Commission Decision 2002/1003/EC required each MS to complete a survey, by July 2003, of 
the prion protein genotype of sheep from flocks of high genetic merit. The survey protocol required 
that at least 50 samples should be collected from each breed, chosen to be representative of the entire 
breed in the MS. Importantly, it was required to include rams used for artificial insemination, but it 
was not required to include rams kept solely for the purpose of breeding with commercial ewes. 
At the same time it became a requirement that the prion protein genotype of positive cases of scrapie 
in sheep had to be determined. 
In 2003, the Regulation was again amended (Regulation (EC) No 2245/2003) to state that the 
genotype should be determined in a minimum of 600 animals in MS with an adult sheep population of 
more than 750 000 animals. In the case of other MS the minimum sample should consist of at least 
Scrapie situation in the EU
 
EFSA Journal 2014;12(7):3781 41
100 animals. It is important to note that at this point the Regulation explicitly stated that the sampling 
should be representative of the entire ovine population, i.e. it was no longer linked to the HGMF. 
With Commission Decision 2003/100/EC, each MS was required to introduce a BP-CS in each of its 
sheep breeds which were native, or which formed a significant population in its territory aimed at 
increasing the frequency of the ARR allele within the sheep flocks, while reducing the prevalence of 
those alleles which have been shown to contribute to susceptibility to TSE. It was mandated that the 
BP-CS should concentrate on flocks of high genetic merit. Participation in these programmes was 
voluntary prior to 2005. Thereafter it was mandatory, with some derogations based on implementation 
of national scrapie control programmes or recognition of scrapie free status (e.g. derogations granted 
to Denmark, Sweden, Finland, Austria). The implementation of BP-CSs became voluntary again for 
MSs from July 2007 onwards, and have now stopped in a number of MSs (see Section 4.5.3). 
Data on specific polymorphisms in goats that may be relevant to CS susceptibility have also been 
published (see also Section 1.2), showing a high genetic heterogeneity by breed of such 
polymorphisms. 
Apart from genetic selection, a number of further control measures have been laid down in the EU 
Regulation. In particular, since 2001 specific measures have been in place when a TSE is suspected 
and/or confirmed in sheep and goats, i.e. a series of movement restrictions of animals in the holding 
until clinical, epidemiological and diagnostic examinations are carried out, the need to carry out an 
epidemiological investigation to identify the sources of infection and other animals at risk, and the 
killing and rendering of positive animals and/or other animals at risk. 
Over the years measures have been reviewed and adapted regularly, with a number of derogations also 
incorporated into the legislation. A differentiation of the measures to be taken has been introduced on 
the basis of the polymorphisms of the prion protein gene in sheep. For example, derogations to the 
destruction of sheep from infected flocks can be granted when these carry resistant genotypes, and 
different movement restrictions and rules on the introduction of new animals in holdings are based on 
genotypes. Control measures can be also partially different depending on the type of TSE identified: 
measures are stricter in the case of BSE, while specific derogations may be granted when CS or AS 
cases are identified. In addition, some conditions (e.g. a low frequency of resistant genotypes available 
in the sheep breed or holding) are defined for which derogations, such as a delay in the killing and 
destruction of the animals, may be possible. The replacement of killing and destruction of healthy 
animals from infected flocks with slaughter for human consumption is also a possibility, provided 
rapid tests are carried out with negative results. Protective measures have also been incorporated into 
the legislation in relation to milk and milk products coming from CS infected flock for the 
supplementary feeding of lambs. 
Similar to the measures taken in cattle, EU legislation also sets measures aimed at preventing the entry 
into the food chain of certain tissues that may contain high levels of PrPSc in small ruminants. A list of 
SRM that should be removed from sheep and goats slaughtered for human consumption is therefore 
defined and includes the skull (including the brain and eyes), the tonsils and the spinal cord of animals 
over 12 months of age, and the spleen and ileum of animals of all ages. 
4.4. Non-genetic strategies to control Classical scrapie 
Often, at least during the last decade in the EU, CS control programmes have included a combination 
of genetic and non-genetic control measures. 
France may represent an interesting case study as it has applied enhanced surveillance measures, and 
shows a decreasing trend for CS in sheep and goats and for AS in sheep. The decreasing trend in CS in 
goats and in AS in sheep and goats suggests that an intensive surveillance activity by itself (shifting 
from a sample-based to an exhaustive strategy) may represent not only a monitoring tool but also a 
disease control measure. That would be consistent with what has been observed in the case of caprine 
CS in Cyprus,  however, other control measures may have played a role in the case of this country. 
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However, in some cases only non-genetic sanitary measures have been applied, to different extents. 
This is the case, for example, for scrapie eradication plans that have been implemented in Iceland 
(1947 to the present day) and in the USA (1952-2000). The study of these specific control 
programmes can enable some assessment of the possibility of controlling/eradicating CS using only 
non-genetic sanitary policies in areas where the disease is endemic. 
4.4.1. Scrapie control and eradication programmes in Iceland 
Scrapie was first reported in Iceland in 1878, and was initially limited to the northern region of the 
country. 
In 1933 Jaagsiekte, Maedi-visna and Johne's disease were also introduced to Iceland, and in the 
framework of the control of these diseases the country was divided into 36 quarantine areas, divided 
by natural boundaries or man-made fences (see Appendix C). Scrapie was present in three of the 
quarantine areas. All the sheep in the areas where scrapie was observed were destroyed during the 
years 1946 to 1949. Most of the farms which were depopulated were restocked within the same year, 
but some were left without sheep for up to three years. Scrapie recurred within two to four years 
following repopulation in certain farms that had displayed a high incidence of the disease (Detwiler, 
1992), and by 1953, when the first scrapie survey was carried out, the disease has spread from the 
Northern part of the country to other quarantine areas (see Appendix C). 
Considering the possibility that scrapie might spread throughout Iceland leaving no scrapie free areas, 
it was decided, in 1978, to implement a specific control and eradication policy for scrapie. The 
approach was based on the culling of scrapie affected sheep in areas already infected and the culling of 
whole affected flocks in newly infected areas, with restocking not permitted for at least two years, and 
restrictions placed on the movement of sheep and hay (see Appendix C). Before restocking, thorough 
cleaning and disinfection of the farm environment and machinery used, including replacement of 
surface soil in some cases, was carried out, and the first harvest of hay from potentially infected fields 
was not permitted to be used as forage for the new stock. Government inspection was required to 
ensure that procedures were completed to the standards set by the scheme. In addition, the use, for 
animal feeding, of any offal from abattoirs in scrapie-infected areas was prohibited (Detwiler, 1992). 
This plan has been continuously applied since then. In 1986, when the epidemic reached its peak and 
the disease had spread to 25 of the restriction zones, and again in 1993, further enhancements of the 
programme were made. These involved various practical aspects of handling scrapie cases, and since 
2012 different measures have been applied to flocks depending on whether they are infected with CS 
or with AS only. Measures have been accompanied by financial assistance and compensation to 
farmers. 
Throughout this period, extensive surveillance has been maintained on farms and at slaughter to 
identify newly-infected flocks. The surveillance methodologies evolved along with the knowledge and 
techniques in the TSE field. Initially surveillance relied solely upon clinical examination, but since 
1978 it was reinforced by  brainstem testing by histological examination and, later, detection of PrPSc 
by IHC. Georgsson et al. (2006) carried out a retrospective epidemiological study based on data from 
the period 1978-2004. This showed that, despite the eradication measures put in place, recurrences of 
the disease had occurred on 33 farms. Recurrences were observed most frequently 4-7 years after 
restocking of the farms, but cases were also observed as late as 12-19 years following restocking, the 
high persistance of the scrapie agent in the environment (see Section 1.2.5) playing an important role 
in this. 
Rapid testing was introduced in 2004, and since then an average of about 3 500 sheep per year have 
been tested, which corresponds to about 10 % of the slaughtered population and about 0.7 % of the 
adult sheep population. Testing has been focusing on healthy slaughtered animals, with very few fallen 
stock sampled. Following this strategy, 19 scrapie index cases have been detected in the period 2004-
2012 (15 CS and four AS cases) (see Appendix C). 
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Appendix C provides more detailed information with regard to the demography of the small ruminant 
population in Iceland, the testing policy applied and the epidemiology of classical and AS in Iceland, 
together with a historical background on the measures applied in the country to control and eradicate 
the disease, as provided by the Institute for Experimental Pathology (IEP) and the Icelandic Food and 
Veterinary Authority (MAST). 
Overall, the scrapie eradication policy in Iceland has resulted in a substantial decrease in disease 
prevalence. However, despite these 35 years of continuous effort, and the drastic sanitary measures 
that had been applied, the disease has not yet been eradicated. This may, at least in part, be attributable 
to the reduced sensitivity of the surveillance methods used historically (clinical ascertainment, 
histopathology, limited active surveillance of fallen stock).  
4.4.2. Scrapie control and eradication programmes in the USA 
The first case of scrapie in the USA was diagnosed in 1947 in a Michigan flock with sheep of British 
origin imported from Canada. Efforts to eradicate scrapie in the USA started in 1952. The initial 
eradication measures relied on the depopulation of identified infected flocks: once the disease was 
confirmed, the flock was quarantined and depopulated, and exposed sheep sold from the flock were 
traced and slaughtered. In 1957 depopulation was extended to source flocks and to all those animals 
sold from source flocks. 
Modifications of this approach were made throughout the years; however, the main focus remained on 
total flock depopulation. This changed as of 1983, when the policy was amended with the adoption of 
the bloodline/surveillance programme. This required removal of the maternal bloodlines of a scrapie-
infected sheep or goat from the flock/herd, followed by a reinforced surveillance of the remaining 
animals for 42 months for evidence of scrapie. The change was made both because of a lack of 
resources to continue funding of total depopulation, and to limit underreporting of the disease by 
farmers, and because of the failure of the depopulation policy in eradicating scrapie. However, in 1985 
it was concluded that the bloodline/surveillance programme should be abandoned because it had not 
been effective. 
From 1991 the scrapie eradication programme for scrapie was again modified: the new programme 
included depopulation with indemnification for all known infected and source flocks, measures on 
identification for movements of sheep from infected or source flocks, and a voluntary flock 
certification programme, aimed at monitoring flocks over a period of five years or more and identify 
flocks free from scrapie. The programme, focused on risk reduction and sound husbandry practices, 
consisted of four scrapie risk levels (Detwiler, 1992; Wineland et al., 1998). 
Wineland et al. (1998) analysed the situation of scrapie in the USA over the 1947 to 1992 period, 
based on reported scrapie cases. During those years, a total of 1 117 clinically affected sheep in 657 
flocks were reported. During the period 1965-1992 the authors identified a slight, significantly upward 
trend of scrapie-positive flocks, which was in part linked to the various changes in the control 
measures put in place. The limited data available did not allow the estimation of the true prevalence of 
the disease, but overall there seemed not to be a clear impact of the control and eradication policies on 
the scrapie prevalence in the USA during this period. 
A study performed in the early 2000s in around 12 500 adult sheep presented for slaughter over the 
different US regions (USDA, 2003) estimated an overall US national prevalence of 0.2 %, based on 
IHC testing of obex, tonsil and retropharyngeal lymph node. 
In the early 2000s the policy was once again modified to integrate the use of PrP genetic criteria into 
the depopulation/repopulation of affected flocks (Detwiler and Baylis, 2003), and a new National 
Scrapie Eradication Program (NSEP) was designed, including a surveillance programme (Regulatory 
Scrapie Slaughter Surveillance (RSSS)) that requires sampling to be performed in different target 
groups (slaughtered animals, fallen stock, suspect animals) (USDA, 2010). 
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4.4.3. Concluding remarks related to Term of Reference 4 
• As shown by the Iceland case-study, detection and eradication measures in affected flocks are 
effective in reducing the observed prevalence of CS in a population with a high prevalence of 
disease. 
• The overall effectiveness of such a policy relies heavily on the detection rate of outbreaks in the 
population. 
• However, because of the persistence of the agent in environment, repopulating scrapie infected 
farms with non-resistant genotype animals can lead to reoccurrence of the disease. 
• Due to the pathogenesis and the epidemiological characteristics of CS, and to the high persistence 
of the CS agent in the environment, a CS eradication policy that relied solely on detection of 
infected flocks by post-mortem testing and subsequent depopulation would be unlikely to succeed. 
4.5. Breeding for resistance 
Based on the accumulating evidence of the role of the genetic susceptibility in the occurrence of CS, 
breeding for resistance was suggested in the mid 1990s as a new, potentially successful strategy to 
control CS (Schreuder et al., 1997): favouring the diffusion of ARR carriers would have the effect of 
reducing the susceptibility to CS of the ovine population. A few years later, in an ad hoc EFSA 
Opinion (EFSA, 2006) the advantages with regards to ovine CS of a controlled approach based on 
breeding for resistance were clearly highlighted: “the selection process will lead to:  
- a major reduction of human exposure risk, because there is no agent (or extremely low agent 
levels) in tissue from ARR carriers exposed animals; because inter-individual transmission is 
theoretically impossible or reduced, considering that ARR animals are not sufficiently 
susceptible and, if infected, the involvement of the lymphoreticular system or tissues other 
than central nervous system is highly reduced or absent;  
- a major control of the animal health problem considering that inter-individual transmission is 
reduced.” 
4.5.1. Definition of a breeding programme 
A breeding programme (BP) aims at modifying the distribution of one or more traits in a group of 
animals in a direction considered as positive. This is achieved in practice through the identification, 
phenotyping, selection and reproduction of breeding animals. In the case of the PRNP gene, after 
identification, animals have to be genotyped at the PRNP locus and those carrying favourable alleles 
used as breeding animals in order to increase the resistant allele frequency in the next generations.   
In this sense, the strategy of simply culling susceptible animals and replacing them with resistant 
animals is not strictly a BP, although this approach, which is generally used in outbreaks and in some 
cases tends to be replicated even in healthy flocks, has a dramatic effect on allele frequency. 
All BPs require three main components: 
(1) Phenotyping step, including an identification and recording system, with information on 
pedigree, phenotype and genotype. In the framework of BP-CS, this step in practice consists in 
the genotyping of animals, and therefore this Opinion will refer to this step as the ‘genotyping 
step’ from here onwards. 
(2) Selection step, including the definition of rules for the qualification of reproducers based on 
the records, and rules for a differential use of animals as reproducers depending on their 
qualification. 
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(3) Dissemination step (i.e. to disseminate resistant reproducers to otherwise non-participating 
flocks), if the previous steps are applied just to part of the population involved in the 
programme. 
If these requirements are universal, the practical organisation of a BP is extremely versatile. The 
simplest situation is that, within a flock, selection is organised by the flock owner. In the most 
sophisticated plans, males are assembled in breeding centres, individually phenotyped for traits such 
as feed conversion rates and functional aptitudes, and the best animals progeny tested on sex limited 
traits or carcass composition, with an extensive use of artificial insemination to disseminate the very 
best in the whole population. 
Generally, BPs are applied to groups of animals belonging to the same breed with a pyramidal 
management of the population: at the top a subset of flocks (hereafter described as nucleus population 
or high genetic merit flocks (HGMF)) owned by breeders sharing the same objectives and rules for the 
improvement of their animals where the three steps are applied and, at the bottom, flocks that  
commercialise the majority of animal products (commercial flocks (CF)), and to which the 
dissemination step is applied. The relative size of HGMF with respect to CF has to be taken into 
account when a BP-CS is conceived. 
A selection scheme focusing only on the improvement of resistance to CS is a very simple case since 
the trait is unique, only one gene (PRNP) is involved and the relationship between its alleles and the 
trait (i.e. resistance to CS) is very strong. This scheme would simply require single locus genotyping 
(the genotyping step), rules for the elimination of carriers of unfavourable alleles and for the use of the 
ARR carriers (the selection step) on a large scale, including their dissemination in commercial 
population (the dissemination step). 
Even if breeding for CS resistance appears simple, effective implementation of such designs in the 
field is not straightforward. The genotyping step requires long term identification of animals on a large 
scale, organization of DNA sampling campaigns in dispersed flocks, the setting up of a network of 
laboratories able to perform correct genotyping with high quality control, and centralised data banks 
with all the human and computing resources for fast and exact merging of data. The selection and 
dissemination steps need the definition of unambiguous rules, and ways to require breeders to apply 
them correctly.  
Partly to face this complexity, in many countries it appeared more efficient to put the implementation 
of BP-CS in the hands of a first tier (HGMF) of farmers able to manage selection tools. This generally 
accepted solution has two consequences: 1) CS resistance is only one of the traits considered in the 
breeding objectives and BP-CS design, and 2) the final success of BP-CSs, to be measured at the 
whole population level, depends upon an efficient dissemination step from HGMF to CF. 
When selection for CS resistance exploits a pre-existing breeding stucture built to genetically 
improving production traits, it must be accepted that selection of the PRNP gene can affect other traits 
of interest by different mechanisms (Elsen et al., 2006; Dawson et al., 2008). The PRNP gene may be 
either directly involved or closely linked to a gene affecting the genetic determinism of a trait. In the 
latter case, the potential effects depend on the strength of the linkage and the phase that may be 
positive (favourable alleles inherited with resistant PRNP alleles) or negative (unfavourable alleles 
inherited with resistant PRNP alleles). The linkage phase is expected to differ between populations or 
between families within a given population, according to the distance between the 2 loci, so that 
associations that are beneficial in one population (family) may be deleterious in another. Several 
studies showed that no association exists bewtween the PRNP gene and the most relevant economic 
traits in the sheep industry (Vitezica et al., 2005; Vitezica et al., 2006; Vitezica et al., 2007; Sweeney 
and Hanrahan, 2008; Gubbins et al., 2009). Regardless of this, the introduction of CS resistance as a 
selection objective leads to a lower selection intensity on the other traits. Moreover, a loss of genetic 
gain on production traits is expected because of the different selection pressures applied on resistant 
and susceptible genotype classes. Indeed, resistant rams are selected even if they show low genetic 
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merit for the other selection traits, whereas susceptible rams are selected only if they show high 
genetic merit for the other selection traits. A BP-CS which exploits a pre-existing breeding structure 
may benefit, in terms of effectiveness, when relationships with selection for production traits are 
considered (see for example the BP-CS implemented in Sardinia (Italy), described in Appendix E). 
Thus, inclusion of selection for CS resistance in already existing BPs cannot be summarised as the 
simple implementation of a genotyping scheme. Genotyping for PRNP is one of the steps of BP-CS, to 
be followed by an appropriate qualification of selected candidates and their consistent use as 
reproducers. This implies that the emphasis put on selecting ARR carriers and/or eliminating 
susceptible allele carriers (selection pressure) is generally limited. Practically, this means that some 
ARR carriers may be excluded from reproduction due to their low estimated breeding values (EBV) 
for the other selection traits or vice versa some homozygous susceptible animals may be used as 
breeding animals due to their high genetic merit for the other selection traits, unless CS resistance is an 
overwhelmingly desirable trait (e.g. in Cyprus). The way of managing the selection for more traits can 
strongly affect the result of the BP-CS. Different choices are probably driven by decisions related to 
CS prevalence and the starting allele frequencies. 
In some other countries BP-CSs were not restricted to the first tier, but rather implemented in a 
uniform way in all flocks, including commercial ones (e.g. The Netherlands, 2005-2007). In other 
cases (e.g. Sardinia (Italy), see Appendix E), CF were involved in the genotyping and selection steps 
only after HGMF reached high resistant allele frequencies with the aim of accelerating the substitution 
rate of susceptible animals or as HGMF was not large enough to fulfill the needs of ram replacement 
in the overall sheep population. 
4.5.2. Principles for assessing the effectiveness of breeding programmes 
The effectiveness of a BP-CS in a given population would ideally be measured by the observed 
evolution of PRNP genotype distribution in the whole population (HGMF and CF). Unfortunately, this 
information is accurate only, very generally, in the HGMF. Thus, the potential evolution of PRNP 
genotype distribution in CF has to be inferred from information about the BP-CS organisation using 
appropriate mathematical models describing the selection in HGMF and dissemination to the CF. 
However, such models are always an oversimplified representation of the real implementation of the 
selection tools, and the actual selection based on PRNP genotypes has to be estimated from the 
observed genotype evolution in HGMF. Thus, three components are needed: 
a) The observed evolution of PRNP genotype distribution. 
This is the most comprehensive  indicator of effective selection pressure. This evolution has to be 
evaluated in a reference class of animals along generations, to avoid bias. For example, it may be a 
random sample of animals before any selection step, all rams entering the breeding centre, or a 
sample of females kept as new reproducers. Finally the simplest approach would be a comparison 
of PRNP allele/genotype distribution in similar animal class at the start of the selection scheme 
and later on during its implementation. It provides information on the consistency of the decision 
rules established by the breeding organization.  
b) The potential evolution of PRNP genotype distribution. 
The effectiveness of efforts made to improve CS resistance, by a breeder organisation or a MS, 
may be estimated using ad hoc mathematical models to forecast the evolution of the PRNP 
distribution given the situation and programme implemented. Based on population and 
quantitative genetics concepts, mathematical models help in optimising the design and evaluating 
the efficiency and profitability of BP-CSs. Simple models estimate long-term annual genetic 
progress, i.e. the linear evolution of the trait mean as an effect of selecting a population in the 
same way over a long period of time (Rendel and Robertson, 1950; Smith and Cimasoni, 1967; 
Bulmer, 1971; Bichard et al., 1973; Elsen and Mocquot, 1976). More classical population genetics 
models are also available, which describe the evolution of allele frequencies at a locus submitted 
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to a selection pressure (Crow and Kimura, 1970; Bulmer, 1971; Hill, 1974; Fournet-Hanocq and 
Elsen, 1998). Again, such models may be used for management or evaluation purposes (Hinks, 
1970; Brascamp et al., 1993; Schaeffer, 2006). The consequences of BPs mixing the 
‘improvement of production’ traits (polygenic) and resistance to CS (monogenic inheritance) may 
be predicted by merging these mathematical models (Lande and Thompson, 1990; Dekkers and 
van Arendonk, 1998; Manfredi et al., 1998; Pong-Wong and Woolliams, 1998). 
Major inputs of the models are: (i) the distribution of the PRNP genotype before selection, and (ii) 
the expected selection pressures put on these genotypes, generation after generation. 
Such modelling gives the expected evolution of PRNP genotype distribution, which depends on 
the starting frequencies of genotypes, the number of animals genotyped, and the contribution of 
each reproducer’s class to the next generation. Such classes are defined by the sex, age and 
reproductive roles of individuals. For instance, rams used in the flocks may be a mix of animals 
classified as representing the medium of the range after the observation of their pedigree and their  
phenotypic value, and animals classified as elites after a progeny test. The potential effectiveness 
indicates the expected time for the BP-CS to reach its objective, and its relative costs in terms of 
genotyping.  
c) The observed selection of PRNP genotypes.  
This approach aims at estimating, from the observed evolution of the PRNP genotypes, what effort 
was put on the selecton for this trait in practice, and can be obtained from field data. It should be 
estimated for those selection steps which include, at least partially, a choice of animals based on 
their genotype, and quantifies the distance between the intention of the plan and what has been 
achieved in practice. Indeed, modelling the potential evolution of the distribution of selected traits 
is always an oversimplified representation of the real implementation of the selection tools. For 
various reasons (e.g. the individual farmer’s preferences for certain morphological types, calendar 
constraints linked to seasonality and market prices, limited acceptance of the shared selection 
rules, selection for production traits, variability of allele frequency across other areas, breeds, or 
flocks within a MS) only a small part of the planned selection pressure is generally applied in 
practice. The concept of effective (observed) ‘selection differential’ defined by Falconer in 1960 is 
a response to this difficulty (Falconer, 1981; Thompson, 1986). The observed selection 
differential, rather than estimating the evolution from the announced selection effort, measures the 
selection effort from the observed difference between candidates and selected animals. 
Considering both the potential evolution of PRNP genotype evolution and the selection effort, 
helps to evaluate how an announced BP was applied in the field, and its management.    
The three approaches described above are complementary, and need to be applied together. The 
observed evolution of PRNP genotype distribution is a simple and global measure of the achieved 
effectiveness of a BP-CS. The potential evolution of PRNP genotype distribution is more difficult to 
estimate, both because it needs the development of an ad hoc model, and because this model has to be 
fed by input data that are not easily available. However, the comparison between them gives an 
evaluation of the quality of the application of a BP-CS in the field. Moreover, comparing the potential 
and observed evolution of PRNP allele frequencies allows discrimination between negative results 
(poor evolution of the PRNP genotype frequency) due to incorrect design of the selection scheme, and  
the unsatisfactory management of promising plans. Finally, the observed selection of PRNP genotypes, 
which needs to record the details of PRNP frequency evolution, identifies the limiting factors of the 
application of BP-CSs (e.g. at which selection steps the genotypes were incorrectly considered when 
choosing future reproducers). 
If these indicators are needed to understand the evolution of the PRNP genotype frequencies in 
HGMF, they must be complemented by an assessment of the dissemination of the expected progress in 
CF, the second tier of the whole population.  
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Most often, this dissemination is operated simultaneously in different ways: it concerns males 
(possibly semen only) and females; males may be sold by individual breeders to CF owners (a very 
general situation) or under the control of the breeding scheme organization (e.g. the flock book) after a 
qualification step (as young rams, after a performance test period or at the end of a progeny test). The 
dynamics of genotype frequencies in a hierarchical population with a nucleus creating genetic progress 
and a second tier making profit of this progress via the diffusion of reproducers from the nucleus, has 
been deeply studied in the past (Bichard et al., 1973; Elsen, 1980; Shumbusho et al., 2013). When the 
trait of interest is polygenic it has been demonstrated that, as soon as a non-zero proportion of the 
reproducers of the second tier originated from the first, and whatever this proportion, the two sub 
populations progress at the same speed (equal annual genetic progress), with a constant lag between 
nucleus and commercial which depends both on the proportion (higher proportion, lower lag) and on 
the selection differential applied on the animals sent to the second tier. The dynamic for monogenic 
traits (the PRNP case) is more complex since a constant selection differential does not give a constant 
response due to the change in gene frequency (Dekkers and van Arendonk, 1998; Costard et al., 2009). 
For various reasons, only a limited proportion of the rams used in the commercial flocks may come 
from the nucleus, even if the ratio between the size of the HGMF and the total number of replacement 
reproducers in the CF is large enough to supply all of them. Here again, this evolution should be 
estimated in a certain class of animals at the start of the selection scheme and later on during its 
implementation. 
The potential evolution of PRNP genotype distribution in the global population may also be estimated 
using ad hoc mathematical models. The most important elements of the models are the proportion of 
new reproducers which were born in HGMF (males and females) and the way they were selected 
(based on the PRNP genotype). The maximum number of reproducers sent to CF is proportional to the 
size of HGMF (‘Nn’), while the total number of replacement reproducers in the CF is proportional to 
the size of this tier (‘Ng’). Thus the ratio ‘Nn/Ng’ is a good indicator of the capacity of the nucleus to 
fulfil its role, and provides information about the potential evolution of PRNP genotype distribution in 
the global population. However, field data to monitor the actual flow of reproducers form HGMF to 
CF is needed. In practice, many factors may affect the predicted flow. For instance, the absence of a 
centralised management of reproducers may have the consequence that a relevant portion of ARR 
animals are excluded from reproduction since they exceed the ability of a single breeder to raise them. 
4.5.3. Breeding programmes for resistance to Classical scrapie in EU Member States 
Information on the implementation of BP-CS in the EU has been gathered by different means, as 
anticipated in Section 4.2. In the EU, a total of 17 MSs have implemented or are currently 
implementing a BP-CS, the earliest being implemented in 1998 in the Netherlands, while the most 
recent started in 2012 in Romania. Austria, Bulgaria, Denmark, Finland, Latvia, Lithuania, Malta, 
Poland, Portugal and Sweden have not implemented a BP-CS. Details on the start and end years of 
BP-CS implementation in the EU MSs are reported in Table 2. 
As already mentioned, a questionnaire (see Appendix A.2) was developed and distributed to the 
different MSs. It was constructed on four pillars, that were considered the four principal elements 
constituting a BP-CS: 
• The population structure: numbers related to total populations, to their subdivision in flocks and to 
the percentage of HGMF vs total population. These were required to know the frame in which 
each MS has to operate. 
• Genotyping effort (BP-CS’s genotyping step): it is clear that this action is fundamental in order to 
obtain a high number of resistant animals to use in a BP-CS. Thus information was required about 
the number of animals genotyped in HGMF and in CF, the period over which the genotyping has 
been undertaken and the proportion of males that are genotyped relative to females. 
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• Rules for selection of rams (BP-CS’s selection step): a genotyping effort can be valid only if 
genotyped rams are properly selected for use afterwards. Information on the presence of rules for 
ram selection and for follow up of the selection made were requested from MSs. In this section the 
starting and final frequencies of resistant animals in the genotyped populations were also 
requested. 
• Rules for dissemination of rams (BP-CS’s dissemination step): given that most of the MSs 
concentrated the genotyping mainly or exclusively on HGMF and in the absence, in most cases, of 
an accurate value related to ARR allele frequency in the general population, rules for the 
dissemination of resistant rams and the presence of controls on their compliance were requested, 
in order to indirectly evaluate the effectiveness of the flow from HGMF to CF. 
Replies to the questionnaire were obtained from: Belgium, Cyprus, Czech Republic, Estonia, France, 
Germany, Hungary, Ireland, Italy, The Netherlands, Slovakia, Slovenia, Spain, UK. 
4.5.4. Assessment of breeding programmes for resistance to Classical scrapie in EU Member 
States 
4.5.4.1. Methods 
The only accurate way to assess the effectiveness of the MSs’ BP-CSs would be to know the precise 
frequency of the ARR allele, and the animals with resistant genotypes, in the general ovine population. 
In the absence of this information, the effectiveness of BP-CSs has been initially evaluated through a 
descriptive analysis of the replies to the questionnaire. 
The four components of the questionnaire were evaluated separately for each MS. The evaluation was 
carried out based on the assumption that the diffusion of ARR allele to CF is mainly determined by: 
• the relative size of HGMF vs. CF tier: the higher the relative size the higher the proportion of 
replacement of CF breeding rams potentially coming from HGMF; 
• the proportion of new rams genotyped in HGMF: the higher this proportion, the higher the number 
of genotyped rams available for CF; 
• the proportion of ARR carrier rams in HGMF: the higher this proportion, the higher the number of 
ARR carriers available for dissemination to CF; 
• the presence of, and compliance with, rules modulating the diffusion of rams from HGMF to CF 
which permit the dissemination of ARR carriers only. 
A deterministic model was then developed to: i) compare the potential and observed evolution of 
PRNP genotype distribution in HGMF, and ii) evaluate the dissemination towards CF. 
The model was based on the approaches defined in Section 4.5.2. The observed evolution of the PRNP 
genotype distribution in HGMF (component 1) was compared to the potential evolution (component 2) 
obtained through a model describing the selection design. When a large discrepancy was observed 
between observed and predicted evolution of PRNP genotypes, the observed selection of PRNP 
genotypes in HGMF (component 3) was used to adjust the model parameters, through an adjustment 
factor (‘rate’), which describes the selection pressure put on traits other than PRNP genotype. Potential 
evolution in the CF was estimated with this adjusted model. 
The core of the model is a diffusion process as described, for instance, by Dekkers and Chakraborty 
(2001) and Costard et al. (2009). The population is divided into classes of animals sharing the same 
sex, age and tier. Each class is described by its PRNP genotype frequencies at a given year. The 
evolution of these parameters follows a Markov process which involves ageing, replacement and 
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selection steps. All elements of the diffusion equations are estimated from the input parameters. 
Details on the model used, including an explanatory diagram, are reported in Appendix F. 
The quantitative assessment has been carried out only for MSs included in the analysis of the 
epidemiological trend (Chapter 3) and that provided replies to the survey (i.e. Belgium, Cyprus, Czech 
Republic, France, Ireland, Italy, The Netherlands, Slovakia, Slovenia, Spain, United Kingdom), since 
the aim was to compared the type of BP-CS with the observed trend of CS, as explained in Section 
1.1. For the United Kingdom, because of a lack of data on some input parameters for the model, the 
analysis has been carried out using data relating to Great Britain only (referred to as United Kingdom 
(GB) from now onwards). 
Table 2 contains an extraction of some data from the replies to the above mentioned questionnaire for 
MSs by which the BP-CS was assessed, and some other parameters, calculated from data collected 
through the questionnaire, which were used as inputs of the deterministic model, or that are crucial for 
their calculation. Where needed, values reported in Table 2 were obtained through approximations and 
assumptions from available data, as further explained in the table. Detailed information on the 
parameters used in the model is reported in Tables 10 and 11 (Appendix F). 
4.5.4.2. Limitations and uncertainties of the model 
The deterministic model is based on a number of assumptions and approximations. Amongst these, the 
most important are that the progress in favourable allele frequency is only due to the selection of rams, 
and that genotypic frequencies in females equalled the values reported for the males, which is an 
optimistic assumption. 
Limitations in the data available also influence the outcome of the model. For example, some 
parameters on the sheep population structure were not available from some MSs, and had to be 
estimated on the basis of specific assumptions, as indicated in Table 2. Variations in the population 
structure over the years were also not available. In other cases, the collected data showed some 
potential inconsistencies. For example, this was the case for the ARR allelic and genotypic frequency 
in the population in some MSs. These values were estimated assuming that the correct value was 
provided for the ARR allelic frequency (see Table 2 and Appendix F), which, ultimately, might not be 
accurate. Some data collected from MSs through a questionnaire survey (see Section 4.2) represented 
average values over the years, as in the case of the number of animals genotyped in HGMF and CF, 
while the precision of the model outputs would benefit from using actual year-by-year data. 
The model assumes that sheep populations in MSs have uniform characteristics, but the actual 
heterogeneity of the population and of the implementation of BP-SCs also influence the evolution of 
the genetics over time. Based on the information provided, different types of BP-SCs and of types of 
dissemination of resistant rams from HGMF to CF were assumed, and used as input of the model (see 
Appendix F). However, these classifications are based on limited qualitative information provided by 
the MSs with variable degrees of detail. 
An additional source of uncertainty originated from the unknown effort that each BP-CS put on the 
concurrent selection for non-scrapie traits: this led to the need to apply an empirical country-specific 
adjustment parameter (see Appendix F). 
Consequently, the results obtained from the use of the deterministic model should not be considered as 
trustworthy point estimates of the ARR/ARR frequency in the sheep population of each MS by tier 
and over time. However, the model has been helpful in describing the national trends of the potential 
evolution of the ARR/ARR frequency, based on the characteristics of the BP-SC, and is a valuable 
tool to inform the comparison the potential evolution of the resistance to CS in the sheep population 
with the trend of CS in the different MSs. 
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Table 2:  Extraction of some data on the characteristics of BP-CSs from replies obtained by MSs for which the BP-CS was assessed, and additional 
parameters, calculated from data collected through the questionnaire ‘Breeding programmes’, which were used as input of the deterministic model, or that are 
crucial for their calculation. Where needed, values reported in the table were obtained through approximations and assumptions from data available, as further 
explained in the footnotes. Detailed information on the parameters used in the model is reported in Tables 10 and 11 (Appendix F). 
Member State Total 
population 
Total 
population 
in HGMF 
(NfH) 
First-last 
genotyping year 
for which data 
are available 
Average 
number 
genotypings
/ year (NG) 
Proportion of 
genotypings 
in HGMF 
(propH) 
Proportion of 
genotypings 
in males 
(propM) 
Annual HGMF 
replacement 
rate for males 
(rnmG) a 
Observed ARR allele 
frequency (HGMF) 
Observed ARR/ARR 
frequency (HGMF) 
first year last year first year last year 
Cyprus 304 894 304 894b 2004-2012c 86 750 1.00b 0.60d 20.48 0.40e 0.99 0.16c 0.76b 
France 5 541 149 536 466 2002-2012 70 300 1.00 0.50 7.86 0.49 0.85 0.26 0.72 
Ireland 3 430 300 127 933f 2004-2012 9 418 0.97 0.53 4.54 0.86 0.998 0.62 0.84 
The Netherlands 1 334 252 66 713g 2005-2013 26 900 1.00h 0.42h 20.32 0.38i 0.70i 0.17i 0.52i 
Slovenia 86 535 13 111 2006-2011 3 649 1.00 0.15 5.02 0.38 0.55 0.14j 0.13 
United Kingdom (GB)k 15 200 000 7 690 000 2002-2008 700 000 1.00 0.20 2.18 0.50 0.69 0.29 0.54 
Belgium 185 624 32 573 2005-2012 733 1.00 0.58 1.57 0.87 0.98 0.76j 0.79 
Czech Republic 159 324 23 217 2003-2012 4 297 1.00 0.34 7.57 0.53 0.85 0.22 0.51 
Italy 7 310 739 529 741 2005-2013 34 734 0.42 0.56 1.85 0.47 0.70 0.23 0.50 
Slovakia 416 952 27 184 2004-2011 3 590 1.00 0.66 10.44 0.395 0.402 0.19 0.51 
Spain 16 609 069 2 157 070 2003-2012 355 214 0.91 0.09 1.56 0.28 0.48 0.11 0.25 
a  Ratio of new HGMF rams genotyped to males needed for replacement (see Appendix F for details on its calculation). 
b  Cyprus makes no distinction between HGMF and CF, and all flocks are considered as a single tier with respect to the BP-CS. 
c  Despite the BP-CS in CY starting in 1999, data in relation to 1999 were insufficient to be used an input in the deterministic model and therefore for this purpose the starting year was 
assumed to be 2004, based on answers from 2010 Commission questionnaire (see Appendix F for details). 
d   In the absence of information on the division of genotyping effort between males/females, it was assumed that all male newborns were genotyped, which leads to the estimation propM=0.60. 
e  Value estimated from ARR/ARR frequencies, assuming HWE is respected. 
f  Number of sheep in HGMF was not reported, and has been estimated based on the number of flocks in HGMF vs. CF, and assuming a similar average size of HGMF and CF. 
g  Approximate number, estimated on the basis of information provided in the questionnaire. 
h  In the absence of information on the division of genotyping effort between HGMF/CF and males/females, it was assumed that all male newborns were genotyped, which leads to the 
estimation propM=0.42. 
i  These values refer to the whole population (HGMF+CF), as reported in the answer to the questionnaire. 
j  Since values collected with the questionnaire were not consistent with allele frequency (HWE not respected), these values were estimated from ARR allele frequencies, assuming HWE is 
respected. 
k  Because of a lack of data on some input parameters for the model, the analysis has been carried out using data relating to Great Britain only. 
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4.5.4.3. Descriptive analysis of the replies to the questionnaires 
• Population structure 
Ireland, France, United Kingdom (GB), Italy, Spain and The Netherlands have large populations 
of more than 1 000 000 heads. The HGMF sheep population in the different MSs ranges from a 
percentage of 3.7 % (Ireland) to a percentage of 50.6 % (United Kingdom (GB)). Most of the 
countries are below 15 %. Cyprus has no distinction between HGMF and CF, and all flocks are 
considered as a single tier with respect to the BP-CS. 
• Genotyping effort 
Nearly all the MSs apply genotyping to the HGMF population only. Spain and Ireland are doing 
some genotyping in the CFs too, while more than half of the genotyping performed in Italy targets 
the CF. In Cyprus all flocks are genotyped. With regard to The Netherlands, in the absence of 
information on the division of genotyping effort between HGMF/CF and males/females, it was 
assumed that all male newborns were genotyped. Genotyping involves a high percentage of flocks 
of the HGMF tier in almost all countries (the figure was not available for Belgium). Generally, 
some females are genotyped, at different percentages and with different aims. 
• Rules for selection of rams 
All the MSs have rules for ram selection and an audit system to check compliance with these 
rules, except Ireland. In all the MSs an increase of the frequency of resistant animals in the target 
population has been achieved. When considering the results from the last year of genotyping, the 
resistant animals in HGMF are on average around 54 % whereas in Spain and Slovenia they are 
still at relatively low frequency (25 % and 13.4 % respectively). 
• Rules for the dissemination of rams 
Ireland and United Kingdom (GB) have no specific rules for dissemination. Belgium, Cyprus and 
The Netherlands allow the dissemination of ARR/ARR rams only. The percentage of compliance 
with the rules is above 80 % of the flocks in nearly all MSs. Italy, Slovenia and Spain have a 
percentage of compliance of 61-80 % (as defined by the questionnaire). All the MSs with rules 
have an audit system in place. The percentage of CFs that have introduced resistant animals from 
the HGMF is declared to be high in Cyprus, Czech Republic, The Netherlands, Slovakia (81-
100 %), 61-80 % in UK, 41-60 % in France and in Italy, 21-40 % in Slovenia and Spain. No such 
estimation of the value was provided with regard to the situation in Belgium and Ireland. 
The overall review showed a generally satisfactory organization of the BP-CSs in the different MSs. 
However, some weaknesses were found, such as the low percentage of HGMF in the majority of the 
MSs, the lack of rules for selection and dissemination in Ireland, the still relatively low frequency of 
resistant animals in the target populations in Slovenia and Spain, the lack of effective rules for 
dissemination in Slovenia, Spain and Italy, and a relatively low percentage of CFs that have actually 
introduced resistant rams from HGMF in France. 
4.5.4.4. Quantitative assessment through the deterministic model 
When analysing the input parameters of the model, a large discrepancy with the Hardy-Weinberg 
Equilibrium (HWE) in the initial ARR allele and ARR/ARR frequencies in three cases (Slovenia, 
Belgium and Slovakia) suggested that the information concerning the initial situation was not fully 
reliable for these values. Moreover, the adjustment factor (rate) was highly variable between countries 
(from 0.14 to 1.0, see Tables 10 and 11 in Appendix F). 
To assess the effectiveness of the national BP-CSs, to try to infer their potential impact in the control 
of CS, and to compare this with national trends of CS, some parameters obtained through the 
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deterministic model may be particularly helpful. Figures 13 and 14 summarise the main outputs of the 
model, and allow some meaningful comparison by country and by CS trend group (statistically 
significant decreasing trend vs. trend not statistically different from a flat one, see Chapter 3) of the 
main achievements obtained by the national BP-CSs in HGMF, CF and in the whole population 
(HGMF+CF). 
However, when analysing the outputs of the model, it should be borne in mind that a BP-CS, when 
effective, creates a progressive change of allele frequencies. Therefore, summarizing a BP-CS’s 
effectiveness by the final situation only (e.g. the adjusted potential evolution of the ARR/ARR 
frequency in the whole population) is a very incomplete description of the dynamics of the BP-CS and 
is not sufficient, on its own, to evaluate the effectiveness of a BP-CS. Other factors have to be 
considered, such as: 
• The initial ARR allele frequency: in a case where the initial ARR allele frequency is very low (e.g. 
Slovakia), even BP-CSs which rapidly increase the ARR allele frequency to intermediate levels 
may not be able to impact on the CS prevalence. On the other hand, when the initial ARR allele 
frequency is high (e.g. Ireland) the trend of the disease may improve even if the effectiveness of 
the BP-CS is low. 
• The initial CS prevalence: in a case where the initial prevalence is low, an effective BP-CS is able 
to show its effect only on in the longer term. 
• The accuracy of surveillance, which affects the ability to describe the evolution of CS in the 
population. 
• The heterogeneity of CS prevalence and ARR allele frequency within a country (e.g. in terms of 
geographical distribution, breeds and flocks). 
Moreover, the evaluation of the effectiveness of a BP-CS simply based on the raw increase of resistant 
allele frequency may underestimate the effort of MSs where the initial ARR frequency was high and, 
on the other hand, emphasise the achievements of MSs where the initial ARR frequency was low. This 
is due to the fact that the raw increase in resistant allele frequency is higher with intermediate starting 
allelic frequencies than with extreme allelic frequencies even when the same selection effort is 
applied. 
Finally, from an epidemiological point of view, the prevalence of CS in a country at a given point in 
time depends on the genotypes frequencies present years earlier. Therefore, the potential effect of the 
current PRNP genotype distribution may result in a change of the situation only in the future, and its 
interpretation may not be straightforward. The current genotype frequencies are at most an indirect 
indicator of the resistance of the population to CS. 
Figure 13 shows scatterplots of MSs, showing: 
• on the X axes: the initial national observed ARR/ARR frequencies at the start of the 
implementation of the BP-CS (in HGMF in Figure 13(a-b), and in CF in Figure 13(c-d)); 
• on the Y axes: the national adjusted potential evolution of the ARR/ARR frequencies (in HGMF 
in Figure 13(a), and in CF in Figure 13(c)), or their relative increase in 2013 compared to the 
beginning of the implementation of BP-CS (in HGMF in Figure 13(b), and in CF in Figure 13(d)). 
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Figure 13:  On the left, evolution of the ARR/ARR frequency in HGMF (a) and in CF (c) populations at the start of the implementation of the BP-CS and as 
estimated in 2013 (‘HGMF end’ and ‘CF end’) for the different countries. On the right, relative increase of the ARR/ARR frequency in HGMF (b) and CF (d) 
population from the start of the implementation of the BP-CS to 2013 (estimated value: ‘HGMF gain’ and ‘CF gain’) for the different countries 
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With regard to HGMF (Figure 13(a-b)): 
• Three MSs, namely The Netherlands, Belgium and Ireland start from a high ARR/ARR frequency 
in HGMF and show a weak (NL, IE) or null (BE) effect of the BP-CS. 
• Two MSs, namely France and the United Kingdom (GB) show an evolution from an initial 
unfavourable state (ARR/ARR frequency close to 30 %) to a very favourable one (high ARR/ARR 
frequency between 70 and 80 %); in the case of the United Kingdom (GB) this is particularly 
important, since the HGMF population is about 50 % of the whole population. 
• Two MSs, namely Slovenia and Slovakia, show a very high relative increase of the ARR/ARR 
frequency; however, due to a lower starting frequency compared to France and the United 
Kingdom (GB), the final ARR/ARR frequency achieved is also lower. 
• The last group of countries shows a variety a situations, with low ARR/ARR frequency at the 
beginning of the BP-CS, and a large range, but not extreme, increase of resistance. 
With regard to CF (Figure 13(c-d)): 
• Two MSs, namely Belgium and Ireland, start from a high ARR/ARR frequency and do not show 
any effect of the BP-CS. 
• Two MSs, namely Cyprus and The Netherlands, show a dramatic change of their situation, from 
an initial unfavourable state (low ARR/ARR frequency, respectively 16 % and 13 %) to a 
favourable one (ARR/ARR frequency of 75 % and 50 % respectively); in the case of Cyprus this 
is a remarkable effect, since this tier represents the whole population. 
• Two MSs, namely France and Czech Republic, show a similar evolution, doubling their initial 
values; however, only in France is an ARR/ARR frequency of 50 % achieved. 
• The last and most numerous group shows a variety a situations, with low ARR/ARR frequency at 
the beginning of the BP-CS, and low or no increase of resistance; the United Kingdom (GB) 
shows a clear decrease in the ARR/ARR frequency in this tier. 
When looking at the mean and median Y values (Table 3) in the two groups of countries defined by 
their CS epidemiological trend (statistically significant decreasing trend (CY, FR, IE, NL, SI, 
UK(GB)) vs trend not statistically different from a flat one (BE, CZ, ES, IT, SK)), they are always 
higher (even though without statistical significance) in the first group compared to the second one, 
suggesting a more favourable genetic evolution. 
Table 3:  Mean and median values of final (2013) ARR/ARR frequency (‘end’) in HGMF and CF 
and of their relative increase (‘gain’) by CS epidemiological trend.  
CS trend HGMF end HGMF gain CF end CF gain 
 mean mean mean mean 
decreasing 0.75 1.34 0.44 1.23 
flat 0.55 1.31 0.37 0.27 
 median median median median 
decreasing 0.77 1.62 0.50 0.68 
flat 0.57 1.59 0.32 0.03 
 
Figure 14 shows the prediction of the deterministic model with regard to the evolution over time of the 
ARR/ARR frequency in the general population (HGMF+CF) for the MSs included in the analysis. 
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Three tendencies can be observed: 
• A relatively flat evolution of the ARR/ARR frequency in the whole population in Belgium, Italy, 
Ireland and Spain, even though those countries started from very different ARR/ARR frequency 
(from less than 10 % to more than 80 %). Three of them (Belgium, Spain and Italy) belong to the 
group of countries where the epidemiological trend of CS was unfavourable, i.e. not statistically 
different from a flat one. In Ireland, despite the fact that the ARR/ARR frequency in the whole 
population did not show any relevant improvement, the favourable evolution of the trend of CS 
may be consistent with the very high initial ARR/ARR frequency. 
• A very strong evolution in most of the countries with a statistically significant decreasing trend of 
CS, namely Cyprus, The Netherlands, France and, to a lesser extent, the United Kingdom (GB), 
where the ARR/ARR frequency in the whole population increases from low levels (15-30 %) to 
very high levels. 
• A moderate increase of the ARR/ARR frequency in the whole population for the other countries 
(CZ, SI, SK), with a very similar slope of the curves, but with varying starting ARR/ARR 
frequencies and starting years, resulting in a large variability of the final ARR/ARR frequency. 
 
 
Figure 14:  Estimated evolution over time of the ARR/ARR frequency in the whole population 
(HGMF+CF) in the different countries. On the left countries with blue squares are the ones with a 
statistically significant decreasing trend of CS in sheep; on the right countries with red diamonds are 
the ones with a trend not statistically different from a flat one. 
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Some considerations are discussed below in relation to the results of the deterministic model for the 
single MSs, grouped according to the observed trend of CS, according to the trend analysis described 
in Chapter 3. More detailed information on the parameters used for the single countries and respective 
results of the model are provided in Appendix F.   
• Countries with a statistically significant decreasing trend in the prevalence of CS: 
- Cyprus: Cyprus is a very specific case since the whole population is involved in the BP-CS. 
The estimated ARR/ARR frequencies in the whole population in 2013 are high, despite the 
fact that the resistant allele was extremely rare in the early stages of implementation of the 
BP-CS. The prediction of the deterministic model is consistent with the characteristics of the 
BP-CS as described in Section 4.5.4.3, in particular the very large genotyping effort which 
allowed a strong selection of rams on their PRNP genotype.  
- France: The BP-CS as described in the questionnaire has a great potential to increase the 
frequency of the ARR allele. However, it is not running at its full speed, and selection of rams 
based also on additional criteria limits the selection pressure on PRNP genotypes. The 
dissemination to the CF probably did not result in more than 50 % of individuals being 
ARR/ARR. As many breeds are present, some not following the rules in a very strict way, this 
global result should be assumed to be heterogeneous within the population.  
- Ireland: The ARR/ARR frequency is very high in both the HGMF and the CF. However, this 
is mainly due to the quite high starting frequency, and the results of the deterministic model 
show a limited increasing trend in HGMF and no increasing trend in CF. Both the relative size 
of HGMF (less than 4 %) and the lack of rules seem to be limiting factors for good results in 
the CF. 
- The Netherlands: The BP-CS implemented in The Netherlands is efficient and correctly 
applied in HGMF. This gives a good evolution of ARR/ARR frequency in this subpopulation. 
If the rule of disseminating only ARR/ARR rams to the commercial flocks was respected, the 
deterministic model predicts that an effect of the BP-CS in the CF would have been observed 
for the last six years (2008-2013). 
- Slovenia: From the deterministic model, the ARR/ARR genotype frequency, starting from an 
unfavourable situation, improved sizeably in HGMF and at a lower level in CF, where it 
doubled. This is consistent with the relative size of the two tiers, and the proportion of HGMF 
rams genotyped. However, the potential evolution, in HGMF, before correction for the extra 
selection pressure on traits other than PRNP genotype, was much higher that the observed 
evolution, showing that the implementation of rules based on ram genotype would to be 
crucial to accelerating results. 
- United Kingdom (GB): The deterministic model suggests that the applied BP-CS had great 
potential to increase ARR/ARR frequency in HGMF. It also shows that dissemination to the 
CF was inefficient, with a negative evolution of the resistance to CS. This result may be 
explained by: i) the almost 1:1 ratio between the two tiers, ii) the absence of dissemination 
rules preventing CF breeders from using susceptible rams born in HGMF, and iii) the low 
selection pressure applied in HGMF. A positive evolution could be predicted to be observed 
from 2016, but the BP-CS was stopped in 2009. 
• Countries with a trend not statistically different from a flat one in the prevalence of CS: 
- Belgium: The ARR/ARR frequency is very high in HGMF and above the mean in the CF. 
However, the evolution in the CF is null, and the high final frequency seems to be due to a 
retention of the high initial frequency. One explanation may be found in the small amount of 
genotyping performed in HGMF (ratio of new rams genotyped in HGMF to males needed for 
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replacement is only 1.57), giving no room for choice of resistant rams to be sent to the CF. 
The low number of genotyped rams along with the rule which permits the diffusion of 
ARR/ARR rams only from HGMF may have reduced the potential evolution in CF mainly 
during the early years of implementation of the BP-CS, when the ARR/ARR ram frequency 
was not sufficient. However, it is likely that in the longer term the BP-CS, after increasing 
ARR/ARR frequency in HGMF, will produce results in CF. 
- Czech Republic: The BP-CS implemented in Czech Republic could be more efficient 
considering the number of genotypes measured and the compulsory rules in place. The 
ARR/ARR frequency after 11 years of selection is much lower than expected, probably due to 
a strong selection of males on traits other than known PRNP genotype. The size of the HGMF 
tier is large relative to the CF, and the dissemination rate could be high. 
- Italy: From the qualitative analysis it seems that poor dissemination would make the BP-CS 
effective only in the longer term, and no positive results would be expected to be visible at 
present. Similarly, the model suggests that the BP-CS may produce results in HGMF but that 
the impact on the general population is not clear. However, the impact of genotyping in CF 
was not modelled. Like France, a better interpretation of results may be achieved by using 
data at a breed level (see for example the BP-CS implemented in Sardinia, described in 
Appendix E). 
- Slovakia: The deterministic model indicates a high positive trend for ARR/ARR frequency in 
HGMF and a positive evolution in CF. The very large amount of genotypings carried out in 
the HGMF, allowing a strong selection in favour of ARR carriers, probably explains these 
results. 
- Spain: The BP-CS as described in the questionnaire has a great potential to increase resistant 
allele frequency. However, even a small pressure on other traits strongly limits the evolution 
of the ARR frequency. This is due to the relatively low proportion of the animals that are 
genotyped being rams, which restricts the selection rate to 0.64 on the male side. The 
dissemination to CF looks very limited. It was assumed in the modelling that there was a strict 
application of the rules (i.e. no dissemination of fully susceptible rams). The majority of the 
genotyping was performed on the ewes, with the declared objectives of flock qualification and 
mating plans. The model does not consider this part of the BP-CS. Its application by the 
breeders shows that PRNP genotype is only a marginal selection objective. 
4.5.5. Interpretation of the lack of a significant trend in the evolution of Classical scrapie in 
some countries 
4.5.5.1. Sheep 
As described in previous chapters, the evolution of the prevalence of CS in sheep in the EU MS during 
the period 2002-2012 is very heterogeneous with some countries detecting a sporadic low number of 
cases, some countries consistently confirming cases with no significant change in the trend and other 
countries in which there has been a statistically significant decline during this period. 
The countries where the trend in the prevalence of CS was not statistically different from a flat one 
over the 2002-2012 period are: Belgium, Czech Republic, Greece, Italy, Romania, Slovakia and Spain. 
In four additional countries (Bulgaria, Germany, Hungary and Poland), CS has been reported only 
sporadically over the mandate period preventing any interpretation of the epidemiological evolution. 
The situation in the above countries with regards to the two main components of the control strategy 
of CS, namely, the cull of infected flocks supported by surveillance for the detection of new cases, and 
the breeding for resistance, is quite variable. It is recognized that all countries comply with the EU 
legislation in terms of quotas for the SHC or the NSHC, as well as with the implementation of 
compulsory eradication measures for infected individuals and flocks/herds. 
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It is not possible to identify causes that can explain objectively the failure to improve the situation of 
CS in specific countries where the disease has been detected consistently during the mandate. Since a 
significant declining trend has been observed in countries where control measures and BP-CSs are in 
place, it is quite plausible that the causes of the unfavourable trend might be linked to ineffective 
implementation of either or both strategies. 
A number of potential reasons to explain the lack of a favourable trend in part of the countries can be 
envisaged, also in light of the information gathered from MSs through a survey on the monitoring 
sampling strategy in EU MSs (see Section 2.3), to which the paragraphs below refer: 
• In relation to the BP-CS: 
- Short duration of implementation of the BP-CS: some countries have not implemented the BP-
CSs for long enough to observe any substantial increase in the overall genetic resistance of the 
sheep population, for example Romania (2012) and Greece (2007). 
- Low ARR/ARR frequency in the target populations when the BP-CS started (e.g. Spain and 
Slovakia). 
- Lack of national coverage of the BP-CS, and in particular regional heterogeneity (e.g. Italy). 
- Effectiveness of the BP-CSs manifested by the low number of genotyped rams in HGMF (e.g. 
Belgium and Spain), the limited rate of selection of rams within HGMF (e.g. Czech Republic, 
Spain and Italy), and the inefficacy of or the lack of rules for dissemination of resistant rams 
from HGMF to CF (e.g. Italy and Spain). 
• In relation to surveillance and non-genetic control measures: 
- Variability and/or reduction of the surveillance pressure: due to changes in the EU 
requirements, countries with less than 750 000 small ruminants ceased the testing of SHC in 
2007 (e.g. Belgium and Czech Republic), leading to a lack of confirmed cases afterwards. For 
example, in Belgium the disease has not been reported since 2008 after some years of an 
apparently decreasing trend. In this country three distinctive periods of different surveillance 
pressure are evident: until December 2003, 3 750 adult sheep/goats were tested within the 
SHC survey. At that point it was decided to stop testing because “the number of animals that 
was tested was not representative of the Belgian sheep and goat population”, as reported in 
the replies to the questionnaire ‘Sampling strategy and control measures’ (see Section 2.3 and 
Appendix A.1). Thus, between January 2004 and January 2006 there were no small ruminants 
tested within the SHC stream. From February/July 2006, all sheep/goats older than 18 months 
were tested, and since July 2007, no more testing of SHC has been conducted. Also the case of 
Czech Republic is not straightforward: an effective BP-CS may have contributed to the 
disappearance of observed cases of disease since 2009. However, as in Belgium, a major 
component of surveillance (SHC) has been interrupted since 2008. 
- Lack of representativeness of the selected animals for testing: over/under representation of 
certain flocks/herds in the SHC and NSHC surveys based on breed, age, geographical areas, 
rendering costs and subsidies (for example in Italy, Romania and Greece).  
- Limitation in data available preventing the detection of trends due to the lack of regular 
detection of cases: trends could not be estimated in countries not detecting cases consistently 
(e.g. Bulgaria, Germany, Hungary and Poland). 
- Short duration and/or the ineffective implementation of sanitary measures due to recent 
admission to the EU (e.g. Romania, Hungary, and Czech Republic), or implementation of  
measures below the EU minimum requirement. In other cases, alternative control measures 
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applied, such as enhanced surveillance in flocks with low CS prevalence instead of the cull 
(e.g. Greece), might have also played a role. 
4.5.5.2. Goats 
In the case of CS in goats, the surveillance efforts are equal to those applied in sheep but with only 
five countries having a goat population larger than 750 000 and being required to test the maximum 
quota (i.e. Greece, Spain, France, Italy and Romania). However, it is not possible to compare the 
patterns of CS in sheep and goats for several reasons, which may also have influenced the absence of a 
favourable trend of CS in goats: 
• Firstly, a difference in the husbandry systems in sheep and goats within countries where CS has 
been confirmed consistently in the goat population. In some cases (e.g. Greece, Spain and Italy) 
there is a high proportion of mixed sheep and goat holdings, which may explain the parallel 
evolution of the epidemic of CS in both species, whereas in other MS the two populations have 
little mixing, presenting different trends (e.g. United Kingdom). 
• Secondly, absence of BP-CSs applied on a large or small scale, and the lack of resistant genotypes 
to be imposed for restocking in infected herds, result in the cull of infected flocks supported by 
surveillance for the detection of new cases, the only tools available to reduce the prevalence of 
CS. In the past, a lack of evidence about the availability of resistant alleles to promote breeding for 
resistance has precluded the implementation by breeders or breed associations of tailor-made 
initiatives to disseminate breeding animals holding resistant alleles or to apply selective culling in 
outbreaks. This was the case of sheep in some MSs well before national BP-CSs were put in place, 
e.g. for Swaledale, Suffolk, Charollais and Welsh Cheviots in Great Britain before the National 
Scrapie Plan was established in 2001. This situation could be reverted now with the mounting 
evidence of satisfactory levels of resistance identified in certain alleles of European breeds (see 
Section 1.2.2). 
• Thirdly, variability of the control measures (which cannot include selective culling) applied in 
infected herds compared to sheep flocks. For example, the most affected MSs (e.g. Cyprus) were 
granted special dispensation from the culling and complete destruction of infected goat herds (the 
only option to apply to infected herds), which was replaced by the killing of animals with clinical 
signs, and the slaughter of healthy animals for human consumption (after testing negative). In 
other cases there was a delay in the implementation of the cull of infected herds (e.g. United 
Kingdom). The favourable evolution of the situation in France (in both sheep and goats) suggests 
the likely effectiveness of a high surveillance pressure in detecting and managing a large 
proportion of outbreaks, which may subsequently lead to a decline of the disease in the general 
population. 
4.5.6. Concluding remarks related to Terms of Reference 1 and 2 
• BP-CSs, which satisfy the minimum requirements of EU legislation, have been implemented by 
17 MSs. Other MSs did not implement BP-CSs, generally because of a favourable situation 
regarding the disease. 
• There is a clear heterogeneity in the characteristics of the different BP-CSs implemented by the 
MSs. There is also heterogeneity within MSs according to different areas, ARR allele frequency in 
the general population prior to BP-CS implementation, breeds and production types. 
• Generally BP-CSs in the EU focus on HGMF and are carried out through three steps (genotyping, 
selection and dissemination), with the aim of increasing the frequency of the resistant alleles in the 
general sheep population. 
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• Such a strategy: 
- requires the dissemination of males from HGMF to CF as a major determinant of the 
effectiveness of the final BP-CS; 
- results in a lag of several years between the initiation of a BP-CS and an effective change in 
the genotype structure of  the general population.  
• Applying a BP-CS does not imply that a genetic control of the disease is achieved. This depends 
on the characteristics of the BP-CS and on its effectiveness, which needs to be assessed based on 
the evolution of the genetic structure of the population. 
• The crucial parameter to assess the effectiveness of BP-CSs in MSs is the frequency of the 
resistant allele in the whole sheep population. 
• In the absence of this parameter, which is generally not available, the potential effectiveness of 
BP-CSs has been assessed in this Opinion through a combination of qualitative expert assessment 
and modelling of the diffusion of CS resistant alleles from HGMF to CF through selected resistant 
reproducers. 
• The result of the dissemination of CS resistant alleles to CF (in terms of the potential evolution of 
ARR/ARR frequency in CF) is not, by itself, a sufficient indicator to evaluate the effectiveness of 
a BP-CS in reducing CS prevalence.  
• The impact of a national BP-CS on the epidemiological situation of CS may be influenced by: i) 
both the ARR allele frequency and the CS prevalence prior to the implementation of the BP-SC, 
and ii) their heterogeneous geographical distribution. 
• Given the characteristics of each national BP-SC, a deterministic model was used to estimate the 
ARR/ARR frequency in the general sheep population over time. Subsequently, the outputs of the 
model were compared with the national CS situations. The results obtained suggest a favourable 
CS situation being linked to better-achieving BP-CSs. 
• Cyprus and the Netherlands, countries in which the improvement in the epidemiological situation 
of CS is clear, applied their BP-CSs to the whole population, without any distinction between 
population tiers. This approach produced an effective change of the genetic structure of the whole 
sheep population, but required extensive genotyping efforts. 
• A more detailed and reliable assessment of BP-CSs would need: 
- A detailed description of the breeding structure of the whole population, possibly by breed, 
with particular reference to the relative size of HGMF. 
- An explicit target for BP-CSs, in terms of time, to get a given ARR frequency in the whole 
population. 
- An information system able to collect: 
 Individual data on identification, genotype, selection, movements (e.g. number  of 
genotyped reproducers moving from HGMF to CF). 
 Population data on the evolution of resistant allele frequencies, estimated through 
representative samples of the whole population. It would be preferable to have 
distinct estimations for each breed. If this is not possible, the sampling strategy 
must take into account breed size. 
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 Effective measures of the amount of reproducers moving from HGMF to CF. 
• Although it is not possible to identify causes that can explain objectively the failure to improve the 
situation of CS, the assessment of the country-specific available data related to the implementation 
of surveillance, non-genetic control measures and BP-CSs may allow the formulation of some 
hypotheses. 
• With regard to sheep, it is quite plausible that the causes of any unfavourable trend might be 
linked to ineffective implementation of either or both strategies. Based on data collected from 
MSs, a number of potential reasons to explain the lack of observation of a favourable trend in part 
of the countries can be envisaged in relation to: 
- The BP-CS: a short duration of implementation of a BP-CS, a low ARR/ARR frequency in the 
target populations when the BP-CS started, a lack of national coverage of the BP-CS, a low 
number of genotyped rams in HGMF, a limited rate of selection of rams within HGMF, and 
inefficiency of, or lack of, rules for the dissemination of resistant rams from HGMF to CF. 
- Surveillance and non-genetic control measures: variability and/or reduction of the surveillance 
pressure, a lack of representativeness of the animals selected for testing, a limitation in 
available data preventing the detection of trends due to the lack of regular detection of cases, a 
short duration and/or ineffective implementation of sanitary measures due to recent admission 
to the EU, or implementation of measures below the EU minimum requirement. 
• With regard to goats, differences in the husbandry systems in sheep and goats within countries, 
absence of BP-CSs, and variability of the control measures (which cannot include selective 
culling) applied on infected herds compared to sheep flocks may explain the lack of observation of 
a favourable trend. The favourable evolution of the situation in France (in both sheep and goats) 
suggests the likely effectiveness of a high surveillance pressure in detecting and managing a large 
proportion of outbreaks, which may subsequently lead to a decline of the disease in the general 
population. 
4.6. Estimating a minimum ARR allele frequency to observe fading-out of Classical scrapie 
Given the very strong resistance of the homozygote ARR genotype to CS, there is a conceptual 
parallel between the ARR homozygote proportion of a sheep population and the proportion 
immunized in a vaccinated population. As a result, in an analogy with the well-known concept of 
critical vaccination coverage (Anderson and May, 1992), one may expect that a minimum frequency 
of the ARR allele in a sheep population exists above which CS may be expected to fade-out. 
4.6.1. The concept of ‘fading-out’ 
It is a basic concept in modern infectious-disease epidemiology that the epidemic spread of an 
infection is under control as soon as the control measures taken reduce the ‘basic reproduction 
number’ (denoted by R0) to a value below one (Anderson and May, 1992). In this situation, each 
infection will cause less than one new infection, and as a result the epidemic will sooner or later come 
to an end (i.e. fade-out). The minimum frequency of the ARR allele in a sheep population above which 
CS may be expected to fade-out is that frequency level for which the R0 for CS in the population 
considered equals one.  
It is important to note that once a sufficiently high ARR allele frequency is obtained (and thus the 
condition R0<1 has been met) in a MS or within a particular breed within a MS, this does not imply 
that after fade-out, if a sufficiently high frequency is maintained, CS cases will no longer occur. 
Rather, CS cases may still occur, either through introduction of infected animals from outside the 
population or from infectivity in the environment, but such cases will no longer pose a risk of causing 
prolonged epidemic spread of CS in the population. 
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In addition, it is important to note that the sheep population in a MS, or of a certain breed in a MS, is 
structured in flocks, and contacts between sheep residing within the same flock will be more intensive 
than that between animals residing in different flocks. This means that it is natural to consider two 
levels of transmission in the population: within-flock and between-flock transmission (Gubbins et al., 
2010). From this point of view, a situation with R0<1 for CS may be interpreted as a situation in which 
isolated within-flock outbreaks of CS may occur but no major between-flock spread will be possible. 
4.6.2. ARR frequency and factors affecting its minimum level for fading-out of Classical 
scrapie 
An analysis of data for The Netherlands has shown that the relative decrease in the prevalence of CS 
in the period 2005-2008 exceeded the relative decrease of the sensitive population (non-ARR carrying 
genotypes) (Hagenaars et al., 2010). This observation indicates that the breeding programme generated 
‘herd immunity’ – expected from the analogy with vaccination – and thus suggests that a minimum 
ARR frequency for CS fade-out indeed exists. In the years since these analyses were published, the 
Dutch CS prevalence found through surveillance has further declined (see Section 3.2.1). It is 
important to note that the minimum ARR frequency is a valid overall minimum level in the population 
as long as there are no large differences between frequency levels in sub-populations. Therefore, if a 
national population consists of several distinct large breeds with substantial differences in genotype 
frequency distribution, the minimum ARR frequency should be calculated for each breed separately. 
The predicted minimum ARR frequency for CS fade-out is not universal, i.e. it is not the same for all 
sheep populations. The reason for this is that the transmissibility of any infectious disease (and thus 
CS in particular) in a given population is not only determined by properties of the agent itself and 
susceptibility properties of the population (i.e. genotype frequencies in the case of CS), but also by the 
prevalence of (further) risk factors which may well differ between populations. The level of lambing 
hygiene may be one such risk factor. A definite risk factor for transmission between flocks is the 
presence of relatively high contact rates between animals from different flocks (caused by co-grazing, 
or by keeping different flocks in relatively close geographic proximity). Likewise, a population in 
which there is a relatively frequent exchange of animals between flocks will be subject to higher CS 
transmission risks. To control these higher risks the predicted minimum ARR allele frequency level 
will be higher. Also, genetic risk factors different from the overall ARR allele frequency level are 
relevant.  Firstly, differences in the level of heterogeneity between flock-level ARR allele frequency 
are expected to have an impact on the minimum ARR allele frequency (Melchior et al., 2010). 
Secondly, the susceptibility properties of the population are not only determined by the ARR allele 
frequency but also the frequency of other alleles in the population. For example, with the CS strain(s) 
encountered in Great Britain and The Netherlands, if sheep population A has a higher VRQ allele 
frequency than population B and all other properties are equal, than the predicted minimum ARR 
frequency for CS fade-out would be higher for A than for B. This is because the remaining non-ARR 
carrying animals in population A are on average more susceptible (VRQ/VRQ and VRQ/ARQ being 
more highly susceptible than ARQ/ARQ in Great Britain and The Netherlands (Hagenaars et al., 
2010)), and thus their frequency is required to be lower to compensate for this. For similar reasons, for 
a given sheep population carrying the VRQ allele, a selective breeding strategy consisting of a 
combination of selecting ARR/ARR rams and selecting non-VRQ carrying ewes for breeding, will 
lead to a lower predicted minimum ARR allele frequency than a strategy based only on selecting 
ARR/ARR rams. For other countries and/or CS strains, the susceptibility pattern across non-ARR 
alleles may be different (Baylis and Goldmann, 2004), leading to a different dependence of the overall 
susceptibility of the population on the frequencies of certain alleles. 
4.6.3. Calculation of the minimum ARR frequency for fading-out of Classical scrapie 
In order to illustrate how the minimum ARR frequency for CS fade-out may be estimated and how it 
may differ between sheep populations, depending on VRQ frequency and between-sheep contact 
patterns, four case-study populations have been considered: sheep in The Netherlands, Sarda sheep in 
Sardinia (Italy), sheep in Cyprus, and sheep in Great Britain (GB). 
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Due to the dependence of the minimum ARR allele frequency on the various factors discussed above, 
data providing information on at least some of these factors is needed to enable a model estimation of 
this minimum level that is not rendered useless by a very wide confidence interval. In the case of The 
Netherlands in particular, the availability of a random flock genotyping sample from a random set of 
flocks in the field gave an insight into the heterogeneity between flock-level genotype distributions, 
and enabled scenario calculations of the minimum ARR allele frequency (Melchior et al., 2009). For 
the other three case study countries/breeds, no such random flock genotyping sample from the field 
was available, and therefore a (relatively) crude model analysis was used, based on input data 
provided by MSs (see Appendix A.4) and on published data (Ortiz-Pelaez et al., 2014a). The reference 
case prevalence was taken from SHC surveillance results for all three case study populations. The 
reference ARR allele frequency was taken from a sample from SHC for GB, and from a sample from 
NSHC for Cyprus (as for Cyprus the SHC sample was likely to suffer from a strong bias towards older 
animals, which have relatively low ARR allele frequencies). For Sarda the frequency of the ARR 
allele in rams genotyped from commercial flocks entering the BP-CS for the first time is used. The 
estimates obtained using the model, should not be considered as trustworthy estimates of the minimum 
ARR allele frequency. These estimates are presented solely for the purpose of illustrating the non-
universality of the minimum ARR allele frequency, and of illustrating the influence of a number of the 
underlying determining factors mentioned above. In line with this, confidence bounds are not 
calculated. In order to illustrate how the model result depends on the assumed CS prevalence in the 
reference year/period, two scenarios are presented for each case study (scenario 1 and 2, see Table 4). 
For the case of the Netherlands a report is available with model scenario calculations of the minimum 
ARR frequency (Melchior et al., 2009). For the purpose of this Opinion, consideration is given to the 
decline in CS prevalence observed in the Dutch active surveillance in recent years, concurrently with 
an increase in the ARR frequency in the Dutch sheep population. In 2013 the latter frequency reached 
a level of approximately 70 % according to random samples from the Dutch active surveillance. 
Recent very low prevalence (only 6 cases in the period 2009-2012 in close to 80 000 tested animals) 
suggests that the minimum ARR frequency for CS control has been reached. It is therefore plausible 
that in The Netherlands the minimum allele frequency required for CS control is in the range of 60 to 
70 percent. As the mandate refers to a minimum allele frequency in the context where no control and 
eradication measure is being applied, there is a need to take into account the effect on the minimum 
allele frequency of cessation of the statutory control and eradication measures. As argued by 
Hagenaars et al. (2010), the effect of this on the reproduction number (and thereby on the minimum 
allele frequency) would be an increase of a few percent. On the basis of these observations and 
arguments it is assumed that the minimum allele frequency for CS control in The Netherlands, in a 
situation where no control and eradication measure is applied, is 70 %. The model calculation for the 
three non-Dutch case studies is based on calculating the R0 for a suitable starting year for which both 
scrapie surveillance data and random genotyping data are available, and subsequently evaluating at 
which minimum ARR allele frequency the R0 is reduced to below 1 when selecting homozygote ARR 
rams for breeding. The calculation is based on scenario assumptions for certain input parameter 
values, and for each of the case study populations two such scenarios are considered. In this crude 
modelling approach there is no explicit structuring of the population into flocks. Instead, the model is 
based on using the population level genotype distribution and the population level CS prevalence, 
which are both defined for a population of animals (and not a population of flocks), as input 
parameters; these are ‘between-animal’ parameters. Population-level random genotyping data in 
healthy slaughter and/or fallen stock and scrapie surveillance data in healthy slaughter are used to set 
these input parameters. The flock level is then included implicitly by using the case of The 
Netherlands to set a parameter that translates from the between-animal to the between-flock level. 
When this approach is applied to a country with a more stratified and/or segregated sheep population 
than the Dutch sheep population, it is likely to lead to underestimation of the between-flock R0. This is 
because ignoring (part of) the structuring of a population will tend to bias the estimated R0 downward 
(Keeling and Rohani, 2008). A further possible difference between countries not taken into account in 
this model is in the contribution of ‘control and eradication measures’ to reducing R0. Although for 
The Netherlands this contribution was estimated to be minor (Hagenaars et al., 2010), this might be 
different elsewhere. Cessation of these measures in that case leads to an increase in the minimum ARR 
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frequency required.  A more detailed description of the modelling approach is provided in 
Appendix D. 
Table 4 lists the model estimates for the non-Dutch case studies together with the input parameter 
values used that were derived from the surveillance and genotyping data. The results for GB suggest 
that only a relatively small increase in ARR frequency would be sufficient to obtain CS control. 
However, additional population heterogeneity due to between-breed differences in GB sheep, not 
taken into account in the model, may in reality lead to a higher minimum ARR frequency requirement. 
In comparison with the minimum level of approximately 70 % for The Netherlands, the predicted 
values of 56 % and 58 % of the two scenarios are low, and this is due to the input parameters which 
represent a lower reference prevalence in susceptible genotypes despite a lower reference ARR allele 
frequency, which may be explained by a combination of less intensive contact rates and lower relative 
abundance of the VRQ allele in GB as compared to NL. 
The results for Sarda sheep in Sardinia also suggest a lower minimum ARR frequency than for NL. 
Here, on the other hand, the reference (starting point) value of CS prevalence in susceptible genotypes 
is higher than for NL (in both scenarios), such that a higher relative increase in ARR allele frequency 
is required to achieve CS control. On the other hand however, at the starting point the ARR allele 
frequency is much lower than for NL reference point. 
The results for Cyprus suggest a minimum ARR frequency close to 100 %, i.e. much higher than for 
the other case study populations. A likely explanation is that contact rates are much higher between 
sheep in different flocks in Cyprus than elsewhere, due to the close geographic proximity of flocks 
located in farming areas on state-owned land. The lack of difference in result between the two 
scenarios for Cyprus illustrates that the input parameters for Cyprus are in a region of values for which 
the model is performing poorly. 
4.6.4. Limitations and uncertainties of the model 
Model calculation of the minimum ARR frequency is used for four case-study populations, as a means 
to illustrate the non-universality of the minimum ARR allele frequency. The model used is crude, as 
lack of more detailed data precluded the use of more detailed models. Consequently, the results merely 
illustrate the influence of a number of the underlying determining factors on the minimum ARR 
frequency, and should not be regarded as trustworthy estimates of the minimum ARR allele frequency. 
One of the reasons why the model is crude is that it uses the case of The Netherlands to set a 
parameter that translates from the between-animal to the between-flock level. When this approach is 
applied to a country with a more stratified and/or segregated sheep population than the Dutch sheep 
population, it is likely to lead to underestimation of the between-flock R0, and thereby of the minimum 
ARR allele frequency. 
Table 4:  Non-Dutch case study results: minimum ARR allele frequencies leading to CS fade-out. 
Breed or country Reference 
year/ period 
Scenario
(a) 
 
Input: 
CS prevalence per 
1 000 in surveillance 
in reference 
year/period 
Input: 
ARR allele 
frequency in 
reference 
year/period 
Result: model 
estimate for 
minimum ARR 
allele frequency
Cyprus 2012 1 2.0 0.706 Close to 100 % 2 0.66 Close to 100 % 
Great Britain 2006-2012 (case prev.) 2012-2013 (ARR freq.) 
1 0.186 0.523 56 % 2 0.256 58 % 
Sarda in Sardinia 2005-2012 1 0.544 0.437 53 % 2 0.777 58 % 
(a) For scenario 1 the point estimate for the case prevalence in SHC is used. For scenario 2 either the upper bound of the 
95 % confidence interval (GB and Sarda), or the 95 % lower bound (Cyprus) is used. Estimated relative abundance of 
VRQ amongst non-resistant alleles: 11.8 % for The Netherlands in 2008, 7.1 % for GB in 2012-2013. 
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4.6.5. Concluding remarks related to Term of Reference 3 
• Given the very strong resistance of the homozygote ARR genotype to CS, there is a conceptual 
parallel between the ARR homozygote proportion of a sheep population and the proportion 
immunized in a vaccinated population. 
• A minimum frequency of the ARR allele in a sheep population can be estimated, above which CS 
may be expected to fade-out. The example of The Netherlands, where CS case prevalence in 
surveillance has become very low in recent years and the ARR frequency is (still) well below 
100 %, provides evidence for the existence of the minimum ARR frequency for CS fade-out in the 
reality of the field. 
• Once the ARR frequency in a MS has increased to above the minimum estimated requirement for 
fading-out of disease, this does not imply that CS cases will no longer occur. CS cases may still 
occur, either through introduction of infected animals from outside the population or from 
infectivity in the environment, but such cases will no longer pose a risk of causing prolonged 
epidemic spread of CS in the population. 
• The concept of fade-out is different from eradication. Whereas eradication involves active 
interventions to remove remaining foci of transmission, fade-out is expected to occur naturally at 
some point in time once a sufficiently high ARR allele frequency is obtained and maintained. 
• The minimum frequency of the ARR allele in the sheep population in a MS above which CS can 
be expected to fade-out, in a context where no control or eradication measure is being applied, is 
not universal and would have to be estimated for each particular national sheep population 
separately. 
• Case studies illustrate the non-universality of the minimum ARR frequency; across the case 
studies it ranges between 53 % and close to 100 % according to a crude model. The case studies 
also provide some insight into how the minimum frequency depends on MS-specific parameters. 
• Maintenance of an ARR allele frequency above the required minimum level needs to be monitored 
by taking representative genotyping samples at regular time intervals. 
4.7. Additional/alternative measures to control Classical scrapie 
Two main operational tools for controlling and eradicating CS have been applied across the EU:  the 
identification and management of infected flocks; and breeding for resistance taking into account the 
evolution of the genetic structure of the population (ARR allele in sheep / potential use of the K222 
and S/D146 in goats) for preventing new cases and outbreaks. The combination of surveillance and 
control measures, together with increased genetic resistance at the population level must be ensured in 
order to achieve successful control of CS. Moreover an overall successful strategy will benefit from 
campaigns aimed at refreshing the knowledge of scrapie among the relevant stakeholders. 
The evolution of the CS prevalence in the EU MSs in the goat and sheep population during the period 
covered by the Opinion (2002-2012) highlights the difficulties of efficiently controlling CS and 
ultimately eradicating it. The positive effect of the current statutory measures implemented across the 
EU has been recognised throughout this Opinion, as reflected in the significant decline in the 
prevalence of CS in sheep in six MSs where a combined strategy of surveillance/control and breeding 
for resistance has been in place. However there is room for improvement of the effectiveness of the 
control measures given the diversity of situations of EU MSs with regard to the size and structure of 
the small ruminant population, the breeding systems and the prevalence of CS. 
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4.7.1. Surveillance and control 
4.7.1.1. Surveillance to detect cases of disease and facilitate its control  
The detection of infected flocks, and the subsequent application of eradication measures, has likely 
played a role in reducing the prevalence and the number of outbreaks in most countries where such 
measures have been implemented (e.g. Iceland, France, UK, Ireland and Cyprus). The approach has 
had a rapid impact (within a few years) on the prevalence of the disease (e.g. Cyprus). 
However, although these measures result in the reduction of prevalence, they are unlikely to result in 
the eradication of disease (i.e. the elimination of all infected cases from the sheep/goats populations of 
a country/region). The impact of these measures depends on their sustained and long term 
implementation, with the subsequent cost in human and physical resources. In a low prevalence 
situation, the number of tests required to detect a new outbreak increases substantially. 
A risk-based approach, targeting subpopulations with a higher risk of disease, would improve the 
detection of new cases.  
It is recommended that: 
• The detection of infected flocks and subsequent disease control will be improved by additional 
risk-based targeted surveillance activities and/or a substantial increase in the tested fraction of the 
population.  
• If additional targeted risk-based surveillance is implemented, data collection enables the 
discrimination between results generated through the continuation of the current surveillance and 
any additional targeted risk-based surveillance. 
• Even after restrictions are lifted, infected flocks are considered at risk and targeted for enhanced 
surveillance, unless they are composed entirely of resistant animals. 
4.7.1.2. Surveillance to monitor the epidemiological evolution in time and space 
The epidemiological evolution of scrapie in the EU is mainly based on data gathered from active 
surveillance. The current EU scrapie active surveillance program, is based on two sample-based 
surveys, with quotas assigned to MSs according to the size of each small ruminant population. 
Assessment of the compliance of MSs with the current EU regulations is beyond the scope of this 
mandate, and the information collated for this purpose had as its only target the assessment of the 
quality and completeness of the data used for the trend analysis. To optimise the efficiency of disease 
surveillance, it should be designed individually for each MS according to the estimated prevalence of 
disease, a predefined precision level, and specific national characteristics of the industry (e.g. 
population size, demography, number of breeds, breeding and production systems). 
It is recommended that: 
• TSE surveillance programmes in small ruminants: 
- are adapted to each MS (number of tests, targeted populations); 
- have a standardised audit/verification system to ensure the correct implementation of control 
measures; 
- include a data collection system facilitating the estimation of prevalence at both population 
and flock/herd level; 
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- systematically and accurately collect raw data regarding major confounding factors (i.e. age in 
years, stream). 
4.7.1.3. Preventing the reoccurrence of  Classical scrapie in infected flocks 
According to Regulation (EC) No 1915/2003, after the destruction of susceptible animals in infected 
flocks, only the following animals may be introduced: a) male sheep of the ARR/ARR genotype; and 
(b) female sheep carrying at least one ARR allele and no VRQ allele. The increase of the ARR allele 
frequency and its maintenance is a powerful measure to prevent the reoccurrence of disease despite the 
persistence of the agent in the environment. 
It is recommended that: 
• Long term/permanent compulsory use of ARR homozygous rams is required in the holdings where 
CS has been detected. 
4.7.1.4. Identification of animals and epidemiological investigation of infected flocks 
Individual identification of sheep and goats is a crucial component of a reliable livestock traceability 
system, necessary for the management of outbreaks. The epidemiological investigations of cases, 
including the movement of animals from infected flocks, cannot be achieved if this is missing.  
It is recommended that: 
• Individual identification of small ruminants is implemented effectively, as part of a functional 
traceability system. 
4.7.2. Breeding for resistance policies 
A BP aims to permanently modify the genetic structure of the small ruminant population. This is a 
long term goal: it requires time to produce effects and remains the only currently known measure in 
sheep that is able to lead to permanent disease eradication.  
The lack of official breeding for resistance policies in goats remains a major difficulty for disease 
control in this species. 
A number of MSs have made substantial efforts to change the genetic structure of their sheep 
population through the implementation of breeding for resistance programmes as defined in 
Commission Decision 2003/100/EC. However, the diverse nature and variable quality of such 
programmes, in terms coverage, dissemination of resistant alleles, rules applied to members, and 
duration, have been highlighted in this Opinion. 
BP-CSs have been effective in modifying the allele frequencies under two scenarios: compulsory use 
of ARR rams in the whole population (The Netherlands and Cyprus) and modification of the genotype 
structure in HGMF by eliminating alleles associated with higher susceptibility to the disease / 
selecting the ARR allele (e.g. France, United Kingdom, Slovenia, Slovakia).  
The current rules for breeding for resistance, as established in the EU Regulation, are loose and do not 
set targets. This has contributed to a lack of effectiveness of the BP-CS observed in certain countries. 
4.7.2.1. Dissemination of the ARR allele in the general population 
The effectiveness of BP-CSs is directly dependent on the dissemination of resistant alleles in the 
general population. This Opinion has highlighted the bottleneck that exists between the HGMF and the 
general population. The Cypriot, Sardinian and Dutch cases demonstrate that it is possible to 
overcome this gap by making the use of ARR rams in all flocks of a country or a region compulsory.  
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Such a measure could be temporarily envisaged, at least in certain populations (e.g. countries/regions 
with high prevalence, or specific breeds with a sufficient initial ARR frequency). The compulsory use 
of ARR/ARR rams over three or four generations would generate a major shift in the genetic structure 
of the entire sheep population. A graph representing the evolution of the ARR allele when just 
ARR/ARR male reproducers are used according to different starting frequencies is presented below 
(Figure 15). This shows that after 6 years, flocks with a starting frequency of 0.10, using only 
ARR/ARR rams, would reach at least an ARR frequency of 0.66 and a frequency of homozygous 
susceptible genotypes less than 0.10 (0.095). 
Figure 15 provides an example of evolution of the ARR allele frequency over time with the use of 
ARR/ARR rams in flocks with different starting frequencies of the ARR allele. The evolution of the 
ARR frequency per year of use of ARR-ARR rams has been obtained by calculating: 
- the expected frequency of the ARR allele in the female replacement at the year n by assuming 
a frequency of 100 % in the male parents and the frequency of the flock in the year n-1 for the 
female parents; 
- the expected frequency in the flock at the year n was obtained by calculating the weighed 
mean of the ARR allele frequency in the replacement (30 %) at the year n and the frequency in 
the flock at the year n-1. 
 
 
Figure 15:  Evolution of the ARR allele frequency over time with the use of ARR/ARR rams in flocks 
with different starting frequencies of the ARR allele (yearly replacement rate of females 30 %). 
However it would be difficult to make this measure compulsory in large populations or in countries 
without BP-CSs or where there are insufficient, or no, rams available of resistant genotypes. 
Alternatively, rules for the dissemination of the resistant alleles from HGMF to CF must be specified 
in order to maximize the benefits of the BP-CSs. 
The presence of incentives to farmers to breed for resistance would increase their compliance with the 
requirement to select for, and disseminate, resistant alleles. All initiatives intended to increase the 
ARR frequency should be implemented in parallel with measures preventing the introduction of 
susceptible alleles via the importation of live animals, embryos, ova and semen. Legislation recently 
introduced in the EU (Regulation (EU) No 630/2013) should ensure that this is the case. Measures to 
create incentives for the dissemination of resistant alleles may include the qualification of flocks 
composed entirely of ARR homozygous animals or the modulation of farming subsidies at national 
and EU level for the benefit of flocks carrying out BP-CSs. 
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However, the classification of flocks based on the genotype frequency in the whole flock is not always 
feasible in terms of efficiency and resources. Most BP-CSs are based on genotyping just male 
reproducers, which represent a small portion of the total population (average sex ratio of 1/40), and 
allows the detection of 50 % of the PRNP gene alleles of the next generation. To determine the 
remaining 50 % of the alleles, genotyping must be performed on about 50 times more animals. An 
alternative classification system could be based on the number of consecutive years of use of 
ARR/ARR reproducers. For example, a possible classification system might be as follows: 
- level 1: flocks exclusively using ARR/ARR breeding rams for at least 10 years; 
- level 2: flocks exclusively using ARR/ARR breeding rams for at least 6 years; 
- level 3: flocks exclusively using ARR/ARR breeding rams;  
- level 4: flocks exclusively using ARR carriers as breeding rams;  
- level 5: flocks which participate in BP-CSs by genotyping breeding rams. 
It is recommended that: 
• BP-CSs, with an explicit temporal target and a fit for purpose information system, are compulsory 
in countries where CS is detected. 
• The compulsory comprehensive use of ARR/ARR rams over three or four generations is 
considered, since it would generate a major shift in the genetic structure of the entire sheep 
population. Alternatively, BP-CSs should be: 
- reinforced in HGMF along with rules and incentives ensuring the dissemination of the 
resistant alleles from HGMF to CF; 
- extended to CF. 
• Special status is granted to flocks with all ARR-homozygous animals and no history of CS, with 
incentives such as subsidies and export certification exceptions. 
• An alternative classification system, based on the number of consecutive years of use of 
ARR/ARR breeding rams, is considered. 
4.7.2.2. Monitoring the PRNP allele frequency in the EU population 
Beyond data that may be generated in the context of a BP-CS, there are two further sources of 
information on sheep prion protein genotypes regulated by the TSE Regulation: i) information on 
genotypes for each positive TSE case in sheep, and ii) information on genotypes to be gathered for a 
minimum sample of ovine animals, which should be representative of the entire ovine population. 
The background for this ‘minimum sample’, de facto 100-600 samples per country, was previously 
outlined by EFSA (2006) in an Opinion. The appropriateness of the determination of these genotypes, 
in order to compare the prevalence of genotypes in TSE infected sheep with the genotypes in the 
general population, was also reviewed, and so was the ability, based on these figures, to monitor the 
evolution of genotypes over time. In this former Opinion it was recommended that, in order to serve 
the first purpose, the genotyping results from flocks where selective culling and TSE testing of a 
sample were applied can be used. Furthermore it was recognized that this ‘random genotyping’ cannot 
serve the second purpose to follow the evolution of genotypes in time, as the data generated might be 
biased due to the limited sample size in combination with the large variation of the PRNP genotype 
distribution between breeds. Subsequently EFSA (2006) recommended ‘to increase the sample size to 
evaluate the genetic progress in sheep breeds, having regard to: - the minimum difference of interest 
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for progress in genotype prevalence, - the variance of genotype prevalence in sheep breeds, - 
acceptable levels of significance and power, - the current genotype distribution’. 
It is acknowledged that the metadata currently available from the random genotyping (country, year, 
amount of samples and genotype) cannot be used in a meaningful way. This is because the information 
available is too limited for an a posteriori analysis, adjustment and monitoring of the sampling design, 
as it lacks of both information on: (i) the strategy followed by each MS to design the sampling frame 
in ‘representative sample’ of the entire ovine population as requested in the legislation, and (ii) the 
further metadata needed for adequate analysis of the results reported (e.g. breed, gender, age, flock 
identification, region). 
It is recommended that: 
• An appropriate system to monitor PRNP allele frequency evolution in the general sheep 
populations in MSs is designed and implemented, according to breed and birth cohort. 
4.7.2.3. Breeding for resistance in goats 
There is a need to develop strategies for breeding for resistance in goats. Robust scientific evidence 
regarding the resistance of certain alleles in the goat breeds of the EU is already available and has 
been described earlier in this Opinion (Section 1.2.2). Some of the polymorphisms conferring 
resistance have worldwide distribution. This knowledge allows the definition of a set of aims for the 
goat species such as: i) building up data on the existence and distribution of bucks carrying resistant 
alleles, and ii) contributing to the eradication of the disease through measures based on selective 
culling of susceptible animals in outbreaks. 
It is recommended that: 
• Genotyping surveys of breeding bucks are performed. 
• Selection activities and dissemination of resistant bucks are promoted. 
• Formal breeding for resistance programmes, similar to those already implemented for sheep, are 
initiated for goats. 
• The stamping out strategy is replaced with outbreak management based on the selective culling of 
susceptible animals, as is currently applied to sheep. 
• Restocking following the application of control measures is done only with resistant animals, 
when they are available in sufficient number. 
4.7.3. Knowledge transfer on scrapie 
Scrapie has lost the profile and visibility within the farming community that it had ten years ago when 
active surveillance started. It is important to remind all stakeholders that classical and AS are still 
present in many MSs and that a range of statutory actions are still in place. In parallel there have been 
advances in the knowledge of pathogenesis, transmission, genetics and epidemiology of TSEs and 
these may not have been effectively disseminated to stakeholders.  
Moreover the experience gained by some MSs with regard to the effective implementation of control 
measures and BP-CSs has not been taken advantage of by other countries.  
Any relaxation of the statutory measures in infected flocks/herds or the implementation of new control 
measures should be weighed against the expected effect (based on scientific evidence) on the risk of 
spread of the disease in the population. 
It is recommended that: 
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• Training activities aimed at disseminating current knowledge to all stakeholders (farmers, 
veterinarians, policy makers) are promoted and implemented, at both EU and MS level. 
• It is acknowledged that no single control policy is appropriate for all MSs due to the heterogeneity 
of the sheep and goat industries across the EU. 
 
CONCLUSIONS 
General conclusions 
• TSEs in small ruminants have a long asymptomatic phase, during which animals can circulate in 
the population. 
• With regards to Classical scrapie (CS): 
- Susceptibility is strongly influenced by different polymorphisms of the PRNP gene. 
- Horizontal transmission is considered to be the main route of transmission, through exposure 
to oral infection (e.g. mainly via placentae or milk from infected animals) or to contaminated 
environments. It is still unclear precisely which sources of infectivity and routes of 
transmission are possible, and which have the greatest effect on the spread and maintenance of 
infection in a population. 
- Animal movements, flock size and age are important risk factors, but are difficult to address 
by preventive measures. 
- The most powerful tools presently available for disease control in any flock which is not 
closed, and disease-free, are the effective identification and removal of infected animals and 
the control of the genetic composition of the flock, i.e. the methods covered (for sheep) by the 
current EU legislation. 
• With regard to Atypical scrapie (AS): 
- The genotypes most resistant to CS occur frequently in the AS-infected population. 
- The late age at onset and the relative protease sensitivity of the atypical PrP limits the 
sensitivity of AS case detection through current surveillance programmes. 
- AS pathogenesis is poorly documented. 
- AS does not present, epidemiologically, like an infectious disease. 
- AS has been identified as occurring at a low but very consistent prevalence in every small 
ruminant population in which there has been screening. 
- AS has been found in populations in which CS has not been reported. 
• Passive surveillance is very ineffective at identifying new affected flocks or herds, especially if the 
prevalence is low and if suspicion reporting may lead to socio-economical consequences such as 
animal movement restrictions or compulsory culling. 
• Active surveillance, enforced since 2002 as a targeted sample-based monitoring of adult small 
ruminants, represents a major improvement of TSE surveillance in the EU. 
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• The EU TSE surveillance in small ruminants allows the monitoring of the evolution of the disease 
and the assessment of the effectiveness of control measures implemented by the MSs. It may not 
take into due account the heterogeneity of the sheep population and scrapie distribution in each 
MS: deviation from the representativeness of the sampled population may result in reduced 
validity of the prevalence estimate. 
• The observed prevalence obtained through the EU TSE surveillance programme in small 
ruminants is affected by two main factors: i) the sensitivity of the detection method given the age 
of the tested animal, the stage of the incubation period and the sampling/testing procedures, and ii) 
the distribution of testing by surveillance stream. The availability of the relevant data allows the 
statistical control of their confounding effects. 
• Surveillance programmes could be designed to ensure detection of as many scrapie cases and 
outbreaks as possible as a tool to facilitate the control or the eradication of the disease in a 
country. 
Answer to Term of Reference 1: 
“On the basis of the results of the TSE monitoring programme laid down in the TSE Regulation, 
what is the trend since 2002 of the situation of Classical scrapie and Atypical scrapie in sheep and 
in goats respectively, in the EU as a whole and in the 27 Member States individually?” 
• In order to analyse prevalence trends: 
- The statistical analysis was restricted to the MSs reporting scrapie cases in the framework of 
EU active surveillance. 
- Cases identified through passive surveillance, or as a result of culling animals from known 
infected flocks, were removed from the data sets prior to analysis.  
- In the case of CS, and in order to prevent the validity of the estimates of the prevalence rates 
being compromised by the confounding effect of surveillance stream, stream-adjusted 
estimates were systematically obtained through the application of ad hoc statistical techniques. 
• Over the period 2002-2012, the overall average prevalence of CS in the sheep population was 8.7 
cases per 10 000 rapid tests (considering the 4.7 million sheep tested in the 17 MSs where CS has 
been reported). The geographical distribution of CS cases in sheep shows great heterogeneity in 
the level of occurrence in MSs: in some cases only a few, or no, cases were detected, whereas 
Cyprus experienced a large epidemic. 
• Country-specific temporal trends of CS in sheep are heterogeneous, preventing any meaningful 
interpretation of the overall temporal trend at the EU27-level. Therefore the analysis and 
interpretation of the temporal trends must be conducted at MS level. With regard to CS in sheep, 
the results of the analysis allow the classification of the EU27 MSs into four groups: 
- countries where CS has been detected, with a statistically significant decreasing trend (Cyprus, 
France, Ireland, The Netherlands, Slovenia and the United Kingdom); 
- countries where CS has been detected with an observed trend not statistically different from a 
flat one (Belgium, Czech Republic, Greece, Italy, Romania, Slovakia and Spain); 
- countries where CS has been reported only sporadically (Bulgaria, Germany, Hungary and 
Portugal); 
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- countries with no cases of CS during the period 2002-2012 (Austria, Denmark, Estonia, 
Finland, Latvia, Lithuania, Luxemburg, Malta, Poland and Sweden). 
• Over the period 2002-2012, active surveillance enabled the detection of AS in sheep in 21 MSs. 
Since the ability to detect cases of AS is essentially restricted to few rapid tests, all the 
calculations were done with the 2.5 million (known) tests carried out with these rapid tests in the 
21 MSs. This restricted the temporal analysis to the period 2006-2012. The overall prevalence of 
AS for this period was 5.8 cases per 10 000 rapid tests. 
• Where detected, AS in sheep showed a similar prevalence over time and space: no large epidemics 
were reported and five countries detected AS in sheep only sporadically. Only two countries 
showed a statistically significant trend, with a reduction in the annual prevalence rates in France 
and an increase in the United Kingdom.  
• CS in goats has been detected in eight MSs, where 1.4 million goats have been tested. The overall 
prevalence of CS in goats (9.8 cases per 10 000 rapid tests) is mostly explained by the unique 
epidemic in Cyprus which paralleled the epidemic in sheep. The prevalence in the remaining 
seven countries where CS in goats was detected was 2.2 cases per 10 000 rapid tests. Statistically 
decreasing trends were evident respectively for France over the entire period (2002-2012) and for 
Cyprus and the United Kingdom after 2007. The favourable French trend may reflect in part the 
impact of a strong surveillance pressure able to detect and manage a large proportion of outbreaks 
in small ruminants. 
• AS in goats was reported by five countries, at a very low prevalence and with no statistically 
significant trend in any of them. 
“Where no favourable trend can be observed, what are the identifiable causes for failure to improve 
the situation of Classical scrapie?” 
• Although it is not possible to identify causes that can explain objectively the failure to improve the 
situation of CS, the assessment of the country-specific available data related to the implementation 
of surveillance, non-genetic control measures and BP-CSs may allow the formulation of some 
hypotheses. 
• With regard to sheep, it is quite plausible that the causes of any unfavourable trend might be 
linked to ineffective implementation of either or both strategies. Based on data collected from 
MSs, a number of potential reasons to explain the lack of observation of a favourable trend in part 
of the countries can be envisaged in relation to: 
- The BP-CS: a short duration of implementation of a BP-CS, a low ARR/ARR frequency in the 
target populations when the BP-CS started, a lack of national coverage of the BP-CS, a low 
number of genotyped rams in HGMF, a limited rate of selection of rams within HGMF, and 
inefficiency of, or lack of, rules for the dissemination of resistant rams from HGMF to CF. 
- Surveillance and non-genetic control measures: variability and/or reduction of the surveillance 
pressure, a lack of representativeness of the animals selected for testing, a limitation in 
available data preventing the detection of trends due to the lack of regular detection of cases, a 
short duration and/or ineffective implementation of sanitary measures due to recent admission 
to the EU, or implementation of measures below the EU minimum requirement. 
• With regard to goats, differences in the husbandry systems in sheep and goats within countries, 
absence of BP-CSs, and variability of the control measures (which cannot include selective 
culling) applied on infected herds compared to sheep flocks may explain the lack of observation of 
a favourable trend. The favourable evolution of the situation in France (in both sheep and goats) 
suggests the likely effectiveness of a high surveillance pressure in detecting and managing a large 
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proportion of outbreaks, which may subsequently lead to a decline of the disease in the general 
population. 
Answer to Term of Reference 2: 
“Has the evolution of the Classical scrapie situation been statistically different in the MS which 
have implemented a breeding programme from 2004 to 2011 compared to the MS without a 
breeding programme in the same period?” 
• Since there were no MSs without a BP-CS with sufficient cases of CS in order to estimate a trend, 
the comparison requested in ToR 2 is not possible. Therefore, based on information collected from 
MSs, the potential effectiveness of BP-CS in the dissemination of resistance into the general sheep 
population was assessed for those countries for which the CS trend analysis was performed. 
Subsequently, the evolution of the CS situation between MSs, depending on the potential 
effectiveness of their BP-CS, was compared. 
• BP-CSs, which satisfy the minimum requirements of EU legislation,  have been implemented by 
17 MSs. Other MSs did not implement BP-CSs, generally because of a favourable situation 
regarding the disease. 
• There is a clear heterogeneity in the characteristics of the different BP-CSs implemented by the 
MSs. There is also heterogeneity within MSs according to different areas, ARR allele frequency in 
the general population prior to BP-CS implementation, breeds and production types. 
• Generally BP-CSs in the EU focus on HGMF and are carried out through three steps (genotyping, 
selection and dissemination), with the aim of increasing the frequency of the resistant alleles in the 
general sheep population. 
• Such a strategy: 
- requires the dissemination of males from HGMF to CF as a major determinant of the 
effectiveness of the final BP-CS; 
- results in a lag of several years between the initiation of a BP-CS and an effective change in 
the genotype structure of  the general population.  
• Applying a BP-CS does not imply that a genetic control of the disease is achieved. This depends 
on the characteristics of the BP-CS and on its effectiveness, which needs to be assessed based on 
the evolution of the genetic structure of the population. 
• The crucial parameter to assess the effectiveness of BP-CSs in MSs is the frequency of the 
resistant allele in the whole sheep population. 
• In the absence of this parameter, which is generally not available, the potential effectiveness of 
BP-CSs has been assessed in this Opinion through a combination of qualitative expert assessment 
and modelling of the diffusion of CS resistant alleles from HGMF to CF through selected resistant 
reproducers. 
• The result of the dissemination of CS resistant alleles to CF (in terms of the potential evolution of 
ARR/ARR frequency in CF) is not, by itself, a sufficient indicator to evaluate the effectiveness of 
a BP-CS in reducing CS prevalence.  
• The impact of a national BP-CS on the epidemiological situation of CS may be influenced by: i) 
both the ARR allele frequency and the CS prevalence prior to the implementation of the BP-SC, 
and ii) their heterogeneous geographical distribution. 
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• Given the characteristics of each national BP-SC, a deterministic model was used to estimate the 
ARR/ARR frequency in the general sheep population over time. Subsequently, the outputs of the 
model were compared with the national CS situations. The results obtained suggest a favourable 
CS situation being linked to better-achieving BP-CSs. 
• Cyprus and the Netherlands, countries in which the improvement in the epidemiological situation 
of CS is clear, applied their BP-CSs to the whole population, without any distinction between 
population tiers. This approach produced an effective change of the genetic structure of the whole 
sheep population, but required extensive genotyping efforts. 
Answer to Term of Reference 3: 
“On the basis of the above analysis, can a minimum level of frequency of the ARR allele in the 
sheep population in a MS be defined or estimated above which Classical scrapie can be expected to 
fade-out, in a context where no control and eradication measure is being applied?” 
• Given the very strong resistance of the homozygote ARR genotype to CS, there is a conceptual 
parallel between the ARR homozygote proportion of a sheep population and the proportion 
immunized in a vaccinated population. 
• A minimum frequency of the ARR allele in a sheep population can be estimated, above which CS 
may be expected to fade-out. The example of The Netherlands, where CS case prevalence in 
surveillance has become very low in recent years and the ARR frequency is (still) well below 
100 %, provides evidence for the existence of the minimum ARR frequency for CS fade-out in the 
reality of the field. 
• Once the ARR frequency in a MS has increased to above the minimum estimated requirement for 
fading-out of disease, this does not imply that CS cases will no longer occur. CS cases may still 
occur, either through introduction of infected animals from outside the population or from 
infectivity in the environment, but such cases will no longer pose a risk of causing prolonged 
epidemic spread of CS in the population. 
• The concept of fade-out is different from eradication. Whereas eradication involves active 
interventions to remove remaining foci of transmission, fade-out is expected to occur naturally at 
some point in time once a sufficiently high ARR allele frequency is obtained and maintained. 
• The minimum frequency of the ARR allele in the sheep population in a MS above which CS can 
be expected to fade-out, in a context where no control or eradication measure is being applied, is 
not universal and would have to be estimated for each particular national sheep population 
separately. 
• Case studies illustrate the non-universality of the minimum ARR frequency; across the case 
studies it ranges between 53 % and close to 100 % according to a crude model. The case studies 
also provide some insight into how the minimum frequency depends on MS-specific parameters. 
• Maintenance of an ARR allele frequency above the required minimum level needs to be monitored 
by taking representative genotyping samples at regular time intervals. 
Answer to Term of Reference 4: 
“In a context where no breeding programme is implemented, are the present mandatory measures 
in terms of active monitoring, eradication and control of Classical scrapie effective to achieve a 
decline of this disease and its eradication on the long term?” 
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• As shown by the Iceland case-study, detection and eradication measures in affected flocks are 
effective in reducing the observed prevalence of CS in a population with a high prevalence of 
disease. 
• The overall effectiveness of such a policy relies heavily on the detection rate of outbreaks in the 
population. 
• However, because of the persistence of the agent in environment, repopulating scrapie infected 
farms with non-resistant genotype animals can lead to reoccurrence of the disease. 
• Due to the pathogenesis and the epidemiological characteristics of CS, and to the high persistence 
of the CS agent in the environment, a CS eradication policy that relied solely on detection of 
infected flocks by post-mortem testing and subsequent depopulation would be unlikely to succeed. 
Answer to Term of Reference 5: 
“What additional measures can EFSA recommend in view of achieving the eradication of Classical 
scrapie in the MS?” 
• With regard to surveillance and control, it is recommended that: 
- The detection of infected flocks and subsequent disease control will be improved by additional 
risk-based targeted surveillance activities and/or a substantial increase in the tested fraction of 
the population. 
- If additional targeted risk-based surveillance is implemented, data collection enables the 
discrimination between results generated through the continuation of the current surveillance 
and any additional targeted risk-based surveillance. 
- Even after restrictions are lifted, infected flocks are considered at risk and targeted for 
enhanced surveillance, unless they are composed entirely of resistant animals. 
- TSE surveillance programmes in small ruminants: 
- are adapted to each MS (number of tests, targeted populations); 
- have a standardised audit/verification system to ensure the correct implementation of 
control measures; 
- include a data collection system facilitating the estimation of prevalence at both 
population and flock/herd level; 
- systematically and accurately collect raw data regarding major confounding factors (i.e. 
age in years, stream). 
- Long term/permanent compulsory use of ARR homozygous rams is required in the holdings 
where CS has been detected. 
- Individual identification of small ruminants is implemented effectively, as part of a functional 
traceability system. 
• With regard to breeding for resistance policies in sheep, it is recommended that: 
- BP-CSs, with an explicit temporal target and a fit for purpose information system, are 
compulsory in countries where CS is detected. 
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- The compulsory comprehensive use of ARR/ARR rams over three or four generations is 
considered, since it would generate a major shift in the genetic structure of the entire sheep 
population. Alternatively, BP-CSs should be: 
- reinforced in HGMF along with rules and incentives ensuring the dissemination of the 
resistant alleles from HGMF to CF; 
- extended to CF. 
- Special status is granted to flocks with all ARR-homozygous animals and no history of CS, 
with incentives such as subsidies and export certification exceptions. 
- An alternative classification system, based on the number of consecutive years of use of 
ARR/ARR breeding rams, is considered. 
- An appropriate system to monitor PRNP allele frequency evolution in the general sheep 
populations in MSs is designed and implemented, according to breed and birth cohort. 
• With regard to breeding for resistance policies in goats, it is recommended that: 
- Genotyping surveys of breeding bucks are performed. 
- Selection activities and dissemination of resistant bucks are promoted. 
- Formal breeding for resistance programmes, similar to those already implemented for sheep, 
are initiated for goats. 
- The stamping out strategy is replaced with outbreak management based on the selective 
culling of susceptible animals, as is currently applied to sheep. 
- Restocking following the application of control measures is done only with resistant animals, 
when they are available in sufficient number. 
• With regard to knowledge transfer on scrapie, it is recommended that: 
- Training activities aimed at disseminating current knowledge to all stakeholders (farmers, 
veterinarians, policy makers) are promoted and implemented, at both EU and MS level. 
- It is acknowledged that no single control policy is appropriate for all MSs due to the 
heterogeneity of the sheep and goat industries across the EU. 
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APPENDICES 
Appendix A.  Data requests to EU Member States in the framework of this Opinion 
A.1. Questionnaire ‘Sampling strategy and control measures’ 
Questionnaire circulated to EU Member States 
A copy of the questionnaire ‘Sampling strategy and control measures’ circulated to MSs is included in 
the following pages. 
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Summary of the replies to the questionnaire ‘Sampling strategy and control measures’ 
A questionnaire survey was delivered by EFSA to all 27 MSs, plus Croatia, during 2013 in order to 
obtain additional information on the implementation of surveillance activities and control measures for 
scrapie in sheep and goats for the mandate period: 2002-2012. The aim of this survey was to gather 
information and knowledge beyond the statutory requirements for reporting that would allow a better 
assessment of the observed trends of scrapie over the same period. Responses were collated and 
summarised. Croatia was not included in the summary since admission to the EU as a full MS 
occurred after the end of the mandate period. In the summary below, and after references to the 
answers for specific questions, the initials (see Abbreviation section at the end of the Opinion) of some 
countries are presented in brackets. These are examples of countries for which the answer applies. 
However they are not exhaustive lists of all MS applying the measure, since not all countries 
participated in the survey, nor is there certainty on whether countries that did not answer that question 
actually implemented it as well. 
Twenty-five of the 27 pre-2013 EU MSs responded to the questionnaire survey. At the time of writing 
this opinion, data from Bulgaria and Lithuania were not available. 
Immunohistochemistry (IHC) and Western blotting (WB) were the tests initially used for TSE 
surveillance until the additional ELISA-based rapid tests were approved by the EU. Changes in the 
testing protocols implemented by MSs for financial or logistic reasons occurred in parallel with the 
inclusion and deletion of authorised tests for screening and confirmation across the period covered by 
the Opinion, as per EU legislation. Some rapid tests applied in the early 2000s, such as Prionics Check 
WB (FI, NL, FR),  Bio-Rad Platelia (UK) and Enfer TSE (IE, IT, SK, FR) were replaced by or used in 
parallel with other tests, more popular in the later years, for example Bio-Rad TeSeE (FI, SK, SE, UK)  
and lately the IDEXX Herdcheck BSE scrapie (DK, IE, NL, SI, SE, FR, IT). 
Small ruminants slaughtered for Human Consumption (SHC) 
There have been changes in the EU legislation over the years with regards to the TSE surveillance in 
small ruminants in sheep and goats slaughtered for human consumption. MSs with small sheep 
populations (< 750 000) were required to test a small sample between 2002 and 2006, to test all SHC 
between 2006 and 2007, and since 2007 there has been no obligation to test any apparently healthy 
animals slaughtered for human consumption. In MSs with large sheep populations, testing 
requirements have been based on a quota. This route of active surveillance is independent of, and 
additional to, the testing of apparently healthy animals slaughtered for human consumption from 
infected flocks/herds under restrictions. 
Most of the countries subject to a quota during all or part of the mandate period applied a structured 
sampling strategy, based on distribution of the quota. The sampling procedures at abattoirs varied by 
country: some allocated numbers by counties, regions, provinces, prefectures (HU, IE, ES, RO, EL) 
while others used throughput data at national level to allocate sub-quotas to each abattoir (PT, FR) or 
region (IT) or to a number of them with throughputs above a threshold (UK). In some cases, quotas 
were also distributed by month or season (IE, UK, IT, FR). A more stringent approach was followed 
by SK whereby as part of the national programme, a minimum number of holdings were selected for 
sampling based on geographical location, age groups (minimum 18 months), breed and season. The 
ultimate approach was applied by CY where “an annual monitoring sampling programme is prepared. 
Circulars […] with instructions for collecting the appropriate samples, with information about the 
farm code, the status of the flock/herd, the animal population and the samples expected to be sampled 
are sent to the slaughter houses. Periodically checks for the sampling, reporting and registration are 
performed”. 
Some countries exceeded the quota by testing 10 % of all SHC sheep > 18 months (NL, FR), with a 
minimum of 1 per slaughterhouse (NL), two sheep per flock (CY), or by testing all SHC (PL). Others 
stopped the testing because the number of animals that were tested was not representative of  the sheep 
and goat population (e.g. BE between 2004 and 2006). 
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Some countries that are not required to test SHC decided to continue with the testing of high-risk 
groups, such as emergency slaughtered animals and those > 18 months of age showing signs of 
wasting or neurological illness (FI). 
The sampling strategy and the selection of individual animals for testing proved to be a challenge for 
many MSs and it is the weakest point of this surveillance route, based on the responses to the 
questionnaire survey. The random selection of animals is not universally applied. It is recognized that 
some flocks/herds are overrepresented in the survey (IT), for example larger flocks/herds (SE) and/or 
certain breeds, like Texel (NL). In other cases the apparently healthy slaughter population is 
underrepresented because old animals are rendered rather than sent to abattoir (SE) or due to the 
selection for testing of animals submitted for slaughter at abattoirs but categorised as unhealthy during 
ante-mortem inspection (SI, IT). Additionally, certain geographical areas are underrepresented due to 
their remote location and/or inaccessibility (EL). 
There is not much information about the selection of individual animals within abattoirs. Some 
countries applied a systematic random selection by abattoir personnel (every xth sheep) (SE) or 
randomly selection of batches arriving at the abattoir (RO). A few others delegate the implementation 
rules to local or regional authorities (PT).   
Some measures are applied to increase the representativeness, such as sampling a maximum of one 
animal per holding (RO), two sheep per holding (CY), sampling a maximum of one sample/year from 
a holding tested the previous year (RO), minimum/maximum sample size per flock (CY, DE, EL, SK) 
or avoiding repeated sampling from the same flock/herd (PT). Equally some risk-based strategies 
aimed to enhance the sensitivity of the SHC survey are applied by some MSs: selection of flocks 
based on their TSE history (EL), targeting animals of specific age bands (CY, ES, MT, LV), targeting 
emergency slaughtered sheep and goats (HU, ES, FI) or identified sick animals during ante-mortem 
(SI) or on farm (MT). This is also applied in goats where in some countries only emergency 
slaughtered animals are selected for testing (HU). 
Small ruminants not Slaughtered for Human Consumption (NSHC) 
The selection of animals for testing is usually carried out at rendering plants. Sixteen out of the 25 
respondents (64 %) declared themselves to be applying a structured sampling strategy, 5 countries (20 
%) a convenience sampling and four other type(s) (16 %). Among those countries with a quota 
assigned over the mandate period that declared a structured sampling strategy, several methods are 
described: minimum/maximum number of sheep found dead per flock selected for testing (CZ, DE), 
specific sampling days in which one animal is selected at random from each holding (DK), assigned 
areas for sampling selected at random where animals are individually selected, based on available data 
(birth holding, date sampling, weekday) (DK). The allocation of sub-quotas proportional to the small 
ruminant population in each region, province, county, throughput of rendering plants, etc., is also 
widely applied for fallen stock (EL, ES, HU, IT, PT). In some cases quotas are distributed by month or 
season (UK, FR, NL, PT, SK), although some seasons are over-represented due to the weather 
conditions or the peak of lambing (UK, SI). In some cases the sampling design is even included in 
national legislation that “foresees sampling according to number from each holding, nature of holding 
(breeding, reproductive, breeding-experimental, commercial), age groups (minimum 18m), even 
testing throughout the year” (SK). 
It is not clear in the answers provided by MSs how the implementation of this survey ensures the 
representativeness of the NSHC sheep selected for TSE testing. Voluntary notification of found dead 
animals, or cost-sharing polices for the collection and testing of fallen stock can introduce inherent 
bias to the selection of animals for testing (UK).  Countries do not specify how the figures for killed or 
found dead animals are collated at either a central or regional level. An isolated example is IE where 
“an analysis of data is conducted every quarter to ascertain how representative of season and region 
the sampling is”. Then sampling is adjusted in terms of number of sampled animal and flocks and 
frequency of sampling at rendering plants. Setting upper limits, for example no more than two eligible 
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animals from same flock/day (IE), selecting every xth carcass at the rendering plant until assigned 
monthly quotas are met (UK), targeting at least one dead animal from each flock per year (CY, SK) or 
at least animals from large flocks (SI) are strategies aimed to improve representativeness at the time of 
selecting individual animals for testing.  
Some countries exceeded the quota by testing all fallen sheep/goats > 18 months, during certain 
periods, in the entire country (DK, FR, IT, RO, SE, SI). The compliance of full testing can be 
challenging (IT) and some countries with small sheep or goat populations struggle to meet their own 
targets (IE).  Being a small country could otherwise be an advantage when all fallen stock is 
channelled to a single central collection centre (MT) or it is easier to set maximum number of tested 
animals per flock/herd (goats in UK). Although attempts are made to distribute the number of samples 
evenly across regions, breeds, production type and age (SI, SK), the implementation of such measures 
is difficult to carry out due to the extra cost.  
Yet again derogations in accordance with EU Regulation (EC) No 999/2001 (‘TSE Regulation’) are 
applied, mainly to some areas due to their remote location and/or inaccessibility (EL, IE) or low farm 
density (SE). 
All the factors described in the sampling strategy lead to the recognition that important subpopulations 
may be over/under-represented in the NSHC population, based on different factors like breed (FI), age 
(LV), geographical  areas (FI, IE, IT, RO, SE), catchment areas of rendering plants (FI), seasons (UK, 
RO, SI), voluntary/compulsory notification (FI, UK), rendering costs and subsidies (IT, RO) and 
eradication measures in place (SE). In other cases bias occurs in areas where there is no organized 
collection of found dead sheep and the selection of animals to be submitted for testing is left to the 
discretion of farmers (FI). 
Although this surveillance route is in itself an exercise of risk-based strategy since it targets high-risk 
sub-populations (found dead) excluding the age where infected animals are not likely to be detected 
yet (< 18 months), certain criteria are applied by MSs to target sections of the fallen stock population 
with known risk factors for CS, for example even older age groups (ES, MT) and larger flocks (IE).  
Control measures for CS 
Most of the MSs started to apply statutory actions to individual cases after confirmation of a case of 
CS, as early as 1970 (SE), 1980 (FI), 1987 (CY), 1988 (DK), 1990 (LU, BE), 1991 (IT), 1993 (UK, 
NL), 1996 (PT) and 1997 (FR, EL). Other MSs enforced control measures against scrapie following 
the enactment of the TSE Regulation (IE, LV), as amended by Regulation (EC) No 1915/2003 or 
when they became members of the EU (HU, CZ).  
Most of the countries stated that all confirmed cases of CS are traced back with the aim of identifying 
the natal flock and the most likely location where the animal could have been infected, resulting in the 
confirmation of infected flocks/herds and the implementation of control/eradication measures. All 
countries stated that detected cases result in the application of control measures, except two: NL 
(29.2 %) and UK (no % provided). Fourteen countries reported the number of sheep flocks on which 
control/eradication measures have been applied. There is a wide range, as expected, given the different 
sizes of the susceptible populations and the prevalence of scrapie: from 529 (IT), 495 (EL, mixed 
sheep and goats), 358 (FR), 83 plus 221 mixed sheep/goat flocks (CY), 144 (IE), 75 (NL), 74 (RO), 
less than 50 (DE, CZ, BE, HU, PT, SI) (ES did not report figures and UK only since 2008).  Eight 
countries reported to have applied control/eradication measures on goat herds: 495 (EL mixed sheep 
and goat farms), 58 plus 221 mixed sheep/goat flocks (CY), 27 (IT), 25 (FR), 5 (FI), 2 (RO), 1 (SI) 
(ES did not report figures and UK only since 2008). 
Among the 17 countries that took action on sheep flocks with confirmed cases of CS, five apply or 
have applied the cull of all animals, regardless of the genotype (BE, CZ, DK, FI, SE), in some cases 
beyond the requirements by “stamping out, cleaning and disinfection and 7-year restriction period for 
sheep/goats since 1970” (SE), three countries apply the cull of animals with a genotype susceptible to 
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CS only (FR, NL, SI),  and nine apply both the total and selective cull, with different ratios:  1 % (total 
cull) / 99 % (selective cull) (IE), 2/98 (CY), 8/92  (DE), 16/84 (IT), 40/60(EL), 43/57 (HU), 90/10 
(PT). Some did not provide ratios (RO, ES, UK). Some MSs have applied only enhanced surveillance 
to infected flocks since 2011 (UK, DE). Additional measures are applied by some countries, such as 
the cleaning and disinfection of premises (AT, DK, FI, DE, EL, HU, RO, SK, SI, ES, SE), grazing 
restrictions based on epidemiological assessments (AT, DK, FI, DE, EL, IE, PT, RO, SK, SI, ES, SE), 
and compulsory enrolment in BP-CSs or qualification schemes (CY, IT, SK). 
Eighteen of the 25 countries participating in the survey carry out systematic standardised 
epidemiological investigations when an outbreak of CS is identified, aimed at confirming disease in a 
particular flock or herd and at investigating the possible origin of the disease. All except one (IE) 
stated that those epidemiological investigations are aimed at elucidating the possible spread of the 
disease to other flocks/herds. 
In countries applying control measures to goat herds, all of them apply the ‘cull and complete 
destruction’ approach. Only one country applies temporary measures to contact herds, beyond the 
requirements of the EU legislation (FI) and another MS (CY), given the high level of scrapie in the 
ovine and caprine populations, was granted formal dispensation from the cull and complete 
destruction, which was replaced by the killing of animals with clinical signs, and the slaughter of 
healthy animlas for human consumption (after testing negative). 
All countries participating in the survey conduct enhanced surveillance during the restriction period, 
according to the EU TSE Regulation, and in one country the cleaning of areas surrounding infected 
holdings is also undertaken (FI). 
The use of the powers granted by the legislation to derogate the implementation of the legislation is 
widely applied by numerous MS. The most common derogation applied is the delay of the cull of 
animals from infected flocks/herds (CY, IT, DE, EL, ES, RO, SI, UK); the second is  the replacement 
of the killing of some animals with the slaughtering for human consumption (IT, ES, UK, SK), 
followed by the derogation of the killing of small ruminants in infected holdings and of parents, and 
the destruction of embryos, ova and last progeny of diseased female animals (ES, IT, UK). The 
derogation of the restriction of movements of animals from infected holdings during the enhanced 
surveillance period after outbreaks has been also applied by one MS (UK). Special mention must be 
made in the case of CY for which transitional measures in relation to eradication measures in scrapie 
infected holdings were granted in January 2004 due to the high level of scrapie in the ovine and 
caprine population, the low level of genetically determined resistance in the ovine population, and the 
nature of farming in the country. Comprehensive animal identification (ruminal EID bolus) and 
traceability systems were put in place covering the entire sheep and goat population, in parallel with a 
compulsory BP-CS only for sheep. 
Control measures for AS 
In countries where AS  has been confirmed, in general all confirmed cases are traced back resulting in 
the confirmation of infected flocks/herds with some control/eradication measures implemented 
currently or in the past. MS started to apply measures with regards to AS when the first case was 
confirmed (FI, DE), when they joined the EU (HU, CZ), or well after the first case of AS was reported 
(UK, NL). 
The measures applied included the cull of a percentage of all affected flocks ranging from 17 % of 
infected flocks (DK, IT), 37 % (AT), 40 % (FI) to 98 % (HU) (SE, DE, PT, ES and IE did not provide 
a figure) and the selective killing and destruction of rams carrying AHQ or AF141RQ alleles (IT). All 
the MSs that reported AS and participated in the survey (17 of them) also apply trade restrictions, 
except ES. One MS temporarily applied (until 2006) measures in excess of the EU requirements, by 
“depopulation and the restrictions with no repopulation allowed for 7 years; after that enhanced 
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surveillance and trade restrictions”, and currently “only enhanced surveillance, according to changes 
in EU legislation” (SE). 
Some derogations have been applied to flocks/herds with AS. For example, since July 2007 animal 
owners are allowed “to apply derogation from killing animals in infected flocks. And since July 2013 
infected flock are subject to movement restrictions and monitoring, but no animals are killed” (FI). 
The substitution of the kill by enhanced surveillance has been applied by various MSs at different 
points in time (FI, IE, SE, SI, UK). 
A.2. Additional information on breeding programmes received from Member States 
A questionnaire “on the implementation of breeding programmes for genetic resistance to TSEs in 
sheep in accordance with Article 6(a) of Regulation (EC) No 999/2001” was circulated by the 
European Commission to all MSs in 2010, gathering information about the implementation of BP-SCs 
in the EU. According to the replies collected by the Commission, 16 MSs declared to have a BP-SC in 
place. In 2013 the European Commission requested all MSs having a BP-CS in place to provide, 
requirements for BP-CSs and annual reports, in accordance with the TSE Regulation. 
Information from the above sources was made available to EFSA, and was used, in addition to 
information described in Appendix A.3, to inform the assessment of BP-SC in EU MSs in the 
framework of the mandate for this Opinion. 
A.3. Questionnaire ‘Breeding programmes’ 
Questionnaire circulated to EU Member States 
A copy of the questionnaire ‘Breeding programmes’ circulated to MSs is included in the following 
pages. 
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1 SHEEP POPULATION AND STRUCTURE [RANGE FROM 1.1. TO 1.2., PLEASE ATTEMPT TO ANSWER ALL QUESTIONS]
1.1. Structure of the general national sheep population
SUB-POPULATION CONSIDERED NUMBER [unit]
[flocks]
[flocks]
[flocks]
[head]
[head]
[head]
REPLY [possible answers]
PLEASE tick this box (i.e. introduce X) if you do not have this information available and cannot be produced within the proposed deadline [X, blank]
1.2. Structure of the breed population
Name the main sheep breeds in your country and indicate the calculated or estimated distribution of the total population within those breeds.
Please note that there is an entry for mixed-breeds. Include further entries if needed
BREED NAME [unit]
[%]
[%]
[%]
[%]
[%]
[%]
[%]
[%]
[%]
[%]
[%]
[%]
[%]
[%]
REPLY [possible answers]
PLEASE tick this box (i.e. introduce X) if you do not have this information available and cannot be produced within the proposed deadline [X, blank]
Number of high genetic merit flocks (HGMF)
Total flocks
Sheep population in HGMF 
Sheep population in CF
Total sheep populaion
Number of commercial flocks (CF)
PERCENTAGE OF 
TOTAL POPULATION
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2 GENOTYPING [RANGE FROM 2.1. TO 2.11., PLEASE ATTEMPT TO ANSWER ALL QUESTIONS]
2.1. Regarding farget flocks for the genotyping activity in the breeding plans (BPs) for scrapie: 
FOR High Genetic Merit Flocks (HGMF): REPLY [unit/possible answers]
2.1.1. [percentage]
2.1.2. [yes/no/unknown]
FOR commercial flocks (CF): REPLY [unit/possible answers]
2.1.1. [percentage]
2.1.2. [yes/no/unknown]
REPLIES [unit/possible answers]
2.2. When (year) did start the scrapie genotyping in HGMF? [year]
2.3. When (year) did end the scrapie genotyping in HGMF? [year/ongoing]
REPLIES [unit/possible answers]
2.4. When (year) did start the scrapie genotyping in CF? [year]
2.5. When (year) did end the scrapie genotyping in CF? [year/ongoing]
2.6. Does an ad hoc data management system exist to collect, collate and analylse the BPs genotyping data?
REPLY [possible answers]
[yes/no/unknown]
2.7. How many genotype analysis  (heads tested) have been carried out annually?
REPLY [unit]
[average all period] REPLY [unit]
[minimum number on one year] [year]
[maximum number on one year] [year]
2.8. What is the proportion of genotypes  been from:
REPLY [unit/possible answers]
HGMF [%/unknown]
CF [%/unknown]
What percentage of total HGMF have been genotyped, i.e. 
"active flocks" within HGMF?
In HGMF, is it a pure ram ONLY genotyping scheme?
What percentage of total CF have been genotyped, i.e. 
"active flocks" within CF?
In CF, is it a pure ram ONLY genotyping scheme?
Maximum number carried out 
in what year was it?
in what year was it?
Annual average on the entire period of the BP
Minimum number carried out 
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2.9. Regarding both HGM and CF, what is the proportion of genotypes been from:
REPLY
rams [%/unknown]
ews [%/unknown]
2.10. What is the reason to genotype ews , if done?
REPLY [unit/possible answers]
[yes/no/unknown/blank]
[yes/no/unknown/blank]
[describe with text/unknown/blank]
2.11. Which is the breed share in the genotyping?
REPLY
BREED 
NAME
share as 
active 
HGMF
share as 
active 
commercial 
flocks
calculated 
or 
estimated? [unit/possible answers]
[breed name] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
[breed name] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
[breed name] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
[breed name] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
[breed name] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
[breed name] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
[breed name] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
[breed name] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
[breed name] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
[breed name] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
[mixed breeds] [%/unknown] [%/unknown] [ cacluated/estimated/blank]
Other reason:
To qualify flocks
To plan matings
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3 SELECTION OF RAMS [RANGE FROM 3.1. TO 3.7., PLEASE ATTEMPT TO ANSWER ALL QUESTIONS]
3.1. With regards to genotypes in rams ONLY, what are the results of the genotyping activity within the BP in terms of:
3.1.1. Frequency of ARR/ARR gentype
REPLY
Year in HGMFs in CFs [unit/possible answers]
in first year of genotyping [year] [%/unknown] [%/unknown]
in last year of genotyping [year] [%/unknown] [%/unknown]
3.1.2. Frequency of ARR allele
REPLY
Year in HGMFs in CFs [unit/possible answers]
in first year of genotyping [year] [%/unknown] [%/unknown]
in last year of genotyping [year] [%/unknown] [%/unknown]
3.2. Has the BP a ram classification system based on genotypes for scrapie resistance?  
REPLY [possible answers]
[yes/no/unknown]
If "yes", please briefly describe key principles
REPLY [describe details in box below]
3.3. Do rules of ram use exist, based on the above classification?
REPLY [possible answers]
[yes/no/unknown]
If "yes", please briefly describe key principles
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REPLY [describe details in box below]
3.4. If existing, the rules were issued as:
REPLY [possible answers]
[compulsory from official authorities/advice-guidelines]
3.5. Does an auditing system monitoring rules compliance exist?
REPLY [possible answers]
[yes/no/unknown]
If "yes", who is in charge of running and coordinating the system?
REPLY [possible answers]
[official authorities/breeder associations]
3.6. What proportion of flocks participating to the BP may be estimated to comply with those rules
REPLY [answer by introducin an "X" in the box that applies]
0-20%
21-40%
41-60%
61%-80%
81%-100%
unknown
3.7. What proportion of rams kept for replcement were born from active flocks that complied with the rules?
REPLY [answer by introducin an "X" in the box that applies]
0-20%
21-40%
41-60%
61%-80%
81%-100%
unknown
Scrapie situation in the EU
 
EFSA Journal 2014;12(7):3781 105
 
4 DISSEMINATION OF RAMS [RANGE FROM 4.1. TO 4.8., PLEASE ATTEMPT TO ANSWER ALL QUESTIONS]
4.1. Has the BP a flock qualification system based on genotypes for scrapie resistance?  
REPLY [possible answers]
[yes/no/unknown]
If "yes", please briefly describe the flock qualification system
REPLY [describe details in box below]
4.2. Do rules of ram dissemination exist, based on the above qualification system or on the ram genotype? 
REPLY [possible answers]
[yes/no/unknown]
If "yes", please briefly describe the rules
REPLY [describe details in box below]
4.3. What proportion of flocks participating to the BP is estimated to comply with those rules?
REPLY [answer by introducin an "X" in the box that applies]
0-20%
21-40%
41-60%
61%-80%
81%-100%
unknown
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4.4. Do rules to avoid/reduce the circulation of susceptible rams exist?
REPLY [possible answers]
[yes/no/unknown]
If "yes", the rules were issued as:
REPLY [possible answers]
[compulsory from official authorities/advice-guidelines]
4.5. What proportion of flocks participating to the BP may be estimated to comply with those rules?
REPLY [answer by introducin an "X" in the box that applies]
0-20%
21-40%
41-60%
61%-80%
81%-100%
unknown
4.6. Does an auditing system monitoring rules compliance exist?
REPLY [possible answers]
[yes/no/unknown]
If "yes", who is in charge of runnig it?
REPLY [possible answers]
[official authorities/breeder associations]
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4.7.
REPLY
Breed
Highly 
strict Less strict
No 
disseminat
ion rules at 
all Unknown
4.8.
REPLY [answer by introducin an "X" in the box that applies]
0-20%
21-40%
41-60%
61%-80%
81%-100%
unknown
Based on the original list of breeds, can you indicate how strict the dissemination rules are in the individual breeds? Please fill the 
table below indicating with a cross in the corresponding cell if the rules are ‘very strict’, ‘less strict’, ‘no dissemination rules at all’ or 
last ‘Unknown, unable to answer’ depending on the case
[answer by introducing an "X" in the box that applies]
OVERALL, what proportion of flocks from the general population (i.e. involved and not involved by the BP) may be estimated to 
have introduced animals originating from the active flocks?
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Summary of the replies to the questionnaire ‘Breeding programmes’ 
Table 5:  Main information from the questionnaire ‘Breeding programmes’ (BE, CY, CZ, FR). 
  Belgium Cyprus Czech Republic France 
Sheep population and structure         
Number total flocks 26337 2032 13246 59961 
Number HGMF flocks 885 unknown 485 1940 
Number CF flocks 25452(a) 2032 12761 58021 
Total sheep population 185624 304894 159324 5541149 
HGMF population 32573 unknown 23217 536466 
CF population 153051(a) 304894 136107 5004683 
Genotyping         
% HGMF flocks genotyped unknown - 100 98 
Pure ram genotyping in HGMF? no 0 No no 
% CF flocks genotyped unknown 100 0 0 
Pure ram genotyping in CF? unknown no n/a n/a  
First year of genotyping in HGMF 2005 n/a 2003 2002 
Last year of genotyping in HGMF ongoing n/a ongoing ongoing 
First year of genotyping in CF n/a 1999 2003 n/a 
Last year of genotyping in CF n/a ongoing ongoing n/a 
Ad hoc data management system exists? yes yes yes yes 
Annual average genotypings 733 86750 4297 70300 
Minimum annual genotypings 455 33391 1283 51100 
Year with minimum genotypings 2007 2004 2003 2011 
Maximum annual genotypings 1395 139016 8626 91600 
Year with maximum genotypings 2005 2010 2006 2003 
% genotypings performed in HGMF 100.0 0.0 100.0 100.0 
% genotypings performed in CF 0.0 100.0 0.0 0.0 
% genotypings performed in rams 58.0 100.0 33.6 50.0 
% genotypings performed in ewes 42.0 100.0 66.4 50.0 
Ewes genotyped to qualify flocks? yes yes no yes 
Ewes genotyped to plan matings? yes yes yes yes 
Ewes genotyped for other reasons? - - no yes 
Selection         
First year of genotyping 2005 1999 2003 2002 
Last year of genotyping 2012 2012 2012 2012 
% ARR/ARR HGMF first year 42.3 n/a 21.5 26.0 
% ARR/ARR HGMF last year 78.8 n/a 50.5 72.0 
% ARR/ARR CF first year unknown 1 ram unknown unknown 
% ARR/ARR CF last year unknown 76.4 unknown unknown 
% ARR HGMF first year 87.3 n/a 53.2 49.0 
% ARR HGMF last year 98.0 n/a  85.1 85.0 
% ARR CF first year unknown 1 ram unknown unknown 
% ARR CF last year unknown 99.0 unknown unknown 
Ram classification system exists? yes yes yes yes 
Rules of ram use exist? yes yes yes yes 
Type of rules of ram use compulsory (BA) compulsory (OA) yes OA, advice/guidelines 
Auditing system to monitor compliance exists? yes yes yes yes 
Who is auditing? OA, BA OA BA OA, BA, TRI 
% flocks complying with rules 81-100 81-100 81-100 81-100 
% rams born from flocks complying with rules 81-100 81-100 81-100 81-100 
Dissemination         
Flock qualification system exists? yes yes yes yes 
Rules of ram dissemination exist? yes yes, ram gen yes yes 
% flocks complying with rules 81-100 81-100 81-100 81-100 
Rules to avoid circulation susceptible rams exist? yes yes yes yes 
Type of rules of avoiding susceptible rams compulsory (OA) compulsory (OA) yes compulsory (OA) 
% flocks complying with rules 81-100 81-100 81-100 81-100 
Auditing system to monitor compliance exists? yes yes yes yes 
Who is auditing? OA OA BA OA 
% flocks general population introducing animals 
from active flocks unknown 81-100 81-100 41-60 
BA: breeder associations; n/a: not applicable; OA: official authorities; TRI: technical and research institutes 
(a): Calculated assuming that number CF flocks (CF population) = number total flocks (total sheep population) - number HGMF flocks (HGMF 
population)  
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Table 6:  Main information from the questionnaire ‘Breeding programmes’ (IE, IT, NL, SK). 
  Ireland Italy The Netherlands Slovakia 
Sheep population and structure         
Number total flocks 32176 95507 28354 3684 
Number HGMF flocks 1200 3806 2835(a) 124 
Number CF flocks 30976 91701 25519(a) 3560 
Total sheep population 3430300 7310739 1334252 416952 
HGMF population unknown 529741 66713(a) 27184 
CF population unknown 6780998 1267539(a) 389768(b) 
Genotyping         
% HGMF flocks genotyped 66 81.82 90 100 
Pure ram genotyping in HGMF? no no no no 
% CF flocks genotyped 1.04 16.43 unknown 0 
Pure ram genotyping in CF? no no unknown n/a 
First year of genotyping in HGMF 2004 2004 1998 2004 
Last year of genotyping in HGMF ongoing ongoing ongoing ongoing 
First year of genotyping in CF 2004 2005 1998 n/a 
Last year of genotyping in CF ongoing ongoing ongoing n/a 
Ad hoc data management system exists? yes yes yes yes 
Annual average genotypings 9418 34734 26900 3590 
Minimum annual genotypings 488 20533 4300 1787 
Year with minimum genotypings 2011 2008 2009 2005 
Maximum annual genotypings 26718 62889 70800 8615 
Year with maximum genotypings 2004 2009 2004 2012 
% genotypings performed in HGMF 97.3 41.8 unknown 100.0 
% genotypings performed in CF 2.7 58.2 unknown 0.0 
% genotypings performed in rams 53.2 56.2 unknown 100.0 
% genotypings performed in ewes 46.8 41.9 unknown 3.9 
Ewes genotyped to qualify flocks? yes yes yes yes 
Ewes genotyped to plan matings? yes yes unknown yes 
Ewes genotyped for other reasons? to facilitate trade - unknown - 
Selection         
First year of genotyping 2004(c) 2005 2005 2004 
Last year of genotyping 2012(c) 2013 2013 2012 
% ARR/ARR HGMF first year 62.4(d) 22.5 17.4(e) 18.7 
% ARR/ARR HGMF last year 83.7(d) 49.8 52.4(e) 51.3 
% ARR/ARR CF first year see above(d) 11.5 see above(e) unknown 
% ARR/ARR CF last year see above(d) 25.4 see above(e) unknown 
% ARR HGMF first year 85.7(d) 46.5 37.5(e) 39.5 
% ARR HGMF last year 99.8(d) 69.8 70.4(e) 40.2 
% ARR CF first year see above(d) 26.7 see above(e) unknown 
% ARR CF last year see above(d) 47.3 see above(e) unknown 
Ram classification system exists? no yes yes yes 
Rules of ram use exist? no yes unknown yes 
Type of rules of ram use n/a advice/guidelines compulsory first, then voluntary compulsory (OA) 
Auditing system to monitor compliance exists? n/a yes unknown yes 
Who is auditing? n/a OA unknown OA 
% flocks complying with rules n/a 41-60 unknown 81-100 
% rams born from flocks complying with rules n/a 21-40 unknown 81-100 
Dissemination         
Flock qualification system exists? no yes yes yes 
Rules of ram dissemination exist? no yes no yes 
% flocks complying with rules n/a 61-80 61-80 81-100 
Rules to avoid circulation susceptible rams exist? no yes unknown yes 
Type of rules of avoiding susceptible rams n/a advice/guidelines unknown compulsory (OA) 
% flocks complying with rules n/a 21-40 unknown 81-100 
Auditing system to monitor compliance exists? n/a no unknown yes 
Who is auditing? n/a n/a unknown OA 
% flocks general population introducing animals 
from active flocks unknown 41-60 81-100 81-100 
n/a:  not applicable; OA: official authorities 
(a):  calculated based on the approximate percentage provided 
(b):  calculated assuming that number CF population = total sheep population - HGMF population 
(c):  not provided but assumed from information provided in previous section of the questionnaire 
(d):  values provided for the whole population included in the BP-CS, without distinction between HGMF and CF. However, since 97.3 % of the 
genotypings were performed in HGMF, it may be assumed that the values provided represent the genotypic and allelic frequencies in HGMF 
(e):  values provided for the whole population included in the BP-CS  
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Table 7:  Main information from the questionnaire ‘Breeding programmes’ (SI, ES, UK(GB/NI)). 
  Slovenia Spain United Kingdom (GB) United Kingdom (NI)*
Sheep population and structure         
Number total flocks 5203 111787 52500 13417 
Number HGMF flocks 221 3607 14000 unknown 
Number CF flocks 4982 108180 38500 unknown 
Total sheep population 86535 16609069 15200000 1969000 
HGMF population 13111 2157070 7690000 unknown 
CF population 73424 14451999 7510000 unknown 
Genotyping         
% HGMF flocks genotyped 85 95 85 unknown 
Pure ram genotyping in HGMF? no no yes no 
% CF flocks genotyped unknown 1 0 0 
Pure ram genotyping in CF? unknown no n/a n/a 
First year of genotyping in HGMF 2006 2003 2001 2003 
Last year of genotyping in HGMF ongoing ongoing 2009 2010 
First year of genotyping in CF 2010 2003 n/a n/a 
Last year of genotyping in CF ongoing ongoing n/a n/a 
Ad hoc data management system exists? yes yes no(a) yes 
Annual average genotypings 3636 355214 700000 16822 
Minimum annual genotypings 2159 34785 unknown 6967 
Year with minimum genotypings 2011 2003 unknown 2010 
Maximum annual genotypings 5281 621893 unknown 27953 
Year with maximum genotypings 2007 2007 unknown 2004 
% genotypings performed in HGMF 100.0 90.6 100.0 100.0 
% genotypings performed in CF 0.0 9.4 0.0 0.0 
% genotypings performed in rams 95.0 8.8 20.0 44.0 
% genotypings performed in ewes 80.0 91.3 80.0 56.0 
Ewes genotyped to qualify flocks? yes yes unknown no 
Ewes genotyped to plan matings? yes yes yes yes 
Ewes genotyped for other reasons? unknown - cost sample size 
Selection         
First year of genotyping 2006 2003 2002 2003 
Last year of genotyping 2011 2012 2008 2010 
% ARR/ARR HGMF first year 4.3 11.3 28.8 23.8 
% ARR/ARR HGMF last year 13.4 25.1 53.9 59.2 
% ARR/ARR CF first year unknown unknown unknown unknown 
% ARR/ARR CF last year unknown 30.3 unknown unknown 
% ARR HGMF first year 38.3 28.0 50.4 45.9 
% ARR HGMF last year 55.4 48.4 68.8 75.9 
% ARR CF first year unknown unknown unknown unknown 
% ARR CF last year unknown 47.9 unknown unknown 
Ram classification system exists? yes yes yes yes 
Rules of ram use exist? yes yes yes yes 
Type of rules of ram use compulsory (BA) compulsory (OA) compulsory (NSPm) compulsory (OA) 
Auditing system to monitor compliance exists? yes no yes yes 
Who is auditing? OA, BA n/a NSP administration OA 
% flocks complying with rules 81-100 81-100 81-100 81-100 
% rams born from flocks complying with rules 81-100  81-100 81-100 81-100 
Dissemination         
Flock qualification system exists? yes yes no no 
Rules of ram dissemination exist? yes yes no no 
% flocks complying with rules 61-80 61-80 n/a n/a 
Rules to avoid circulation susceptible rams exist? yes yes yes yes 
Type of rules of avoiding susceptible rams compulsory (OA) compulsory (OA) compulsory (NSPm) compulsory (OA) 
% flocks complying with rules 61-80 81-100 81-100 unknown 
Auditing system to monitor compliance exists? yes no unknown no 
Who is auditing? OA n/a n/a n/a 
% flocks general population introducing animals 
from active flocks 21-40 0-20 61-80 unknown 
*  Northern Ireland not included in the assessment of BP-SC because of the lack of some data (see Section 4.5.4.1). 
BA:  breeder associations; GB: Great Britain; NI: Northern Ireland; NSPm: NSP members; n/a: not applicable; OA: official authorities 
(a):  data management system existed, but is considered unfriendly for large data extractions and manipulation  
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Table 8:  Main information from the questionnaire ‘Breeding programmes’ (EE, DE, HU). 
  Estonia* Germany* Hungary* 
Sheep population and structure       
Number total flocks 1549 299130 6700 
Number HGMF flocks 34 1375 200 
Number CF flocks 1515 10600 6500 
Total sheep population 77265 1799700 890000 
HGMF population 3779 5323 40000 
CF population 73486 1741000 850000 
Genotyping       
% HGMF flocks genotyped 100 unknown(a) 100 
Pure ram genotyping in HGMF? yes unknown yes 
% CF flocks genotyped 0 unknown 2 
Pure ram genotyping in CF? n/a  unknown unknown 
First year of genotyping in HGMF 2006 2006 2004 
Last year of genotyping in HGMF ongoing ongoing ongoing 
First year of genotyping in CF n/a 2002 2004 
Last year of genotyping in CF n/a ongoing ongoing 
Ad hoc data management system exists? yes no unknown 
Annual average genotypings 286 46179 4500 
Minimum annual genotypings 160 4747 2400 
Year with minimum genotypings 2012 2009 2004 
Maximum annual genotypings 448 13458 4776 
Year with maximum genotypings 2006 2006 2012 
% genotypings performed in HGMF 100.0 unknown 43.8 
% genotypings performed in CF 0.0 unknown 56.2 
% genotypings performed in rams 78.0 unknown 40.0 
% genotypings performed in ewes 22.0 unknown 60.0 
Ewes genotyped to qualify flocks? no yes yes 
Ewes genotyped to plan matings? yes - no 
Ewes genotyped for other reasons? no reporting unknown 
Selection       
First year of genotyping 2006 2006 2004 
Last year of genotyping 2012 2012 2012 
% ARR/ARR HGMF first year 20.5 unknown(b) 16.1 
% ARR/ARR HGMF last year 41.3 unknown(c) 46.8 
% ARR/ARR CF first year unknown unknown(d) unknown 
% ARR/ARR CF last year unknown unknown(e) 22.2 
% ARR HGMF first year 41.5 unknown 42.9 
% ARR HGMF last year 69.1 unknown 66.4 
% ARR CF first year unknown unknown unknown 
% ARR CF last year unknown unknown 46.5 
Ram classification system exists? yes no yes 
Rules of ram use exist? yes yes unknown 
Type of rules of ram use compulsory (OA) compulsory (Smon) n/a 
Auditing system to monitor compliance exists? yes no yes 
Who is auditing? OA n/a  BA 
% flocks complying with rules 81-100 41-60 81-100 
% rams born from flocks complying with rules 81-100 unknown 81-100 
Dissemination       
Flock qualification system exists? yes yes no 
Rules of ram dissemination exist? yes no yes 
% flocks complying with rules 81-100 21-40 81-100 
Rules to avoid circulation susceptible rams exist? yes no yes 
Type of rules of avoiding susceptible rams compulsory (OA) n/a advice/guidelines 
% flocks complying with rules 81-100 unknown 81-100 
Auditing system to monitor compliance exists? yes no yes 
Who is auditing? OA n/a BA 
% flocks general population introducing animals from active flocks 61-80 unknown 81-100 
* Estonia, Germany and Hungary not included in the assessment of BP-SC because analysis of the epidemiological trend was not performed (see Section 
4.5.4.1).  BA: breeder associations; OA: official authorities; n/a: not applicable; Smon: scrapie monitoring 
(a): in total, 7518 farms genotyped  (b): percentage not provided; absolute number of genotypings provided (5661) (c): percentage not provided; absolute 
number of genotypings provided (3340)  (d): percentage not provided; absolute number of genotypings provided (4801) (e): percentage not provided; 
absolute number of genotypings provided (371)                                                                                                                                                                        
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A.4. Request for data to model the minimum frequency of the ARR allele to observe fading-out 
of Classical scrapie in some case studies 
A request for data was made to some Member States (i.e. Cyprus, Italy and the United Kingdom) in 
order to obtain information allow the calculation of the minimum frequency of the ARR allele to 
observe fading-out of CS for some case-studies. Case-studies included sheep in Cyprus, Sarda sheep in 
Sardinia (Italy), and sheep in Great Britain. 
Information requested included: 
- Qualitative information on the type of selective breding strategy. This information was needed 
to inform the construction of relevant breeding strategy scenarios for model extrapolation. 
- Data from active surveillance, in particular in relation to: i) total number of animals tested by 
year and by stream; ii) number of positive cases by year, by stream and by genotype. These 
data were needed for the calculation of the CS transmission level (quantified by R0) at a given 
year, for which random genotyping data are also available (see below). 
- Data on frequency of genotypes, based on a random genotyping sample from the population of 
interest. for at least one year, for which data on tested and positive animals are also available 
(see above). These data were needed for the calculation of allele and genotype frequencies for 
the given year. 
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Appendix B.  Analysis of scrapie trends (2002-2012): materials and methods 
Materials 
With regards to the two species of interest, i.e. sheep and goats, the European Commission made 
available two different sources of data covering the 2002-2012 period:   
• Testing data by species from both passive and active surveillance and from the eradication cull 
of the animals in outbreaks. The individual record was based on aggregated data given by the 
combination of sampling year, sampling month, target  group (i.e. the surveillance stream) and 
type of test by country, providing the total number of tested animals, and of positive and 
negative/inconclusive results. Due to the large proportion of missing data, some of the original 
variables (i.e. age, regional location, flock status) were skipped. Data on the type of test were 
largely missing for the 2002-2005 period.  
• Individual case data that includes information on each individual scrapie case: country, month 
and year of sampling, case type (Classical vs. Atypical), species, surveillance stream and type 
of test. 
The available data were used for the estimation of prevalence of scrapie over time, separately by 
species and country and after taking into account the potential effect of confounding factors (e.g. the 
surveillance stream).  
Data collation, manipulation, cleaning and analyses were conducted using Stata (v11.2; Stata Corp, 
College Station, TX).     
Animals tested  data (2002-2012): the source of denominators 
The initial extraction of the EU dataset included 5 356 057 tested sheep and 1 745 335 tested goats.  
In the case of sheep 5 049 092 were tested in the frame of active surveillance, 17 578 in passive 
surveillance and the remaining mostly in activities linked to outbreak management.    
In the case of goats 1 697 775 were tested in the frame of active surveillance, 14 204 in passive 
surveillance and the remaining mostly in activities linked to outbreak management.    
It was decided to focus the data analysis on the active surveillance data only. Data obtained from 
passive surveillance and from eradication culls following an outbreak were not considered fit for 
purpose due to their inherent limitations and biases. 
Therefore only the data relating to the two main streams ‘slaughtered for human consumption’ (SHC), 
i.e. healthy slaughtered animals, and ‘not slaughtered for human consumption’ (NSHC), i.e. fallen 
stock, were kept in the dataset, aggregated  by year. 
The final testing datasets available for statistical analysis for each species include the following 
variables: country, year, stream, type of rapid test, and total tested animals. As it was not possible to 
discriminate the type of scrapie among the cases, only denominator figures were used from these 
datasets.  
Finally, with regard to AS, all testing results referring to rapid tests not able to consistently detect the 
disease (i.e. other than Bio-Rad and IDEXX rapid tests) were excluded from the denominators. As a 
result the prevalence estimation was possible only for the period 2006-2012.   
Individual case data (2002-2012): the source of numerators 
The datasets included detailed data on each individual case allowing the discrimination between CS 
and AS cases by country, year, stream and type of rapid test used to confirm the disease.  
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Before any data analysis, as for the testing datasets, all cases detected in categories other than those of 
active surveillance (i.e. NSHC and SHC) were dropped.  
The case type category was largely missing in the period before 2006 when an EU system of 
automatic upload was set up. Therefore it was decided to consider as CS cases also those cases that 
before 2006 were categorised as unknown or with the case type variable missing. 
Finally a certain number of duplicate entries were detected and dropped: they originated through the 
automatic multiplication of records in the EU information system when more than one rapid test had 
been used in the case detection process. 
Methods 
Data analysis was split to consider separately species (sheep vs. goats) and disease (CS vs. AS). In 
each individual subset, descriptive frequency tables were produced to show the breakdown of animals 
tested and cases by country, year, stream and rapid test. The potential  confounding effect of stream in 
the case of CS, in both sheep and goats, was observed when comparing the stream-specific prevalence 
and the different distribution of the number of tests carried out in each stream by country or by year. 
No significant difference in prevalence by stream was evident in case of AS. Moreover the effect of 
the type of rapid test on the prevalence estimation has been excluded.    
Space and time analysis 
A brief spatial description of the epidemiological impact of the diseases (scrapie types) on the two 
populations of small ruminants was carried out by mapping at the European level the reporting of CS 
and/or AS by species. After that, the European geographical distribution of each disease by species 
was obtained through proportional symbol mapping of the national stream adjusted (for CS) or crude 
(for AS) prevalences over the 2002-2012 period. The adjustment on stream was carried out by means 
of a direct standardization using as standard population the European proportion of tests carried out in 
NSHC vs. SHC in sheep and goats respectively over the same period. 
Time trends analysis 
Before any multivariate analysis, EU-wide and national stream-specific annual prevalences (cases per 
10 000 rapid tests) with 95 % CIs were obtained and plotted for  the 2002-2012 period. Individual 
plots were produced separately by scrapie type, species and surveillance stream. 
Temporal trends of annual prevalence for CS and AS by species were tested by fitting Poisson and 
negative regression models.The negative binomial regression is applied to estimate count models 
when the Poisson estimation is inappropriate due to over-dispersion. While in a Poisson distribution 
the mean and the variance are equal, negative binomial regression should be applied when the variance 
is greater than the mean. The models were compared with the Akaike Information Criterion (AIC). 
This criterion is calculated using the log-likelihood penalized by the number of parameters in the 
model. For models with the same dataset, the best model is the one with the lowest AIC.  
The number of cases confirmed by year was used as a dependent variable, the year as an independent 
variable and the annual number of animals tested as an offset of the model. Two different models 
using year as a categorical or a continuous variable, respectively were fitted for the EU as a whole and 
for each country. When year was used as a categorical variable, an estimate of the expected prevalence 
was obtained for each individual  year, whereas year was used as a continuous variable to describe the 
annual linear change in the prevalence over time and to test its statistical significance (see below). To 
account for confounding, surveillance stream (SHC vs. NSHC) was entered in the models as a 
covariate (internal reference). 
The models served to obtain the annual stream-adjusted prevalence rates over the period 2002-2012 
and the adjusted annual prevalence ratios (PRs). In models where year was entered as a continuous 
variable, the PR provided an estimate of the average relative change in prevalence per year. A PR 
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larger than one indicates an increasing trend whereas a PR less than one is associated with a 
decreasing trend. The PR is statistically significant when its 95 % CI does not include one (that would 
indicate a flat trend). 
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Appendix C.  Information on the control of Classical scrapie in Iceland 
Following to a request for information from EFSA to Iceland, a comprehensive report was kindly 
provided by the Institute for Experimental Pathology of the University of Iceland (IEP, S. 
Thorgeirsdottir) and the Icelandic Food and Veterinary Authority (MAST, L. Arnthorsdottir). A copy 
of such report, including historical information on the control of CS in Iceland, is provided in the 
following pages. 
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Figure 2. Distribution of sheep farms in Iceland 
6 
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Appendix D.  Approach used to model the minimum frequency of ARR allele to observe 
fading-out of Classical scrapie: methods 
Modelling strategy 
In the case studies discussed below the minimum ARR frequency for CS fade-out in a sheep 
population is defined as that value for which the basic reproduction number R0 for CS in that 
population equals one. For the case of The Netherlands, the model explicitly models the 
heterogeneities of mixing as well as genetic heterogeneities at the between-flock level, thus producing 
a between-flock R0. The modelling strategy for this case is described in more detail below. For the 
other case studies, in the absence of data on the genetic differences between flocks in the MS/breed of 
interest, population level data is used  to parameterize the model: the population level genotype 
distribution and the population level scrapie prevalence. As these are both defined for a population of 
animals (and not a population of flocks), these are ‘between-animal’ parameters. We define a 
parameter that extrapolates from between-animal input parameters to the between-flock R0 quantifying 
the transmission intensity of CS in a context where no control or eradication measure is being applied. 
This parameter is calculated based on a scenario assumption for the true minimum ARR allele 
frequency for The Netherlands and on between-animal input parameters for the Netherlands.  
Mathematical details: the model used for the non-Dutch case studies 
For a suitable reference year or period an initial R0 is calculated. A reference year or period is suitable 
when for that year both scrapie surveillance data and random genotyping data are available. 
Subsequently we use a simple model to extrapolate the R0 in new situations (to subsequent years) with 
a higher ARR allele frequency, and calculate for which minimum ARR allele frequency  the R0 is 
reduced to one.  
In the standard SI (susceptible, infectious) model for a homogeneously susceptible and 
homogeneously mixing population, the following relationship holds between R0 and the endemic 
infection prevalence  ݅כ : 
ܴ଴ ൌ
1
1 െ ݅כ
 
It is assumed that the case prevalence in the healthy slaughter (HS) surveillance at any given moment 
in time approximately represents an endemic equilibrium prevalence corresponding to the genotype 
frequencies in the population at that moment in time. In a population in which a proportion ݊ோ of 
animals have resistant genotype, the above relationship generalizes to:  
ܴ଴ ൌ
ଵ
ଵି ೔
כ
భష೙ೃ
  
 
In analogy with a vaccination campaign, the BP-CS reduces R0 by a factor equalling the remaining 
susceptible proportion of the population. In this case this factor is 
1 െ ݊ோሺݕሻ
1 െ ݊ோሺܻሻ
 
Here ܻ is the reference year for which R0 was estimated, and ݕ is the year or interest. Thus: 
ܴ଴ሺݕሻ ൌ
ଵି௡ೃሺ௬ሻ
ଵି௡ೃሺ௒ሻ
ܴ଴ሺܻሻ  
The approximation is used that this relation also holds for the between-flock reproduction number 
ܴ଴
௕௙. For this quantity ܴ଴
௕௙ the model used is: 
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ܴ଴
௕௙ ൌ
1
1 െ
ߠ݅ுௌ
כ
1 െ ݊ோ
  
, 
where ݅ுௌכ  is the case prevalence in HS and ߠ is a proportionality factor that translates the ‘between-
animal’ ratio ௜ಹೄ
כ
ଵି௡ೃ
 into a between-flock equivalent. Assuming Hardy-Weinberg equilibrium (which is 
appropriate to model the transmission risk in a situation in which application of control and 
eradication measures are no longer being applied) and assuming that ARR heterozygote animals, if 
infected, do not transmit CS to other animals, then: 
1 െ ݊ோ ൌ ሺ1 െ ஺݂ோோሻଶ 
A minimum ARR allele frequency for CS fade-out ஺݂ோோ௖௥  for The Netherlands can be defined. If we 
assume that as R0=1 for ஺݂ோோ ൌ ஺݂ோோ௖௥ , then: 
ܴ଴ሺܻሻ ൌ  
൫ଵି௙ಲೃೃሺ௒ሻ൯
మ
൫ଵି௙ಲೃೃ
೎ೝ ൯
మ  
The factor ߠ can now be calculated using ஺݂ோோ
௖௥,ே௅ for The Netherlands and using Dutch reference input 
parameters ݅ுௌכ ሺ ேܻ௅ሻ and ஺݂ோோሺ ேܻ௅ሻ, as follows: 
ߠ ൌ ௜ಹೄ
כ ሺ௒ಿಽሻ
൫ଵି௙ಲೃೃሺ௒ಿಽሻ൯
మ
ିቀଵି௙ಲೃೃ
೎ೝ,ಿಽቁ
మ 
Setting ܴ଴
௕௙ሺݕሻ ൌ 1 now leads to the following expression for the minimum ARR frequency for the 
non-Dutch population of interest:  
ሺ1 െ ஺݂ோோ
௖௥ ሻଶ ൌ ൭൫1 െ ஺݂ோோሺܻሻ൯
ଶ
െ
݅ுௌ
כ ሺܻሻ
݅ுௌ
כ ሺ ேܻ௅ሻ
ቀ൫1 െ ஺݂ோோሺ ேܻ௅ሻ൯
ଶ
െ ൫1 െ ஺݂ோோ
௖௥,ே௅൯
ଶ
ቁ൱ 
In case the right-hand side is smaller than (or equal to) zero a minimum ARR allele frequency of 
‘close to 100 %’ is reported. 
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Appendix E.  Selection for resistance to Classical scrapie in the Sarda dairy sheep breed 
Description of the Sarda breed population 
The Sarda breed is the largest Italian dairy sheep breed (51 % of the national stock) with 
approximately 2.5 million ewes bred in Sardinia on 11 000 farms8. The selection scheme for the Sarda 
breed is based on a pyramidal management of the population (Barillet, 1997). The high genetic merit 
population, consisting of around 240 000 ewes in 800 HGMF, forms the top of the pyramid (Carta et 
al., 2009). Selection tools are applied in HGMF to generate genetic progress that is successively 
transferred to the CF, mainly by rams for natural mating. The time-lag between HGMF and CF is 
proportional to the relative size of HGMF and the flow of breeding animals. An artificial insemination 
(AI) programme is used in HGMF with three main purposes: to create genetic links, to progeny test 
young males, and to enable planned matings between elite rams and elite ewes. Only 8-10 % of 
replacement ewes were born from AI rams. In the selection scheme, AI is coupled with controlled 
natural mating. Breeders manage natural mating by grouping ewes with a single ram (‘mating group’) 
during the reproduction period (Salaris et al., 2008). This management strategy makes it easy to 
determine the correct sire of a lamb based on the lambing date.  
Milk yield is the main selection goal. CS resistance (Salaris et al., 2007) and udder morphology (Casu 
et al., 2006) selection criteria have only been implemented recently. Evolution in the number of flocks 
and population demographic patterns across years were reported in Salaris et al. (2008).  
The Sarda breed selection plan for CS resistance 
Implementation 
Genotyping of AI rams at the PRNP locus started in 2000. Successively, in order to estimate allelic 
frequency, 2 075 rams and 6 424 ewes of HGMF (Salaris et al., 2004) and 5 677 rams of CF (Mura et 
al., 2004) were genotyped. The official selection plan for CS resistance started in 20059, according to 
the European and national guidelines. 
The Sarda Plan aims at reducing the risk of CS in sheep flocks by increasing the frequency of the ARR 
allele and eliminating the VRQ one, and this HGMF plan is managed with the scientific and technical 
support of an advisory group including experts from of all the involved industry and government 
institutions. The HGMF plan is managed, with the scientific support of the Sardinian Agency for 
Research in Agriculture (AGRIS Sardegna), by the National Sheep Breeders Association 
(ASSONAPA) and the Regional Ministry of Health. The data is centralised within the National 
database of the Italian BP-CS, based in Turin. The CF activity is managed by the regional and national 
Health Authorities with the scientific support of both the Istituti Zooprofilattici of Sardinia and 
Piemonte (the latter as National Reference Laboratory for animal TSEs). .  
Two steps were planned. In the first (until 2009), genotyping and selection of rams was applied mainly 
in HGMF to increase the availability of ARR carrier rams while preserving the genetic merit for 
production traits. The selection plan established that all the breeding males and the young ewes with 
high pedigree genetic merit for milk yield, and therefore candidates to generate male reproducers,  had 
to be genotyped. To preserve production traits, in the early stages of the plan even homozygous 
susceptible rams with high genetic merit for production traits were used for breeding. These rams were 
preferably mated to ARR homozygous ewes. With the same goal, no distinction was made between 
homozygous and heterozygous ARR carriers and both were selected according to the genetic merit for 
production traits. On the other hand, young ARR homozygous rams without any progeny test for 
production traits were licensed to generate male reproducers when their pedigree index was beyond a 
                                                     
8  See www.istat.it 
9  Ministry of Health, 2005. DM n.17, December 2004. Piano nazionale di selezione genetica per la resistenza alle 
encefalopatie spongiformi negli ovini. Gazzetta Ufficiale n. 51, 03.03.2005. 
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Table 9:  Genotype and ARR frequency in rams of the commercial population. 
Birth year Susceptible Heterozygous 
resistant 
Resistant Total %ARR 
2004 4 280 6 137 2 458 12 875 42.9 % 
2005 2 174 3 249 1 206 6 629 42.7 % 
2006 3 042 4 413 1 747 9 202 43.0 % 
2007 3 283 5 015 2 038 10 336 44.0 % 
2008 3 451 5 048 2 098 10 597 43.6 % 
2009 3 324 5 127 2 255 10 706 45.0 % 
2010 1 866 3 392 1 599 6 857 48.1 % 
2011 1 554 2 890 1 655 6 099 50.8 % 
2012 659 1 580 965 3 204 54.8 % 
 
The CF comprises 2.5 million ewes. For this population, approximately 50 000 males are used every 
year (sex ratio 1 to 50). Assuming a replacement rate of 0.33, 16 666 new rams are needed yearly. 
HGMF are able to produce 18 000 rams per year by using 40 % of ARR homozygous lambs selected 
for the best production traits. Tools to monitor the flow of rams from HGMF to CF should be 
implemented. 
The introduction of selection for CS resistance in the BP did not produce any decline in the genetic 
trend for milk yield (Salaris et al., 2007). 
Overall considerations of the case-study 
The Sarda selection programme for production traits is based on a pyramidal management of the 
population with HGMF at the top  and CF at the bottom. This breeding structure has been exploited 
also for selection for CS resistance. The basic idea was to create the genetic progress in HGMF and 
then transfer it to CF. A two-step plan combined with rules for preserving genetic merit for production 
traits and facilitating the use of ARR/ARR rams has produced good results in HGMF. These results 
are now being quickly transferred to CF.  However, further tools to precisely monitor the ram flow 
from HGMF to CF should be implemented. 
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Appendix F.  Assessment of breeding programmes for resistance to Classical scrapie in EU 
Member States 
Description of the model 
A deterministic model, written in Fortran language, was developed to: i) compare the potential and 
observed evolution of PRNP genotype distribution in the HGMF; and ii) evaluate the dissemination of 
resistant breeders towards the CF. Classifications of resistance (R or S) were considered rather than the 
different PRNP alleles. Thus, the PRNP gene was simplified as being biallelic with one resistant allele 
(R) and one susceptible allele (S) which includes all susceptible polymorphisms. With this model a 
single animal can be at the resistant homozygous state (RR), at the heterozygous state (RS) or at the 
homozygous susceptible state (SS). If it is assumed that the resistant allele is dominant, RR and RS are 
phenotypically equivalent, but the breeding value of RS animals equals one half of RR since they 
transmit the S allele to one half of their progeny. The diagram in Figure 17 summarises the structure of 
the model. 
The model is based on a number of hypotheses and in particular assumes that: 
• Males were used for three years, without mortality, giving a replacement rate RRM = 1/3. 
• Females were used 5 years, without mortality, giving a replacement rate RRF = 0.20. 
• On average a female gave birth to FtoF = 0.34 young replacement candidate ewe lamb /year 
(prolificacy 1.4, survival 0.9, sex ratio 0.5, elimination of ewe lambs for standard defects 1/3, 
no replacement from 1 year old females). 
• On average a female gave birth to FtoM = 0.17 young replacement candidate ram lamb /year 
(prolificacy 1.4, survival 0.9, sex ratio 0.5, elimination of ram lambs for standard defects 2/3, 
no replacement from 1 year old females). 
• One ram could mate SR = 40 ewes/year. 
• Only two generic alleles were considered for PRNP : R for resistant allele, S for susceptible. 
All those parameters could be modified to better fit the observation in the presence of data derived 
from actual observations, and to allow the estimation of the robustness of the results given the 
uncertainties about their values (by sensitivity analysis). These hypotheses are optimistic concerning 
the evolution of PRNP allele frequencies. The resulting model is a starting point from which better fits 
are sought, to take into account selection for other traits. 
The available data for the HGMF part were: 
• Number of females   NfH 
• Number of  PRNP genotypes measured/ year   NG 
• Proportion of genotyping for HGMF  propH 
• Proportion of genotyping for males   propm 
• First year R allele frequency  prr 
• Duration of the selection scheme maxtime 
• Selection rate applied on other traits rate 
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The last parameter (‘rate’) was set to 1 in a first run of the model. The R frequency in HGMF given by 
the model was compared to the frequency observed (from the questionnaire ‘Breeding programmes’, 
see Appendix A.3) in 2012, or at the end of the BP-CS if it was stopped before this date. When a large 
difference was observed (more than 20 %), a value for the selection rate on traits other than the 
resistance to CS (rate < 1) was estimated by trial and error to force the model to fit the observation. 
The model run corresponding to this fitted selection rate gave the expected evolution of the R 
frequency in the commercial flocks. It must be emphasized that, given that improving resistance to CS 
is only one amongst, possibly many, other selection objectives, intense selection rates on other traits  
are to be expected in well-designed BP-CSs.  
From these parameters, it was estimated that: 
• Number of males in HGMF NmH = NfH/SR 
• Number of needed new males / year NnmH = NmH·RRM 
• Number of needed new females / year NnfH = NfH·RRF 
• Number of males produced in HGMF / year  NpmH = NfH·FtoM 
• Number of available new males for commercial flocks NpmHtoC = NpmH-NnmH 
• Number of genotyped rams in HGMF NGmH = Ng·propH·propM 
• Number of available genotyped rams for CF NgmHtoC = NGmH-NnmH 
 
The model manipulated genotype and allele frequencies of classes of individuals defined by sex (s = 
male/female), age (a = 1 to 5) and tier (l = HGMF/CF).  
It was assumed that a selection on PRNP genotype was operated on the young rams within their first 
year and that matings were at random. Following responses to the questionnaire, which never 
mentioned selection of ewes for the replacement of the female reproducers, selection on the female 
side was not incorporated into the model.  
Let psalg(t) the genotype g (RR,RS,SS) frequency in class [s,a,l]. 
The ageing process was simply described by psalg(t) = psa-1lg(t-1).  
The R allele frequencies in the reproducers flocks were given by fsl(t) = meana(psalRR(t)+½psalRS(t)).  
Assuming random matings, genotype frequencies in the newborns were h0lRR(t) = fml(t-1)·ffl(t-1), 
h0lRS(t) = fml(t-1)·(1-ffl(t-1))+(1-fml(t-1))·ffl(t-1) and h0lSS(t) = (1-fml(t-1))·(1-ffl(t-1)) for RR, RS and SS, 
respectively. As no selection was assumed for the females, pf0lRR(t) = h0lRR(t). 
The model was run considering allele R initial frequency (fmH(0) = prr) as given in the questionnaire. 
The Hardy-Weinberg Equilibrium (HWE) was first checked comparing the initial RR frequency as 
given in the questionnaire to the square of prr. A large discrepancy between these data points is an 
indication that the data may be of poor quality. 
It was assumed that the initial genotype frequencies psalg(1) were identical in all classes (whatever m, a 
and l) and followed the HWE (psal1(1) = prr·prr; psal2(1) = 2·(1-prr)·prr; psal3(1) = (1-prr)·(1-prr)). 
Depending on the values of the parameters, different hypotheses were made concerning the selection 
and diffusion of rams in the BP-CS. 
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Selection in HGMF 
TypeBP1: When NGmH > NnmH/rate (the number of genotyped males is higher than the number of 
males needed for the replacement of the rams in the flock), a selection rate qmH = 
inf(1,NnmH/(rate·NGmH)) was applied to the genotyped males. This creates a change in genotype 
frequencies. The following rules of selection were applied: 
If  qmH < h0HRR(t) (i.e. all replacement rams may be RR) ⇒  
pm0HRR(t) = 1 
pm0HRS(t) = 0 
pm0lHS(t) = 0 
If  h0HRR(t) < qmH < h0HRR(t)+h0HRS(t) (i.e. all replacement rams may be R carriers)   ⇒  
pm0HRR(t) = h0HRR(t)/qmH 
pm0HRS(t) = 1- pm0HRR(t) 
pm0HSS(t) = 0 
If  h0HRR(t)+h0HRS(t) < qmH (i.e. it is needed to use some SS rams for the replacement) ⇒  
pm0HRR(t) = h0HRR(t)/qmH 
pm0HRS(t) = h0HRS(t)/qmH 
pm0HSS(t) = 1-( pm0HRR(t)+pm0HRS(t)) 
TypeBP2: When NGmH < NnmH/rate (the number of genotyped males is lower than the number of 
males needed for the replacement of the rams in the flock), it was (possibly suboptimally) assumed 
that the genotyping was only used to discard SS rams. The quantity frac = 1/qmH = 
rate·NGmH/NnmH represents the proportion of genotyped rams amongst the newborns and the rules 
give the following genotype frequencies 
pm0HRR(t) = frac·h0HRR(t)/(h0HRR(t)+h0HRS(t))+(1-frac)·h0HRR(t) 
pm0HRS(t) = frac·h0HRS(t)/(h0HRR(t)+h0HRS(t))+(1-frac)·h0HRS(t) 
pm0HSS(t) = (1-frac)·h0HSS(t) 
 
Dissemination from HGMF to CF 
The available data for the CF part were: 
• Number of females in CF NfC 
• Dissemination mode TypeDI 
• Maximum proportion of young males in the CF born in HGMF Difrate 
This dissemination mode was inferred from the responses to the questionnaire ‘Breeding programmes’ 
(questions Q4.2 to Q4.7, see Appendix A.3) which gave an idea about the dissemination rules, their 
compulsory or voluntary bases and the way they were controlled: TypeDI1 when only RR males were 
disseminated, TypeDI2 when only R carriers males were disseminated, TypeDI3 corresponded to the 
fixed proportion of rams coming from HGMF, with a selection classifying RR rams before RS rams 
and RS rams before SS rams, and TypeDI4 when rams sent from the HGMF to the CF were not 
selected on their PRNP genotype.  
Different numbers of rams born in HGMF and available for CF were needed to describe the 
dissemination: 
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• Number of RR rams RRHtoC = max[0,NGmH·h0HRR(t)-NnmH·pm0HRR(t)]  
• Number of RS rams RSHtoC = max[0,NGmH·h0HRS(t)-NnmH·pm0HRS(t)]  
• Number of R carrier rams RcarHtoC = RRHtoC+RSHtoC 
• Number of SS rams SSHtoC = NGmH·h0HSS(t)-NnmH·pm0HSS(t)] 
Whatever the BP type (1 or 2), the dissemination rules depend on the relative value of the CF 
replacement needs potentially covered by the HGMF (difrate·NnmC) and the availability of RR and/or 
RS rams (DispHtoC = RRHtoC, RSHtoC, RcarHtoC). In TypeDI1 and TypeDI2, the maximum 
proportion of new CF rams born in HGMF (DispHtoC/NnmC) may be less than difrate. In these 
situations, the dissemination rate was adjusted accordingly: difrate = min[difrate,DispHtoC/NnmC]. 
TypeDI1: Only RR males are sent from the HGMF to the CF 
The number of RR rams available for diffusion RRHtoC was compared to the number of new HGMF 
rams needed in the CF:  difrate·NnmC. When the number of available RR rams was insufficient to 
cover the needs, the diffusion rate was adjusted accordingly: difrate = min[difrate,RRHtoC/NnmC]. 
pm0CRR(t) = difrate+(1-difrate)·h0CRR(t) 
pm0CRS(t) = (1-difrate)·h0CRS(t) 
pm0lCSS(t) = (1-difrate)·h0CSS(t) 
When the number of RR rams available for diffusion (RRHtoC) was negative, the previous equation 
was used, with difrate=0. 
TypeDI2: Only R carriers (RR or RS) are sent from the HGMF to the CF.  
When the number of RR rams available for diffusion (RRHtoC) is higher than the replacement need 
(difrate·NnmC), only homozygous rams are sent to the CF  
pm0CRR(t) = difrate+(1-difrate)·h0CRR(t) 
pm0CRS(t) = (1- difrate)·h0CRS(t) 
pm0lCSS(t) = (1- difrate)·h0CSS(t) 
When the inequality RRHtoC < difrate·NnmC < RcarHtoC holds, all available RR rams and only a 
fraction of RS rams are sent to the CF, giving: 
pm0CRR(t) = RRHtoC/NnmC+(1-difrate)·h0CRR(t) 
pm0CRS(t) = (difrate·NnmC-RRHtoC)/NnmC+(1-difrate)·h0CRS(t) 
pm0lCSS(t) = (1-difrate)·h0CSS(t) 
When the number of Rcarrier rams available for diffusion (RcarHtoC) is lower than the replacement 
need (difrate·NnmC), the previous equations are used after adjustment of difrate:  difrate = 
min[difrate,RcarHtoC/NnmC]. 
TypeDI3: Rams sent from the HGMF to the CF are selected on their PRNP genotype with a 
decreasing preference from RR to SS. 
When the number of RR rams available for diffusion (RRHtoC) is higher than the replacement need 
(difrate·NnmC), only homozygous rams are sent to the CF  
pm0CRR(t) = difrate+(1-difrate)·h0CRR(t) 
pm0CRS(t) = (1-difrate)·h0CRS(t) 
pm0lCSS(t) = (1-difrate)·h0CSS(t) 
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When the inequality RRHtoC < difrate·NnmC < RcarHtoC hold, all available RR rams and only a 
fraction of RS rams are sent to the CF, giving: 
pm0CRR(t) = RRHtoC/NnmC+(1-difrate)·h0CRR(t) 
pm0CRS(t) = (difrate·NnmC-RRHtoC)/NnmC+(1-difrate)·h0CRS(t) 
pm0lCSS(t) = (1-difrate)·h0CSS(t) 
When the number of R carrier rams available for diffusion (RcarHtoC) is lower than the replacement 
need (difrate·NnmC), SS individuals are sent to the CF and the equations become: 
pm0CRR(t) = RRHtoC/NnmC+(1-difrate)·h0CRR(t) 
pm0CRS(t) = RSHtoC/NnmC+(1-difrate)·h0CRS(t) 
pm0lCSS(t) = difrate-RcarHtoC/NnmC+(1-difrate)·h0CSS(t) 
TypeDI4: Rams sent from the HGMF to the CF were not selected on their PRNP genotype but 
randomly chosen according to this criteria.  
pm0CRR(t) = difrate·RRHtoC/NpmHtoC+(1-difrate)·h0CRR(t) 
pm0CRS(t) = difrate·RSHtoC/NpmHtoC+(1-difrate)·h0CRS(t) 
pm0lCSS(t) = difrate·SSHtoC/NpmHtoC+(1-difrate)·h0CSS(t) 
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Figure 17:  Diagram summarising the structure of the deterministic model. Boxes in red represent the 
main outputs of the model. After a first run of the model, the parameter ‘rate’ is estimated by trial and 
error to force the model to fit the observation, and the model is run again (see text for details). 
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Results of the model 
This section reports detailed results of the deterministic model, when applied to the eleven MSs for 
which an analysis was done to compare the effectiveness of their BP-CSs to the trend of CS from 2002 
to 2012. 
Tables 10 and 11 report the input and output parameters of the deterministic model for the different 
MSs. 
A short discussion of the results of the model is provided for each country, together with information 
on some aspects of the BP-CSs. Figures 18 and 19 show the evolution of the ARR frequency in 
HGMF and CF as estimated by the deterministic model. 
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Table 10:  Parameters used and results estimated by the deterministic model (countries with a statistically signficant decreasing trend of CS). Parameters in 
bold are obtained from the answer by MSs to the questionnaire ‘Breeding programmes’ (see Appendix A.3), or estimated based on information provided in the 
questionnaire. Parameters preceded by * are outputs of the model. 
Parameter Abbreviation Calculation CY FR IE NL SI UK (GB) 
Number of females in HGMFa NfH 304894 536466 127933 66713 13111 7690000 
Number of males in HGMF NmH NfH/SR 7622 13412 3198 1668 328 192250 
Number of needed new males in HGMF / year NnmH NmHxRRM 2541 4471 1066 556 109 64083 
Number of needed new females in HGMF / year NnfH NfHxRRF 60979 107293 25587 13343 2622 1538000 
Number of males produced in HGMF / year NpmH NfHxFtoM 51832 91199 21749 11341 2229 1307300 
Number of available males for CF NpmHtoC NpmH-NnmH - 86728 20683 10785 2120 1243217 
Average number of genotypings / year NG   86750 70300 9418 26900 3649 700000 
Proportion of genotypings performed in HGMF propH   1 1 0.97 1 1 1 
Proportion of genotypings performed in males propM   0.6 0.5 0.53 0.42 0.15 0.2 
Number of genotyped HGMF males / year NGmH NGxpropHxpropM 52050 35150 4842 11298 547 140000 
Number of genotyped HGMF females / year NGfH NGxpropHx(1-propM) 34700 35150 4294 15602 3102 560000 
Number of genotyped males available for CF NGmHtoC NGmH-NnmH - 30679 3776 10742 438 75917 
Ratio of new males genotyped to males needed for replacement rnmG NGmH/NnmH 20.48 7.86 4.54 20.32 5.02 2.18 
Ratio of new females genotyped to females needed for 
replacement rnfG NGfH/NnfH 0.57 0.33 0.17 1.17 1.18 0.36 
Rate  rate   1.00 0.22 0.28 1.00 0.50 1.00 
Males selection rate without extra selection   NnmH/NGmH 0.049 0.13 0.22 0.049 0.20 0.46 
Males selection rate considering extra selection qmH NnmH/(NGmHxrate) 0.049 0.58 0.79 0.049 0.40 0.46 
Number of females in CFb NfC   - 5004683 3430300 1267500 73424 7510000 
Population size ratio HtoC NfH/NfC - 0.11 0.04 0.053 0.18 1.02 
Number of needed new males in CF / year NnmC NfC/120 - 41706 28586 10563 612 62583 
Max proportion of replacement males from HGMF / year propnmHtoC NpmHtoC/NnmC - 2.08 0.72 1.02 3.46 19.87 
Max proportion of dissemination new males genotyped   NGmHtoC/NnmC - 0.74 0.13 1.02 0.72 1.21 
Initial observed ARR/ARR frequency in HGMF (year) ifRRH   0.16 (2004)c 0.26 (2002) 0.62 (2004) 0.17 (2005)d 0.14 (2006)e 0.29 (2002) 
Initial observed ARR frequency in HGMF (year) ifRH   0.40 (2004)c 0.49 (2002) 0.86 (2004) 0.38 (2005)d 0.38 (2006) 0.50 (2002) 
Final observed ARR/ARR frequency in HGMF (year) ffRRH   0.76 (2012)c 0.72 (2012) 0.84 (2012) 0.52 (2013)d 0.13 (2011) 0.54 (2008) 
Final observed ARR frequency in HGMF (year) ffRH   0.99 (2012)c 0.85 (2012) 0.998 (2012) 0.70 (2013)d 0.55 (2011) 0.69 (2006) 
*Final adjusted potential ARR/ARR frequency in HGMF (year) affRRH   -c 0.77 (2013) 0.87 (2013) 0.88 (2013)d 0.46 (2013) 0.76 (2013) 
*Final adjusted potential ARR/ARR frequency in CF (year) affRRC   0.75 (2013)c 0.50 (2013) 0.62 (2013) 0.50  (2013)d 0.20 (2013) 0.083 (2013) 
Relative estimated increase of ARR/ARR frequency in HGMF rifRRH (affRRH/ifRRH)-1 -c 1.96 0.4 0.45d 2.29 1.62 
Relative estimated increase of ARR/ARR frequency in CF rifRRC (affRRC/ifRRH)-1 3.69c 0.92 0.00 3.03d 0.43 -0.71 
a: Approximated as total HGMF population. b: Approximated as total CF population. c: In the case of CY, parameters ifRRH and ifRH have been obtained from answers from 2010 Commission questionnaire 
(see text section for CY for details). In CY there is no distinction of HGMF and CF, and the population is organised as a single-tier with respect to the BP-CS. Parameters affRRC and rifRRC are therefore 
referred to the whole population (HGMF+CF). d: In the case of NL, parameters ifRRH, ifRH, ffRRH, ffRH refer to the whole population (HGMF+CF), as reported in the answer to the questionnaire 
‘Breeding programmes’. The initial (2005) values for ARR/ARR frequency in HGMF and CF have been estimated as being 0.61 and 0.13 respectively (see text section for NL for details), which have been 
used to obtain parameters rifRRH and rifRRC. e: Value estimated from parameter ifRH because of a lack of consistency of the data provided with HWE. 
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Table 11:  Parameters used and results estimated by the deterministic model (countries with a trend of CS not different from a flat one). Parameters in bold 
are obtained from the answer by MSs to the questionnaire ‘Breeding programmes’ (see Appendix A.3), or estimated based on information provided in the 
questionnaire. Parameters preceded by * are outputs of the model. 
Parameter Abbreviation Calculation BE CZ IT SK ES 
Number of females in HGMFa NfH   32573 23217 529741 27184 2157070 
Number of males in HGMF NmH NfH/SR 814 580 13244 680 53927 
Number of needed new males in HGMF / year NnmH NmHxRRM 271 193 4415 227 17976 
Number of needed new females in HGMF / year NnfH NfHxRRF 6515 4643 105948 5437 431414 
Number of males produced in HGMF / year NpmH NfHxFtoM 5537 3947 90056 4621 366702 
Number of available males for CF NpmHtoC NpmH-NnmH 5266 3754 85641 4394 348726 
Average number of genotypings / year NG   733 4297 34734 3590 355214 
Proportion of genotypings performed in HGMF propH   1 1 0.42 1 0.91 
Proportion of genotypings performed in males propM   0.58 0.34 0.56 0.66 0.087 
Number of genotyped HGMF males / year NGmH NGxpropHxpropM 425 1461 8169 2369 28122 
Number of genotyped HGMF females / year NGfH NGxpropHx(1-propM) 308 2836 6419 1221 295122 
Number of genotyped males available for CF NGmHtoC NGmH-NnmH 154 1268 3754 2142 10146 
Ratio of new males genotyped to males needed for replacement rnmG NGmH/NnmH 1.57 7.57 1.85 10.44 1.56 
Ratio of new females genotyped to females needed for 
replacement rnfG NGfH/NnfH 0.05 0.61 0.06 0.22 0.68 
Rate     0.66 0.22 0.90 0.180 0.90 
Males selection rate without extra selection   NnmH/NGmH 0.64 0.13 0.54 0.096 0.64 
Males selection rate considering extra selection qmH NnmH/(NGmHxrate) 0.97 0.60 0.60 0.53 0.71 
Number of females in CFb NfC   153051 136107 6781000 391768 14451999 
Population size ratio HtoC NfH/NfC 0.21 0.17 0.08 0.07 0.15 
Number of needed new males in CF / year NnmC NfC/120 1275 1134 56508 3265 120433 
Max proportion of replacement males from HGMF / year propnmHtoC NpmHtoC/NnmC 4.13 3.31 1.52 1.35 2.90 
Max proportion of dissemination new males genotyped   NGmHtoC/NnmC 0.12 1.12 0.07 0.66 0.08 
Initial observed ARR/ARR frequency in HGMF (year) ifRRH   0.76 (2005)c 0.22 (2003) 0.23 (2005) 0.19 (2004) 0.11 (2003) 
Initial observed ARR frequency in HGMF (year) ifRH   0.87 (2005) 0.53 (2003) 0.47 (2005) 0.40 (2004) 0.28 (2003) 
Final observed ARR/ARR frequency in HGMF (year) ffRRH   0.79 (2012) 0.51 (2012) 0.50 (2013) 0.51 (2011) 0.25 (2012) 
Final observed ARR frequency in HGMF (year) ffRH   0.98 (2012) 0.85 (2012) 0.70 (2013) 0.40 (2011) 0.48 (2012) 
*Final adjusted potential ARR/ARR frequency in HGMF (year) affRRH   0.80 (2013) 0.57 (2013) 0.50 (2013) 0.59 (2013) 0.29 (2013) 
*Final adjusted potential ARR/ARR frequency in CF (year) affRRC   0.78 (2013) 0.44 (2013) 0.22 (2013) 0.32 (2013) 0.08 (2013) 
Relative estimated increase of ARR/ARR frequency in HGMF rifRRH (affRRH/ifRRH)-1 0.05 1.59 1.17 2.11 1.64 
Relative estimated increase of ARR/ARR frequency in CF rifRRC (affRRC/ifRRH)-1 0.03 1 -0.07 0.68 -0.27 
a: Approximated as total HGMF population. b: Approximated as total CF population. c: Value estimated from parameter ifRH because of a lack of consistency of the data provided with HWE. 
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A. Countries with a statistically significant decreasing trend in the prevalence of Classical 
scrapie 
Cyprus 
The population 
The sheep population in Cyprus consists of about 305 000 sheep (about 2 000 flocks).  18.7 % of the 
animals are pure Chios, while most of the other animals are crossbred. 
The breeding programme 
The Cyprus situation is very particular since all flocks are involved in the BP-CS, without any 
distinction between HGMF and CF. The programme started on a small scale in 1999 with the creation 
of two governmental nucleus units which produced ARR animals for the industry. Since 2004, the BP-
CS was organized on a large scale, involving all flocks. Since 2008, it has been restricted to all rams 
only. 
No precise information about the repartition of genotype data between males and females was 
available, even if it was clear that females were genotyped both for flock qualification and mating 
purposes. With a mean of 86 750 genotypings performed each year since 2004, there was clearly the 
opportunity to genotype females. The worst scenario was considered in the model (i.e. genotyping all 
available males, meaning 59.8 % of the genotyping effort). 
The genotyping programme allows a very strong selection of the replacement males on their PRNP 
genotype (qmH = 0.050), and a weak selection of females (neglected in the modelling). 
As described in the questionnaire, breeders are obliged to genotype all their rams, and only use 
ARR/ARR as reproducers. An auditing system exists, and the rules are considered as fully followed. 
From the information provided by Cyprus to the European Commisson in 2010, 15.9 % (n = 5308) of 
the genotyped animals in 2004 were ARR/ARR, 48.6 % (n = 16 240) were ARR/X, giving an ARR 
allele frequency of 40.2 %. The HWE is therefore respected. 
From this information, the model predicts 100 % of ARR allele and 68 % of ARR/ARR genotypes in 
2012. The first figure is in agreement with the evolution observed and reported in the questionnaire 
‘Breeding programmes’. Nevertheless, the 68 % genotype frequency is less than the 76.4 % observed 
in practice. This last reported frequency is surprising since it leads to a strong divergence from HWE 
(even if all non-ARR/ARR animals were ARR/X, this would give an ARR allele frequency of 88 %). 
The numbers of analyses performed each year are very large, and a sampling error seems very 
improbable. Globally the results obtained suggest that the rules of the BP-CS, as described in the 
responses to the questionnaire ‘Breeding programmes’, were fully implemented, with an optimal effect 
at population level. 
France 
The population 
The total number of ewes is more than 5.5 million. There are a large number of breeds (54), five of 
them being bred for milk production, and half of the others being of very limited population size.   
The breeding programme in HGMF 
Selection for CS resistance started in 2002 and was organized on a large scale with the help of the 
state. It is still running. The BP-CS focuses on HGMF, on which a very large proportion of the 
genotyping was performed. Compulsory rules were established for the replacement of HGMF 
reproducers, and more recently for dissemination to the CF. 
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All the males used for replacement in the HGMF are genotyped, and the possible selection rate on 
PRNP genotype is large. According to the rules, only ARR/ARR rams are selected in HGMF, 
classifying the BP-CS as TypeBP1. 
The initial allelic and genotypic frequencies are consistent with HWE. The observed frequency after 
11 years of selection is below the predicted one. An extra selection rate of 22 % gives the correct 
adjustment.  
Dissemination to the whole population 
The relative size of the two tiers only allowed a full dissemination of genes from HGMF to the CF in a 
selection of 50 % of flocks. From the questionnaire, 50 % of the flocks introduced rams from the 
HGMF. The model was run with this hypothesis, considering a selection rate of 0.22 on unknown 
traits in HGMF, and assuming that half of the replacement males are ARR/ARR rams from HGMF.  
The evolution of the ARR/ARR frequency in the CF is very limited. 
Ireland 
The population 
The sheep population is large (3.4 million ewes), shared between 25 breeds, with 1 200 HGMF  and 
31 176 CF. The number of HGMF ewes was not given in the responses to the questionnaire ‘Breeding 
programmes’, and was assumed to be proportional to be number of flocks, giving around 130 000 
individuals. 
The breeding programme in HGMF 
Selection for CS resistance started in 2004 on a voluntary basis, with subsidies from the Department of 
Agriculture Fisheries and Food (DAFF) regardless of whether flocks were HGMF or CF. The DAFF 
contribution was cancelled in 2006 or 2007, with a concomitant large decrease of genotyping effort. 
The number of sheep being genotyped has fallen from 26 178 in 2005 to 601 in 2012. Even if limited 
in some years, the number of genotypes produced/year in HGMF was sufficient to largely cover the 
needs for replacement. 
Thus, all the males used for replacement in the HGMF were genotyped, and the possible selection rate 
on PRNP genotype was large. As no compulsory rules were imposed on the breeders, the hypothesis 
of a real selection on PRNP (TypeBP1) is optimistic. 
Genotypic frequencies were 62 % ARR/ARR at the beginning (2004) and 84 % at the end (2012), 
while allelic frequencies were 86 % (2004) and 99.8 % (2012). These frequencies were provided for 
the whole population included in the BP-CS, without distinction between HGMF and CF. However, 
since over 97 % of the genotypings were performed in HGMF vs. less than 3 % in CF, it was assumed 
that the starting frequencies could represent the situation in HGMF, and these values were therefore 
used as inputs of the model. The model results are roughly consistent with this observation, an extra 
selection rate of 0.28 giving a very good fit. 
Dissemination to the whole population 
The relative size of the two tiers did not allow a complete replacement of commercial rams by HGMF 
animals. As a consequence, there is a lag between the two tiers. The replies to the questionnaire do not 
provide specific information about the rate of dissemination (proportion of new rams in the CF born in 
HGMF). 
The model was run assuming an extra selection rate of 0.28 in HGMF and, either a full replacement or 
half of the replacement in CF from the HGMF. Even with all these constraints, the evolution of the 
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ARR/ARR frequency in the CF is noticeable, but still far from establishing the R allele in this 
population. 
The Netherlands 
The population 
The sheep population comprises 1 334 000 ewes, 5 % of them belonging to HGMF. The most 
numerous breed is the Texel, but many other breeds (67)  are present.  
The breeding programme in HGMF 
Selection for CS resistance started in 1998 on a voluntary basis, became compulsory in 2004, and 
continued up to 2007 when it moved to being voluntary. The general idea is that rams must be 
ARR/ARR, with some variability in the way this is applied from breed to breed. 
Information on several questions provided in the questionnaire was lacking, and therefore it was 
difficult to obtain a clear picture on certain aspects of the situation in the country. 
The allelic and genotypic frequencies were given for the whole population, not separating HGMF and 
CF tiers. An additional adjustement of the data was therefore made to estimate values for HGMF and 
CF. Given the global allelic frequency in 2005 (0.375) and the relative sizes of the two tiers (5 % for 
HGMF and 95 % for CF), the frequencies of the ARR allele in the two tiers in 2005 (fARR(HGMF) 
and fARR(CF)) were chosen to obtain a model output fitting the observation in 2013, as follows: 
- 0.05·fARR/ARR(HGMF)+0.95·fARR/ARR(CF) = 0.524, given that: 
- 0.05·fARR(HGMF)+0.95·fARR(CF) = 0.375 in 2005. 
On average, 26 900 genotypes were obtained per year. There is no information about their repartition 
between HGMF and CF, or between males and females. To run the model, it was assumed that all 
rams produced were genotyped, meaning 42 % of genotyping for males. 
The number of genotyped males allows a very strong selection of replacement rams. 
The allelic and genotypic frequencies are roughly consistent with the HWE. 
The model was run assuming no selection on the female path but a full selection for the male path.  
Dissemination to the whole population 
The relative size of the two tiers only allows a full dissemination of genes from HGMF to the CF 
when there is no selection of rams moving to the lower tier. The model was run with this hypothesis, 
assuming a dissemination of ARR/ARR rams only. As the number of ARR/ARR rams in the HGMF is 
not sufficient to provide  full replacement of rams  in the CF, only a part of the replacement comes for 
HGMF during the first years. 
Slovenia 
The population 
The sheep population is small (86 000 ewes), with 5 pure breeds, the most abundant being Bela 
Krajina Pramenka and Istrian Pramenka, and a number of crossed animals. 
The breeding programme in HGMF 
The BP-CS started in 2005. It is mostly based on HGMF, and the CF make profit of the progresses 
through the dissemination of good rams. Breeders’ participation is voluntary, with expenses covered 
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by the State. The main principle is the elimination of NSP4 and NSP5 rams, and a limited use of NSP3 
rams. An auditing system controlled by official authorities exists. The rules are followed by 70-80 % 
of HGMF breeders and 30-40 % of CF breeders.  
The number of genotyped rams is above the replacement needs, allowing a selection on PRNP. 
However, only 15 % of the genotyping effort is targeted to males, lowering its effectiveness. 
The initial frequencies are not consistent with HWE. The limited sample sizes may be an explanation. 
The model was run with the allele frequency value, and assuming that the genotype frequencies 
followed HWE. 
Comparing the results of the model and the data provided in the questionnaire, the selection of PrP 
genotypes is much lower than expected. An extra selection on other traits with a 0.50 rate was 
assumed for the rams. 
Dissemination to the whole population 
The relative size of the two tiers allowed a complete replacement of CF rams by HGMF animals. 
However, the dissemination rate was limited to 20 %, as indicated in the questionnaire ‘Breeding 
programmes’. As a consequence, independently of the extra selection rate considered, the evolution in 
the commercial flocks is not as good as possible, reaching only 20 % ARR/ARR in 2013. 
United Kingdom (Great Britain) 
The population 
The British sheep population is very large (15.2 million animals). It includes about 100 breeds, 13 of 
which have a significant population size and represent 50 % of the total, and crossbred animals. The 
HGMF population is about 50 % of the entire population. 
The breeding programme in HGMF 
The BP-CS started in 2001 and stopped in 2009. It was mostly based on HGMF, i.e.  pure breeds,  and 
dissemination of males. The specificity of the British ovine industry is the large proportion of 
crossbred animals. As a result, the British HGMF population is extremely large (more than 7.5 million 
ewes). The BP-CS consisted of the PRNP genotyping of all males in the population, with an 
elimination of VRQ carriers. 80 % of the genotyping was performed on ewes, with a limited impact on 
the genetic progress.  
Rams were classified with the NSP system and a selection favouring the most resistant classes was 
given as a rule. 
These rules were compulsory, with an auditing system monitored by the NSP administration center. 
The number of rams genotyped were above the replacement needs, allowing some selection on PRNP. 
Despite the very amount of genotyping, because only a small fraction is performed on the males the 
selection pressure is limited, with about half of the genotyped rams kept for replacement. 
The initial frequencies are consistent with HWE. The final ARR allele and ARR/ARR genotype 
frequencies are consistent.  
The results of the model fit well with the observed and do not suggest that  selection was based on 
other factors.  
 
  
Scrapie situation in the EU
 
EFSA Journal 2014;12(7):3781 149
The dissemination to the whole population 
The size of the HGMF population is huge compared to the CF. This is due to the definition of HGMF 
in the British context. No rules were in place for the dissemination (TypeDI4). This dissemination 
system, coupled with the hypothesis that 70 % of the CF rams came from HGMF, had a negative 
effect during the first years of the BP-CS, with a decrease of resistance in the CF. This is due to the 
fact that most of the resistant animals were selected for the HGMF replacement, leaving mostly 
susceptible rams for the dissemination process. The initial ARR/ARR frequency will  recover only in 
2016 and real progresses should be observed only after this date. It is interesting to note that, despite 
the cancellation of the BP-CS in 2009, the CF is still progressing in terms of favorable allele 
frequency. 
B. Countries with a trend in the prevalence of Classical scrapie not statistically different 
from a flat one 
Belgium 
The population 
The sheep population in Belgium consists of about 185 000 sheep (about 26 000 flocks). 
The breeding programme in HGMF 
The BP-CS started in 2005. It is still running and concerns only HGMF. On average, 733 genotypes 
were obtained per year, including both males and females. Ewes were genotyped for qualification of 
flocks and mating purposes. Rules for the selection and use of ARR/ARR rams exist, but on a 
voluntary basis, and are the basis for flock status classification An auditing system exists, monitored 
by the breeders organisations and the authorities. 
The genotyping programme allows some selection of the replacement males on their PrP genotype, but 
nearly no selection of females (VRQ elimination is marginally feasible).  
The initial allelic and genotypic frequencies are inconsistent with HWE  (0.87·0.87 = 0.76, which is 
inconsistent with the reported value of 0.42). Previous information collected by the European 
Commission in 2010 indicated an earlier starting year for the BP-CS (2004), which  suggests that 
some selection may have occurred before 2005.  
The model was run assuming no selection on the female path but a full selection for the male path 
(selection rate 64 %, no deviation from the voluntary rules). After eight years of selection, the 
modelling of PRNP evolution reaches an end point of 100 % ARR for the young males whatever the 
starting point (0.42 or 0.76). An extra limited selection (rate = 0.655) adjusts the simulation to the 
observation.  
However, the situation is polymorphic. About 60 % of the genotyping concerned the Texel breed. It 
may be that in some minor breeds the selection rate and rules were different, giving another final state. 
The dissemination to the whole population 
The size of HGMF was sufficient for a full dissemination of genes from HGMF to the CF. From the 
questionnaire ‘Breeding programmes’, in HGMF following the voluntary plan, all rams sold are 
ARR/ARR, and this is followed by all breeders in the major breeds. It must be concluded that only a 
maximum of 12.1 % of the males needed are provided to the commercial tier by the HGMF, all being 
ARR/ARR. The model was run assuming that only ARR/ARR rams were sold to the commercial tier, 
with no selection on the female path. After seven years of BP-CS, the model does not predict any 
change in the ARR/ARR frequency in the CF. 
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Czech Republic 
The population 
There are 25 different breeds in Czech Republic, the most important being the Suffolk (26 % of the 
total population), Romney Marsh (16 %) and Suvama sheep (11 %).  
The breeding programme in HGMF 
The rules of the BP-CS are applied more strictly for the major breeds than for the minor ones. 
The BP-CS started in 2003, is still running, and concerns only HGMF. The principle of the plan is to 
increase ARR with a selection of rams belonging to risk groups I and II, elimination of those from 
groups IV and V. The situation for Risk group III depends on the breed. 
On average, 4 297 genotypes were obtained per year, from both males and females. Ewes were 
genotyped for mating purposes.  
The genotyping programme allows a very strong selection of the replacement males based on their 
PRNP genotype, and a weak selection of females (which is not included in the model). 
The initial allelic and genotypic frequencies are consistent with HWE. This is not the case for the final 
frequencies. 
The model was run assuming no selection on the female path but a full selection for the male path 
(selection rate 13 %, no deviation from the voluntary rules). After 11 years of selection, the modeling 
of PrP evolution reaches an end point of nearly 100 % ARR and 84 % ARR/ARR. This is very 
optimistic as compared to the sampling result, suggesting that selection on traits is independent from 
selection on PRNP occurring after genotyping. The observed evolution only fits the modelled one 
when an extra strong selection rate of 0.184 is applied to the rams. 
The dissemination to the whole population 
The size of HGMF was sufficient for a full dissemination of genes from HGMF to the CF. From the 
replies to the questionnaire ‘Breeding programmes’, in HGMF following the compulsory plan, rams 
sold should belong to Risk groups I and II with exception for group III depending on the breed. This 
suggests that the required  number of rams could come from HGMF to the CF. The model was run 
with this hypothesis. The number of rams available for dissemination to the commercial tier being 
very large, the evolution in this subpopulation is not far from the evolution in the HGMF. 
Italy 
The population 
The sheep population in Italy comprises 7.3 million ewes, in about 95 000 flocks, with about 10 
different breeds participating in the BP-CS. The HGMF population is about 7 % of the entire 
population. 
The breeding programme in HGMF 
The BP-CS started in 2005. It is not based on HGMF, and all flocks may be involved in the scheme. 
The BP-CS for the Sarda breed in Sardinia is an exception (see Appendix E). Rams and flocks are 
classified in categories: classes I (highest genetic resistance) to class IV (lowest genetic resistance) for 
rams, and level I (highest genetic resistance) to level IV (lowest genetic resistance) for flocks.  
The BP-CS is based on rules defining the type of rams to be used, depending on the initial ARR 
frequency of the breed.  
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A maximum of a third of males used for replacement were genotyped (assuming no selection of these 
males). When selection occurs, a case expected in the BP-CS, this proportion decreases. Considering 
this point and the description provided, the BP-CS was classified as TypeBP2. 
The Initial ARR frequency was given as fARR= 0.41 at the global level in the first questionnaire, with 
some variability between breed (from 0.13 in Biellese to 0.56 in Merinizatta). No information was 
provided about the final frequencies. 
The model slightly overestimated the effect of nine years of selection, an extra selection rate of 90 % 
for other traits giving the correct adjustment. 
The expected improvement in the frequency of resistant alleles after eight years of selection is still 
very limited. 
The dissemination to the whole population 
The relative size of the two tiers did not allow a complete replacement of CF rams by HGMF animals, 
and a very small fraction of replacement rams are genotyped. From the qualitative analysis it seems 
that poor dissemination would make the BP-CS effective only in the longer term, and no positive 
results would be expected to be visible at present. However, the impact of genotyping in CF was not 
modelled.  
Slovakia 
The population 
The sheep population (417 000 ewes) comprises 34 breeds, 4 of them (Zoslachtena valaska, Cigaja, 
Lacaun and Merino) representing more than 80 % of the total. The HGMF population is about 6.5 % 
of the entire population. 
The breeding programme in HGMF 
The BP-CS started in 2004, and is based on HGMF. Compulsory rules, with an official auditing 
system, define the structure of the BP-CS. Genotypes are classified in groups based on the resistance 
to CS, and range from Group I (highest resistance) to Group V (lowest resistance). The BP-CS 
includes detailed rules for the selection and use of rams. The number of genotyped rams is far above 
the replacement needs, allowing a strong selection based on PRNP. 
The initial frequencies are consistent with HWE; however the final ARR allele and ARR/ARR 
genotype frequencies are not consistent with HWE. 
The results of the model indicates a strong selection for other factors. An extra selection rate of 0.18 
gives a good fit for the observed evolution of resistance. 
The dissemination to the whole population 
The relative size of the two tiers did not allow a complete replacement of CF rams by HGMF animals. 
The dissemination type was considered to beTypeDI2. Applying these hypotheses, the modelled 
ARR/ARR frequency reached about 32 % in 2013. 
Spain 
The population 
The Spanish sheep population is very large (16.6 million animals in 112 000 flocks), with 50 different 
breeds. 
The breeding programme in HGMF 
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The BP-CS started in 2003. Initially compulsory, it has become voluntary since 2013. It is mostly 
based on HGMF. A specificity of the programme is that a very high proportion of the genotyping 
effort is applied to females (91.25 %). Nevertheless, the BP-CS includes rules for the selection and use 
of rams, with a classification into three groups, depending on the genotypes, and ranging from Group I 
(highest resistance) to Group III (lowest resistance). 
These rules are compulsory rules, but their application is left to breeding associations, without any 
official auditing system. 
The number of rams genotyped is above the replacement needs allowing some selection on PRNP. 
Despite the very extensive genotyping programme, the selection pressure is rather low (0.636) because 
only a small fraction is performed on the males.  
The initial frequencies are consistent with HWE. The final ARR allele and ARR/ARR genotype 
frequencies are also consistent.  
The results of the model fit well with the observed data (extra selection rate of 0.9 on production 
traits), showing that the effects of the BP-CS are only now starting to be visible. 
The dissemination to the whole population 
The relative size of the two tiers allowed a complete replacement of CF rams by HGMF animals. 
However, only a very small fraction are genotyped, and, considering the rules of dissemination, this 
TypeDI2 dissemination system is not efficient in terms of PRNP genotype evolution. 
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Figure 18:  Evolution of the ARR/ARR frequency in HGMF and CF as estimated by the deterministic model (countries with a statistically signficant 
decreasing trend of CS). For The Netherlands, the starting frequency for HGMF and CF is different, since an ad hoc adjustment of the model was needed to 
estimate those values from the available frequency value, related to the whole population (see text for details). 
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Figure 19:  Evolution of the ARR/ARR frequency in HGMF and CF as estimated by the deterministic model (countries with a trend of CS not statistically 
different from a flat one). 
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ABBREVIATIONS 
Member States of the European Union 
AT Austria 
BE Belgium 
BG Bulgaria 
CY Cyprus 
CZ Czech Republic 
DE Germany 
DK Denmark 
EE Estonia 
EL Greece 
ES Spain 
FI Finland 
FR France 
HR Croatia 
HU Hungary 
IE Ireland 
IT Italy 
LT Lithuania 
LU Luxembourg 
LV Latvia 
MT Malta 
NL Netherlands 
PL Poland 
PT Portugal 
RO Romania 
SE Sweden 
SI Slovenia 
SK Slovakia 
UK United Kingdom 
 
